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Glossary  
Acute Coronary Syndrome A sudden onset of chest pain due to a 
narrowing or blockage in one of the coronary 
arteries 
 
Acute Coronary Syndrome with 
Low Troponin 
 
As above, but with small amounts of damage 
below the cut off point for MI 
 
Bundle Branch Block  
 
 
A defect of the heart’s electrical system 
 
 
 
Cardiovascular disease This includes Coronary Heart Disease (about 
50%), stroke (25%), and all other diseases of 
the circulatory system 
 
Coronary Artery Bypass Graft  
 
An operation to bypass a section or sections 
of coronary arteries and improve blood 
supply to the heart 
 
Coronary Heart Disease Coronary Heart Disease occurs when the 
walls of the coronary arteries become 
narrowed by a gradual build-up of atheroma 
 
Co-morbidity  A state where an individual has two or more 
diseases 
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Dyspnoea Laboured or difficult breathing, otherwise 
known as breathlessness 
 
Fibrinolytic Therapy Patients are given a clot dissolving drug 
which reduces the damage that is caused by 
a Myocardial Infarction 
 
Heart Failure This occurs if the heart becomes less 
efficient at pumping blood around the body 
due to damage to heart muscle 
 
Hypertension High blood pressure, systolic blood pressure 
>140mmHg, diastolic blood pressure > 
90mmHg 
 
Incidence A measure of morbidity based on the number 
of new episodes of an illness in a population 
over a period 
 
Myocardial Infarction  Death of heart muscle (myocardium) which 
follows sudden reduction in or cessation of 
the flow of blood down the coronary arteries, 
can be either Non ST Elevation Myocardial 
Infarction  or ST Elevation Myocardial 
Infarction 
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Morbidity  A state of being diseased 
 
Mortality The incidence of death in a population in a 
given period 
 
Myocardial Ischaemia 
 
Myocardial ischaemia occurs when blood 
flow to the heart muscle is decreased by a 
partial or complete blockage of your heart's 
arteries 
 
Myocardial Necrosis  
 
Death of tissue due to general or local 
inadequacy of blood supply to the heart 
muscle 
 
Non ST Elevation Myocardial 
Infarction 
 
Myocardial Infarction, where all other 
indicators with the exception of ST elevation 
are present. 
 
Prevalence A measure of morbidity based on current 
sickness in the population at a particular time 
 
Percutaneous Coronary 
Intervention 
Normally includes coronary angioplasty and 
stenting as an arranged admission  
 
 
x | P a g e  
 
Primary Percutaneous Coronary 
Intervention 
Normally includes coronary angioplasty and 
stenting as an emergency in the hour 
following diagnosis of MI 
 
Primary Prevention The prevention of the development of a 
condition e.g. CHD, by avoidance of factors 
known to contribute to its development 
 
Secondary Prevention In CHD, interventions such as lifestyle 
changes or drugs aimed at prevention 
slowing or reversing the progression of the 
disease 
 
Stable Angina Term used for angina, which is relatively 
predictable and the intensity and frequency of 
which remains similar over long periods 
 
ST Elevation Myocardial 
Infarction 
Myocardial Infarction, where >1mm ST 
elevation is present on at least two limb leads 
or >2mm ST elevation is present in chest 
leads 
 
Troponin T 
 
An enzyme in the blood that can detect 
amounts of damage to the heart muscle  
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Abstract  
Background: Cardiac Rehabilitation (CR) has been shown to be effective in 
reducing mortality and morbidity in Coronary Heart Disease (CHD). There is a 
limited amount of research that evaluates the impact of menu-based CR, in 
patients with Acute Coronary Syndrome with Low Troponin levels (ACSLT).  
Aim: This thesis contains a feasibility study and an exploratory study. The 
feasibility study aimed to examine the feasibility of a Randomised Controlled 
Trial (RCT) which would test the impact of a menu-based CR programme, on 
individuals diagnosed with ACSLT, against standard care. This feasibility study 
included staff views. The exploratory study aimed to explore the impact that 
ACSLT and CR can have on this client group.  
Method: The feasibility study was a repeated measures case-control trial of 
menu-based CR based on the theoretical framework of the Common Sense 
Model of Self-Regulation (CSM), using a range of health assessments. The 
areas assessed included misconceptions, symptoms, anxiety, depression and 
Health Related Quality of Life (HRQoL). In addition, focus groups were held with 
both ward and specialist CR staff to seek their views on the feasibility of a RCT 
of menu-based CR for ACSLT.  
The exploratory study consisted of description and analysis of the data that 
had been collected from the participants over the two year period as above. In 
addition it included qualitative data that had been collected during interviews 
with the participants. 
Findings: Participants (n=33) were recruited from cardiology wards following an 
admission with ACSLT.  They were assessed at baseline  (T1), nine months (T3) 
and 24 months (T4). Twenty-five participants completed the studies.  The 
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feasibility study was successful in its aim of testing the CR intervention and 
protocols for a further RCT. The intervention was acceptable to the participants 
and to the specialist staff, although the ward staff did not see the need for a 
RCT. The measures used, with the exception of the self-reporting measures, 
were suitable and provided a wide range of data that could be utilised in a RCT. 
However the changes to diagnostic categories meant that a RCT would no 
longer be feasible.  
The exploratory study found that both groups were similar on a range of 
baseline demographic and clinical factors. There was a tendency to benefit 
within the exploratory study which favoured the intervention. An additional 
finding from the exploratory study was the degree of uncertainty experienced by 
the participants, within the context of a changing political and clinical landscape.   
Discussion and conclusions: The studies presented in this thesis add to our 
knowledge by highlighting some of the difficulties in designing a RCT of menu-
based CR in a specific subgroup of CHD and by presenting outcome data for a 
small group of participants that have not previously been studied within the 
literature. This data suggests that there was a tendency to benefit for the 
intervention that requires further study.  
Implications for practice: Patients with ACSLT are now being included in CR 
programmes due to the changes within the diagnostic criteria. Clinicians have 
little understanding of the impact of CR on this group of patients, or what type of 
interventions would work best. Large RCT’s will however be problematic and 
this thesis has highlighted that further work is required to explore how CR can 
best improve the well-being of individuals with ACSLT. 
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Chapter One Introduction & overview of thesis 
1.1 Introduction  
This chapter briefly outlines the rationale for the focus on this area of clinical 
practice and the organisation of this thesis, which contains: a feasibility study 
and an exploratory study. The feasibility study aimed to examine the feasibility 
of a Randomised Controlled Trial (RCT) which would test the impact of a menu-
based Cardiac Rehabilitation (CR) programme, on individuals diagnosed with 
Acute Coronary Syndrome with Low Troponin levels (ACSLT), against standard 
care. This feasibility study included staff views. The exploratory study aimed to 
explore the impact that ACSLT and CR can have on this client group.   
The research base for ACSLT relates mainly to medical treatment and there 
has been little attention paid to the impact that CR could have on this group of 
individuals. This thesis aims to contribute to the body of knowledge regarding 
CR and ACSLT and to inform future research design and service provision.  
1.2 Personal statement 
When I applied to start this clinical doctorate, I was asked a question about 
the gap between research and practice and how did I think it could be altered. 
The original answer I gave is lost in the mist of years of study. However this 
concept of a gap between research and practice remained crucial to the 
formulation and design of this thesis. Not only the gap in time between research 
being undertaken and its implementation in practice, or not, but also the fact 
that research is often not carried out in the areas that clinical practice currently 
requires.  
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From the time that I decided to enter nursing, I had no doubt that I wanted to 
work within cardiology.  I came from a family where the impact of Coronary 
Heart Disease (CHD) is well recognised.  Following my training, I have spent 26 
years within the speciality, as a staff nurse, specialist nurse and latterly as a 
consultant nurse. I have progressed from someone who provides care for this 
group of patients, to someone who influences policy and service development 
through my participation in local, regional, and national forums. I have been 
involved in standard setting and benchmarking exercises in cardiology 
throughout the National Health Service (NHS) in Scotland.  But, despite this 
progression and slight change of focus in my career, I have remained 
committed to ensuring that the best possible care is provided for the individuals 
within my caseload and that this care is based on the emerging evidence base. 
However, I have also been aware that much of what we do in CR has a limited 
evidence base, and often we advise individuals based on clinical expertise 
alone.  
Clinical practice changes rapidly and is based on a pragmatic approach to 
the situation that clinical teams find themselves in. Choices are made, about 
what works well and what doesn’t, using feedback systems from individuals and 
clinical staff.  In addition, clinical teams have to respond to policy changes and 
this does not always closely follow the research base. This is very apparent in 
CR, where the research base focuses primarily on Myocardial Infarction (MI) 
and Coronary Artery Bypass Grafts (CABG) with a smaller research base for 
other cardiac diagnoses. Yet clinical teams committed to the specialty, voluntary 
organisations and individuals who have undergone CR and have felt the benefit, 
have managed to influence opinion and alter policy. This is reflected in both the 
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National Service Framework for CHD (DOH 2000) and the CHD and Stroke 
Strategy for Scotland (SGHD 2009a). These strategies go beyond the evidence 
base and health professionals must now look to develop services for groups not 
previously offered CR.  At the time these strategies were developed, there had 
been limited research on the impact comprehensive CR can have on groups, 
such as the elderly, ethnic minority groups, women and particularly on clients 
with other cardiac diagnoses. I had been involved in, and supportive of, the 
strategies and was clearly aware that they posed significant challenges to CR 
clinicians in providing evidenced based care. In summary, this conflict between 
my role in policy and my role as an evidenced based practitioner is key to the 
way in which I developed this thesis. 
1.3 Background 
Cardiovascular disease (CVD) refers to any disease that affects the 
cardiovascular system, principally CHD, vascular diseases of the brain and 
kidney, and peripheral arterial disease. Cardiovascular diseases remain the 
biggest cause of deaths worldwide.  An estimated 17.3 million people died from 
CVD in 2008 yet 80% of these deaths were preventable (WHO 2012).  
The most common form of CVD is CHD. An estimated 7.3 million people 
died of CHD worldwide in 2008 (WHO 2012).  In Europe, CHD accounts for an 
estimated 1.95 million deaths each year and is the most common cause of 
death in the UK, with a total of 88,000 deaths attributed to CHD in 2008 (British 
Heart Foundation (BHF) 2012b). Scottish CHD mortality is amongst the highest 
in Western Europe (Tunstall-Pedoe et al 1999). Significant attention has been 
paid over recent decades to reducing mortality and morbidity from CHD.  There 
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have been a wide range of treatments developed to minimise the damage and 
impact of the disease process. These include the introduction of thrombolysis in 
the 1980’s, the development of a range of secondary prevention drugs such as 
aspirin, beta-blockers, statins and ace-inhibitors, and the more recent 
development of primary angioplasty (PPCI) across most of Scotland (SGHD 
2009a). New diagnostic techniques have allowed clinicians to pick up a wider 
range of damage to heart muscle and this has led to changes in diagnostic 
categories over the last ten years. This improved ability to detect disease has 
allowed clinicians to introduce preventative strategies at a far earlier stage in 
the development of CHD. Increasingly, methods of risk assessment such as 
Framingham (D’Agostino et al 2001) or ASSIGN (Woodward et al 2007) are 
being used to guide prevention strategies. These have focused on the 
modifiable risk factors of smoking, hypertension, lack of physical activity, diet 
and blood cholesterol, with more recent focus on psychosocial risks such as 
depression and deprivation.  All of these improvements have led to a reduction 
in deaths from CHD in Scotland of 60% over the last ten years (ISD 2011).  
The research suggests that modification of currently known risk factors has 
the potential to prevent most premature cases of MI worldwide (Yusuf et al 
2004). Deaths and rates of morbidity, from all forms of CHD, fell by at least 50% 
in most countries from about 1980 to 2000 (Capewell and O’Flaherty 2009). 
It has been argued that two-thirds of this decline can be attributed to a decrease 
in adverse events and reflects reductions in the prevalence of major risk factors. 
The remaining third is attributable to reduced case-fatality rates, owing mainly to 
treatments (Tunstall-Pedoe et al 1999).  However it is clear, from the evidence 
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above that any intervention designed to reduce the highlighted risk factors can 
have a significant impact on the health of the individual ith CHD.   
Cardiac Rehabilitation is one of the interventions designed to uti lise this 
evidence base and to improve the life of individuals following a cardiac event.  
It aims to return them to as normal a lifestyle as possible through exercise, 
education, support for behaviour modification, and attention to psychosocial 
factors (Bethell et al 2008). The evidence base for CR shows that there are 
large differences in the quality of evidence for the various components of such a 
complex intervention. The evidence base for the exercise component of CR is 
comprehensive and compelling. Although focusing in the main on MI, CABG 
and PCI, there is evidence that CR can have an impact on the physical health of 
participants with a variety of diagnoses through exercise. There is also some 
suggestion of benefit from psychological interventions within CR.  However this 
evidence base is currently ambiguous and there is a need for further research 
into misconceptions, anxiety, depression, and Health Related Quality of Life 
(HRQoL). The research base on the impact of educational interventions in CR is 
varied. There are some difficulties in differentiating the impact of education and 
psychological interventions within CR. There is a need therefore for further 
exploration of the role that menu-based CR can play in the care of individuals.  
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1.4 Cardiac Rehabilitation as a complex intervention  
Cardiac Rehabilitation is now a cornerstone in the recovery process for 
individuals with CHD. There are many definitions of CR around, however the 
Scottish Intercollegiate Guideline Network (SIGN) defined the key elements as:  
‘ the process by which individuals with cardiac disease, in partnership with a 
multidisciplinary team of health professionals, are encouraged and supported to 
achieve and maintain optimal physical and psychosocial health’ (SIGN 2002 p1) 
Increasingly, CR has been accepted by the United Kingdom (UK) and 
devolved governments as an essential component of care (DOH 2000, SIGN 
2002, NICE 2007).  
The evidence base for CR has gradually evolved over the last thirty years, 
with the first meta-analysis being completed in 1988 and latest meta-analysis 
being completed in 2011. This evidence base will be explored in greater detail 
in chapter 3. However, much of the evidence to date has been collected in the 
MI and CABG populations. Current healthcare policy in the UK argues that CR 
should be provided to a wider range of cardiac diagnoses, despite the limited 
evidence base (SIGN 2002). This is a challenging situation for clinicians and 
further research is needed to support clinical practice. 
Originally, CR services in the UK focused on exercise programmes alone. 
Standard CR had historically taken the form of a structured exercise programme 
in a hospital setting with educational and psychological support and advice on 
risk factors. During the 1990’s this meant that programmes often had strict 
exclusion criteria, based on fitness to exercise. Patients such as the elderly, 
those with complex co-morbidities and those with ongoing symptoms were often 
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excluded (Tod et al 2002).The move towards a more inclusive process saw the 
introduction of firstly the term comprehensive and then menu-based CR.  
Comprehensive CR describes the addition of a variety of services to the 
exercise based component of CR. Menu-based in contrast makes exercise only 
one part of the menu and focuses on a wider range of treatment options.  
In standard or comprehensive CR, the exercise component consisted of an 
exercise programme, based mainly in hospital, working at moderate intensity, 
usually twice a week and in a group setting. The other components of the 
programme were delivered within this context. If a patient was unable to access 
the exercise component, they often did not receive the other elements of CR.  
Clinicians recognised that this type of intervention did not suit a lot of patients 
and clinical practice in CR developed into a menu-based approach for the 
provision of care (SIGN 2002).  
A menu-based approach recognises the need to tailor the delivery of 
services to an individual’s goals and circumstances. A menu-based programme 
could include specific education to reduce cardiac misconceptions and 
encourage smoking cessation and weight management. It could include 
vocational rehabilitation to assist return to work or retirement; or referral to a 
psychologist, cardiologist, or exercise physiologist.  Exercise is no longer the 
primary focus, but only one of the services that could be provided as part of the 
menu. In addition exercise could be provided in a variety of ways from the 
traditional moderate intensity hospital class, to a low intensity class, a class in 
the community, or a home exercise programme, depending on the needs of the 
patient.  
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The choice of interventions, within a menu-based programme, is 
individualised according to need and can vary considerably from individual to 
individual. These diverse components act, and interact, with one another to 
achieve a range of outcomes. However the evidence base on menu-based CR 
is limited. 
This increasing focus on individualised care within CR has highlighted that 
CR programmes need to become more effective in addressing the 
psychological needs of the individual as well as their physical needs (Linden et 
al 1996, Mayou 1996, Taylor et al 2004). Surveys have highlighted that 
psychosocial factors are still poorly assessed (Lewin et al 1998) and that the 
measurement of psychological and quality of life (QoL) criteria within 
programmes is not universally carried out (Bethell et al 2000). Healthcare 
professionals within CR do not use psychological interventions systematically 
due to limited identification of the patient’s illness beliefs and expectations. 
Programmes do not ground interventions in a specific theory or framework. The 
need to pursue the establishment of a well-grounded theoretical framework to 
develop models of care that deliver effective CR interventions, has been clearly 
recognised (DOH 2000), and highlighted, in guidelines issued by the British 
Association of Cardiac Rehabilitation (BACR) (Coats et al 1995).  
Menu-based CR is a complex intervention with varied pathways according to 
individual need. There is a need for further research on menu-based CR that 
addresses the needs of individuals with cardiac diagnoses other than MI and 
CABG. 
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1.5 Acute Coronary Syndrome Low Troponin 
The need for further research within CR has been highlighted in section 1.4, 
but a diagnosis that requires further exploration is ACSLT.  This is a term that 
has appeared in the last decade within the CHD medical terminology (SIGN 
2007a). However the term of ACSLT is relatively new and poorly understood 
across many healthcare organisations and communities. This group would 
previously been classified as unstable angina (UA) as the biomarkers in use, 
prior to the discovery of the troponins, would have been unable to detect this 
low level of damage to cardiac muscle. Research has shown that the morbidity 
and mortality of patients with ACSLT is similar in severity to those diagnosed 
with MI (SIGN 2007a).  
In 2004, individuals with ACSLT would not have met the referral criteria in 
force in the majority of CR programmes (Lewin et al 2004). The evidence base 
for this cardiac diagnosis focused mainly on medical treatment and there were 
limited data on other forms of treatment including CR.  Audit data in NHS 
Ayrshire and Arran showed that the numbers likely to be affected by this 
diagnosis were similar to the numbers of individuals diagnosed with MI; 
approximately 400 a year.  This group of individuals were discharged, with a 
diagnosis that was poorly understood, and received care that did not reflect the 
standards of those diagnosed with MI, but they faced similar challenges in 
terms of mortality and morbidity.  This therefore made ACSLT and CR a priority 
area for further research. This thesis will therefore focus on individuals with 
ACSLT and will contribute to the evidence base on CR for this diagnosis. 
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1.6 Theoretical framework for Cardiac Rehabilitation  
The need for further research within menu-based CR that utilises a 
theoretical framework has been highlighted in section 1.3. The Common Sense 
Model of Self-Regulation (CSM) is particularly suited to understanding and 
improving an individual’s management of their chronic illness (Leventhal et al 
1980, Leventhal et al 2003). The theory involves individuals monitoring their 
efforts and outcomes in managing tasks and using this information to regulate 
the process towards achieving desired goals. As a theoretical model, it 
describes patients as active problem solvers who make sense of a threat to 
their health such as physical symptoms or an illness, by developing their own 
cognitive representations of the threat, which in turn, determine how they 
respond. (Leventhal et al 1980, Leventhal et al 2003). As has been stated 
previously, many CR programmes do not utilise a theoretical framework when 
designing a programme. The impact of using a framework such as the CSM 
model to underpin a complex intervention such as CR is one that requires 
further study.  
1.7 A framework for research 
The need for further research within menu-based CR has been highlighted 
in chapter 1.3-1.6.  Healthcare is moving toward the goal of implementing 
evidence-based interventions that have been rigorously evaluated and found to 
be both efficacious and effective (Bowen et al 2009).  However the design and 
evaluation of complex interventions, such as CR, is problematic. There are a 
large number of diverse components within a CR programme, including the 
theoretical framework, which, act and interact with one another to achieve a 
range of outcomes for the individual.  
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The Medical Research Council (MRC) provides a framework for researching 
complex interventions, setting out four phases in the development and 
evaluation of such interventions (Campbell et al 2000, Medical Research 
Council 2000). Since its publication in 2000, this framework has been used in 
research concerning a wide variety of treatments, services and interventions 
(Robinson et al 2005, Byrne et al 2006, Blackwood 2006, Redfern et al 2006). 
This thesis will focus on the first three phases of the MRC framework, by 
examining the underpinning evidence for CR (pre-clinical Phase) and by 
modelling what the CR intervention should look like (Phase I). The research 
studies carried out in this thesis encompasses Phase II, where mechanisms are 
identified and outcomes are predicted. It is intended that the feasibility study will 
test the feasibility of carrying out a large study in this population group. It wi ll 
describe the components of the intervention, test their likely effects on the 
population and revise the intervention on the basis of the results. This would 
allow for the development of a RCT to test the intervention further, with an 
appropriate level of power (Phase III). The exploratory study will provide further 
data on the impact that ACSLT and CR can have on this client group. It is 
hoped these studies will contribute to the body of knowledge regarding CR in 
order to inform future service provision (Phase IV). 
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Figure 1:1: The MRC framework for the evaluation of complex interventions 
MRC 2000 
1.8 Aim of the thesis  
This thesis contains a feasibility study and an exploratory study. The 
feasibility study aimed to examine the feasibility of a RCT which would test the 
impact of a menu-based CR programme, on individuals diagnosed with ACSLT, 
against standard care. This feasibility study included staff views. The 
exploratory study aimed to explore the impact that ACSLT and CR can have on 
this client group.  
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1.9 Research questions 
In attempting to meet the aim of the thesis, specific research questions were 
devised:  
Feasibility Study  
 Would a RCT of a menu-based CR programme for individuals with a 
diagnosis of ACSLT be feasible? 
 How do staff caring for individuals with ACSLT view the  study and the 
feasibility of a RCT of CR 
 
Exploratory Study 
 What  impact did a menu-based CR programme for individuals with a 
diagnosis of ACSLT have on four areas   
o Cardiac misconceptions  
o Cardiac symptoms 
o Anxiety and depression. 
o HRQoL 
 How do individuals with ACSLT view their illness? 
 
This thesis includes a feasibility study and an exploratory study. However, these 
studies used the same group of participants, who were recruited while in-
patients within the wards, and data were collected from the participants 
throughout the timescale of the studies. The data relating to feasibility are 
reported in the feasibility study and the data gathered from both quantitative and 
qualitative measures are reported in the exploratory study.  
The term participant will be used for the patients who took part in the studies. 
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Nursing and physiotherapy staff took part in the focus groups as part of the 
feasibility study and they will be referred to as staff.  The terms; feasibility study, 
exploratory study, studies, and thesis will be used throughout. In order to avoid 
confusion, the term “feasibility study” will be used when it relates to issues of 
feasibility. The term “exploratory study” will be used when it relates to the data 
collected from participants. The term “studies” will be used when information 
from both studies is being discussed and the term “thesis” will be used to 
describe the work overall. 
1.10 Timeline of the thesis  
This thesis was carried out in a time of change within cardiology and this 
had a substantial impact on the outcome of the studies. Figure 1:2 highlights 
some of the events that have influenced this thesis. 
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Figure 1:2 Timeline for thesis 
 
 
 
 
Oct 2004-Oct 2005 
 First  review of relevant literature 
October 2005 
 Research proposal completed 
March 2005  Ethics application submitted to NHS Ayrshire and Arran  and 
Stirling University Ethics Committees* 
Jan 2006 
 Ethics approval granted  
November 2006 
 Start of recruitment at site 1 and 2 
February 2007  Recruitment now difficult at site 1 due to changes in clinical 
diagnosis 
June 2007 
 Two  additional nurses tasked with recruitment 
October 2007  Recruitment now difficult at site 2 due to changes in clinical 
diagnosis, making recruitment difficult at both sites  
November 2007  Scottish Government release guidance on definition of MI* 
November 2007 
 Recruitment Stopped 
July 2008  
 Data Collection completed  
2008-2012  Data analysis, and write up * 
2011-2012 
 Second review of literature 
Oct  2013 
 Submission 
 
 
 
 
 
 
* Leave of absence 
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1.11 Organisation of the thesis 
In this first chapter, the context for this thesis has been described. This 
includes a discussion on CR as a complex intervention and areas where further 
study would be beneficial. The MRC framework for complex interventions has 
been discussed (MRC 2000) and will form the underlying framework for the rest 
of the thesis.  
In the second chapter, a review of the literature in relation to CHD describes 
the impact of this disease on the health of the Scottish population, and the 
factors contributing to its development. This chapter then continues by 
describing the many improvements in the management of CHD that have 
occurred in recent decades, and how the risk and impact can be mitigated by 
modern developments in cardiac care. This encompasses the Pre-clinical 
Phase of the MRC framework.  
In the third chapter, the development of one of these improvements, that of 
CR will be discussed. The historical background and evidence base for this 
treatment will be considered and suggestions for further research highlighted. 
There will be an exploration of the theories which can underpin CR practice, in 
particular, the CSM (Leventhal et al 1980, Leventhal et al 2003). This chapter 
relates to Phase I of the MRC framework where components of the intervention 
and underlying mechanisms are identified.  
The fourth, fifth and sixth chapters relate to Phase II of the MRC framework. 
The fourth chapter will describe and discuss the methodology employed to meet 
the aims of the thesis, taking into account the clinical context and information 
from the literature. The design of the studies and coordination will be discussed 
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first, followed by ethical considerations and recruitment. The measures and 
process for data collection will then be addressed, and finally, timescales.  
The fifth chapter will present the issues explored in the feasibility study.  
These issues include: recruitment and retention, the acceptability of a CR 
intervention to participants and staff, and the appropriateness of the outcome 
measures chosen to measure cardiac misconceptions, symptom severity, 
anxiety, depression, and HRQoL.  
In the sixth chapter, the results obtained using these outcome measures and 
participant interviews will be presented.  
In the seventh chapter, the findings of the thesis which illustrate new 
knowledge are discussed along with, the limitations of the studies, implications 
for clinical practice, and recommendations for future research. 
1.12 Conclusion  
This chapter has outlined the rationale for the focus on this area of clinical 
practice. There is a need for further research that examines menu-based CR 
grounded in a theoretical framework. This is particularly important in the context 
of ACSLT. This group of individuals were discharged, with a diagnosis that was 
poorly understood, and received care that did not reflect the standards of those 
diagnosed with MI, but they faced similar challenges in terms of mortality and 
morbidity. This therefore made ACSLT and CR a priority area for further 
research. The overall aim of this thesis is to contribute to the body of knowledge 
regarding CR and ACSLT and to inform future research design and service 
provision. This will be achieved by both feasibility and exploratory studies.  
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Chapter Two Coronary Heart Disease      
2:1 Introduction 
This chapter will follow the MRC framework (MRC 2000) for researching 
complex interventions, by highlighting the evidence base for CHD. Studies 
appearing in MEDLINE, and CINAHL databases were initially accessed 
between 2003 and 2005, and reviewed regarding objectives, methodological 
issues, results and clinical relevance. The literature review was then ongoing 
from 2005 until 2012. Both electronic and manual searches were conducted, 
using the key words ‘patients’, ‘Coronary Heart Disease’ ‘Acute Coronary 
Syndrome”. These words were coupled with ‘CHD risk factors’ and ‘treatment’, 
in searches of the literature undertaken to review the current research base on 
interventions for CHD. Meta-analysis, systematic reviews, randomised 
controlled trials and observational studies were reviewed with respect to the 
aforementioned areas.  
This chapter will describe the incidence of CHD and changes in clinical 
practice within cardiology that have led to the development of the diagnostic 
category of Acute Coronary Syndrome (ACS) and the sub-category of ACSLT. 
This chapter then continues by discussing the risk factors for CHD and the 
many improvements in the management of CHD that have occurred in recent 
decades.  
2.2 Background 
Cardiovascular disease (CVD) refers to any disease that affects the  
cardiovascular system, principally CHD, vascular diseases of the brain and 
kidney, and peripheral arterial disease. This group of diseases remain the 
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biggest cause of deaths worldwide.  An estimated 17.3 million people died from 
CVD in 2008, yet 80% of these deaths were preventable (WHO 2012). Over the 
last two decades, CVD has increased, at an astonishingly fast rate, in low and 
middle-income countries. At the same time, mortality rates have declined in 
many high-income countries (Mendis et al 2011). Rates of mortality and 
morbidity from CVD fell, by at least 50%, in many high-income countries from 
1980 to 2000 (Unal et al 2005, Capewell and O’Flaherty 2009). Some two-thirds 
of this decline can be attributed to a decrease in adverse events and reflects 
reductions in the prevalence of major risk factors. The remaining third is 
attributable to reduced case-fatality rates, owing mainly to treatments (Tunstall-
Pedoe et al 1999). However flattening rates of death from CVD in younger age 
groups have also now been reported in the United States (US), the UK, 
Australia and elsewhere (Capewell and O’Flaherty 2009). Worsening trends in 
CVD may be even greater among people in socially deprived groups 
(O’Flaherty et al 2009). The main cause of death in the UK remains CVD, with 
191,000 deaths each year, one in three of all deaths (BHF 2010).  
The most common form of CVD is CHD. An estimated 7.3 million people 
died of CHD worldwide in 2008 (WHO 2012). In Europe, CHD accounts for an 
estimated 1.95 million deaths each year and is the most common cause of 
death in the UK, with a total of 88,000 deaths attributed to CHD in 2008 (BHF 
2012b). Death rates have fallen in the UK over the last fifty years, but the 
prevalence continues to increase, due to improvements in treatments and the 
rising age of the population (Unal et al 2005, BHF 2012a). Currently there are 
2.7 million people in the UK living with CHD (BHF 2012a). Rising life 
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expectancy and improvements in prognosis can only have a further impact on 
prevalence in the coming decades (Unal et al 2005). 
 
Figure 2:1 Differences in Age-standardised CHD mortality rates by sex and country 
2009 United Kingdom 
 
BHF trends in CHD 1961-2011(BHF 2012) 
Note: Percentages refer to the difference in age-standardised mortality for men 
or women compared to the male or female rate in England  
2.3 Coronary Heart Disease in Scotland  
This worldwide challenge of tackling CHD is reflected in the health of the 
Scottish population. As seen from Figure 2:1, the CHD mortality rate for men 
living in Scotland is 25% higher than England and 36% higher for women. CHD 
will directly affect the majority of the Scottish population, at some point in their 
life, either individually or through their family or friends. The incidence of CHD is 
higher amongst men, the elderly and in deprived areas of Scotland (SIGN 
2007b).  
Significant attention has been paid in Scotland over recent decades to 
reducing mortality and morbidity from CHD. Within Scotland a target was set of 
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a 60% reduction between 1995 and 2010. The age-standardised mortality rate 
(for under 75’s) for CHD has fallen from 124.6 per 100,000 population in 1995, 
to 49.0 per 100,000 population in 2010, a reduction of 60.7%. The target has 
therefore been achieved (ISD 2011). 
However, although mortality from CHD has fallen, it is a matter of concern 
that rates of decline in CHD mortality for men and women aged 35-54 years 
show recent, significant flattening. Specifically, the annual percentage change in 
men was – 6.28% between 1986 and 2003, but only – 0.55% between 2003 
and 2006.  Between 2003 and 2006 the two most deprived quintiles of the 
Scottish population showed an increase of CHD mortality of 16.8% and 10% 
respectively (SGHD 2009a).  
In the Scottish health survey of 2008, the prevalence rates for CHD were 
6.9% for men and 5.6% for women (SGHD 2009a) with the prevalence rate 
increasing dramatically across the age groups, peaking in the 75+ age group at 
26.8% and 20.2% respectively. This has implications for the healthcare sector 
as the population of the UK is ageing. Over the last 25 years, the percentage of 
the population aged 65 and over increased from 15 per cent in 1984 to 16 per 
cent in 2009, an increase of 1.7 million people. By 2034, 23 per cent of the UK 
population is projected to be aged 65 and over (Office of National Statistics 
2012).  This will mean increasing numbers of individuals with CHD, who require 
healthcare from the NHS in Scotland. It is therefore not a surprise that the 
Scottish government in its strategy ‘Better Health, Better Care’ confirmed that 
CHD remains a clinical priority (SGHD 2007).  
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2.4 Coronary Heart Disease in NHS Ayrshire and Arran 
This thesis was based in NHS Ayrshire and Arran on the west coast of 
Scotland. Even within Scotland, a variation in CHD mortality between health 
boards can be seen, with NHS Ayrshire and Arran having one of the highest 
mortality and prevalence rates in Scotland (SGHD 2011, BHF 2012b). As can 
be seen in Figure 2:2, CHD is therefore an area of huge challenge for NHS 
Ayrshire and Arran. 
Figure 2:2 CHD Premature Mortality rates per 100,000, by sex and local authority, 
2008-2010 
 
CHD statistics in Scotland 2012 (BHF 2012b) 
NHS 
Ayrshire & 
Arran  
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2.5 Manifestations of Coronary Heart Disease    
Chapter 2:1-2:4 has demonstrated that CHD is a major challenge for 
healthcare systems both internationally, nationally and locally. This section will 
focus on the manifestations of CHD and specifically on ACS and ACSLT. The 
development of CHD happens over a number of years and a number of 
diagnoses are associated with it. These are: 
 ACS where one of the coronary arteries become narrowed or blocked 
and causes damage to the muscle of the heart. This leads to symptoms 
of chest pain and admission to hospital. This diagnosis can be divided 
into several categories which will be described below.  
 Stable Angina where the artery may become so narrow that it cannot 
deliver enough oxygen-containing blood to the heart muscle, when its’ 
demands are high, resulting in pain or discomfort. This does not lead to 
blockage and damage to heart muscle, but can restrict life choices. 
 Heart Failure (HF), which occurs if the heart becomes less efficient at 
pumping blood around the body, due to damage to the heart muscle. 
The term ACS is one that is not well understood by a large portion of the 
population. It is an umbrella term for MI and UA (Fox et al 2004). Both have a 
common aetiology in the formation of thrombus on an inflamed and complicated 
atheromatous plaque. Patients with erosion or rupture of an atheromatous 
coronary plaque may or may not go on to develop MI. This confers particular 
risks, as a result of impairment of left ventricular function, and mechanical and 
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arrhythmic complications (Fox et al 2004). An accurate and consistent diagnosis 
of MI is therefore important to guide patient management.  
The World Health Organization (WHO) classification of MI states that the 
term MI is generally used when myocardial necrosis due to myocardial ischemia 
is evidenced in a clinical setting (WHO 1979).  Their criteria for the identification 
of MI recommended that the condition can be diagnosed if any two of the 
following three features were present:  
 Symptoms of myocardial ischemia (continuous chest pain for 20 minutes)  
 Electrocardiograph(ECG) changes with ST segment elevation or Q wave 
development 
 Elevation of sensitive and specific cardiac enzymes in the circulation 
The third of these criteria has led to debate among cardiologists over the last 
decade. With the development of more sensitive assays of cardio-specific 
enzymes such as Troponin T, there has been confusion around the terminology 
describing patients with MI. Particularly those who have an elevation of cardio-
specific enzymes, but do not meet the second criteria of ST elevation or Q wave 
development (Fox et al 2004). This led to the development of the current 
classification system for MI, which is described as either: 
 ST elevation MI (STEMI), where >1mm ST elevation is present on at 
least two limb leads or >2mm ST elevation is present in chest leads. 
 Non ST elevation MI (NSTEMI), where all other indicators with the 
exception of ST elevation are present. (Fox et al 2004) 
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An additional area of debate has been the level of cardio-specific enzyme 
rise that would be considered positive for MI. In 2000, a joint working group 
from the European Society of Cardiology (ESC) and the American College of 
Cardiology (ACC) published a redefinition of MI which stated that any elevation, 
however small, of troponin levels is evidence of a MI (ESC/ACC 2000). 
However, within the UK, the British Cardiovascular Society (BCS) Working 
Group recommended that in the context of a typical ACS, MI should be 
diagnosed when the maximum Troponin T increase is >1.0ng/ml (Fox et al 
2004). This recommendation was made on the basis that the risk of death at 
this level of rise in Troponin T is similar to that seen with the WHO definition 
(WHO 1979). 
Table   2:1 Worldwide definitions of Acute Coronary Syndrome  
12 hour serum Troponin T concentration (ng/l) 
 <0.01 >0.01 and <1.0 >1.0 
BCS definition  ACS with UA ACS with myocyte 
necrosis 
ACS with clinical 
MI 
ESC/ACC UA MI MI 
WHO definition UA  UA  MI 
30 day mortality  4.5% 10.4% 12.9% 
6 month mortality 8.6% 18.7% 19.2% 
SIGN (2007a)  
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As can be seen from Table 2:1, the disparity amongst the definitions, relates 
to the middle group (Troponin T >0.01 and <1.0) or ACSLT as defined within 
this thesis. Before the identification of the troponins, patients with ACSLT would 
have been classified as UA, as the cardio-specific markers in use at that time 
would have been unable to detect any damage to cardiac muscle. Yet the 
current definitions from BCS/ACC/ESC recognise that patients with ACSLT are 
different from those with UA. They have an adverse prognosis, including 
increased risk of death, compared with patients with UA without an increased 
marker.  The data used to calculate this risk of death comes from the Global 
Registry of Acute Coronary Events (GRACE). This is a widely accepted method 
of determining risk, developed from a international observational database of 
outcomes for patients who are hospitalized with ACS. The database includes; 
over 200 hospitals, in 28 countries, that enrol a total of more than 10,000 
patients per year (GRACE investigators 2001). From this data, the researchers 
have been able to establish factors that influence survival. These include: age, 
heart rate, systolic blood pressure (BP), creatinine levels, presence of HF, ECG 
changes, cardiac arrhythmias, and raised cardiac enzymes. The data is entered 
into a table and the probability of death or MI in the next six months can be 
calculated.  From Table 2:1 it can be seen that individuals with ACSLT are at 
similar risk to those with MI and research is required into what interventions 
would benefit these individuals.   
2.6 Risk factors for Coronary Heart Disease    
There is a large amount of evidence about the reasons why some 
individuals develop CHD and also consensus that there are key contributory risk 
factors.  Large studies have shown that multiple risk factors, rather than a single 
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risk factor, significantly increases the risk of CHD (Tunstall-Pedoe et al 1999). 
The risk increases with age and men are more likely to suffer from CHD 
prematurely than women. Family history also appears to play a part in the 
development of this disease (BHF 2012a).  
The INTERHEART study assessed the importance of risk factors for CHD 
worldwide (Yusuf et al 2004). Nine measured and potentially modifiable risk 
factors accounted for more than 90% of the proportion of the risk for acute MI. 
These risk factors included smoking, elevated blood cholesterol, lack of physical 
activity, psychosocial factors, history of hypertension or diabetes, poor dietary 
pattern, obesity, and alcohol consumption. The effect of these risk factors was 
consistent in men and women, across different geographic regions, and by 
ethnic group. Worldwide, the two most important risk factors were smoking and 
abnormal lipids. Hypertension, diabetes, psychosocial factors and abdominal 
obesity were the next most important, but their relative effects varied in different 
regions of the world (Yusuf et al 2004). The British Regional Heart Study found 
that smoking, BP and abnormal lipids accounted for 90% of attributable risk of 
CHD (Emberson et al 2003).  
 If we consider the risk factors individually, we can see that smoking is 
closely related to premature mortality. Men under 65 who smoke are three times 
more likely to die of CHD than non-smokers of a comparable age and men 
between 65 and 84 who smoke are twice as likely to die as non-smokers (Doll 
el al 2004). Yusuf et al (2004) showed that there  was a strong relationship 
between the number of cigarettes smoked and the risk of MI, while individuals, 
who smoke more than 40 a day, had ten times the risk of non-smokers. It has 
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been argued that in developed countries around 12% of all disease burden a nd 
over 20% of CVD was due to smoking (WHO 2002). Yusuf et al (2004) 
estimated that 29% of heart attacks in Western Europe were due to smoking, 
and that smokers and former smokers were at almost twice the risk of a heart 
attack, compared to those who never smoked. 
The link between CVD risk and variation in blood lipid concentration was 
shown in a study of over 356,000 men aged 35-57 years who were followed up 
for six years (Stamler et al 1986). The study demonstrated a continuous, 
graded, strong relationship between serum cholesterol and six year age 
adjusted CHD mortality. A meta-analysis of data from 90,056 participants in 14 
randomised trials of statin therapy showed that a 1.0 mmol/l reduction in Low 
Density Lipoprotein (LDL) cholesterol lowered the five year relative risk of a 
major vascular event by 21%, irrespective of sex, age, BP, pre-existing diabetes 
or history of a previous vascular event (Baigent et al 2005). 
Light to moderate physical activity in healthy adults has been recommended 
to reduce the risk of mortality and morbidity from any disease. Observational 
studies show that those with higher physical activity levels are less likely to 
develop CHD than those who are more sedentary. The research also shows 
that those who increase their physical activity decrease their chances of 
developing CHD irrespective of their starting level (Lee et al 2000, Manson et al 
2002, Lee et al 2003). These studies confirmed an inverse relationship between 
physical activity and the risk of a cardiac event after controlling for other key risk 
factors.  
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Psychological distress, particularly depression, has been recognised as a 
risk factor for CHD (Anda et al 1993, Barefoot et al 1996, Hemingway and 
Marmot 1999). The INTERHEART study found that subjective stress and  
self-reported depression appeared to be associated with increased risk of 
developing an acute MI across gender, nationality, ethnic groups, and to be 
independent of smoking and socio-economic status (Rosengren et al 2004). 
Depression is highly prevalent in cardiac patients. Carney et al (1988) 
followed up 52 patients who had angiography for suspected CHD. At 12 
months, 78% of the depressed patients had sustained at least one major 
cardiac event. Depression symptoms in the cardiac population have been 
associated with an increased risk of recurrent cardiac events (Frasure-Smith et 
al 1995), mortality (Barefoot et al 1996) as well as poorer prognosis (Vaccarino 
et al 2001). Depression is also associated with increased risk following a MI, 
and it has been shown that persistent psychological distress and poor social 
support are powerful predictors of outcome independent of the degree of 
physical impairment (Hemingway and Marmot 1999).   
The high prevalence of psychological symptoms and disorders in patients 
with CHD has been documented by Rugulies (2002). Many people with CHD 
experience anxiety, depression, emotional and social disturbance, reduced 
HRQoL and failure to return to work (Petrie and Weinman 1997). Anxiety while 
in the coronary care unit is associated with an increased risk of ACS and 
arrhythmic events over the following 12 months (Frasure -Smith et al 1995). A 
number of studies demonstrate the link between negative perceptions and poor 
outcome in people with CHD (Maeland and Havik 1987, Petrie et al 1996, Furze 
et al 2005). Psychological distress is also an important predictor of 
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hospitalisation costs following a cardiac event, with distressed patients accruing 
four times the cost of non-distressed patients (Levin 1991).   
Blood pressure has been found to be directly related to mortality from CHD 
(Selmer 1992, Stamler et al 1993). Results from the Seven Countries Study 
have suggested that the relative increase in mortality from CHD, for a given 
increase in BP, is similar among different populations and cardiovascular risks 
(Menottie et al 1996).  
Diabetes is recognised as an independent risk factor for CHD in both men 
and women (Wilson et al 1998, Lotufo et al 2001).  Women with diabetes seem 
to lose most of their inherent protection against developing CHD (Brezinka and 
Padmos 1994). Lotufo et al (2001), in their study of male US physicians, found 
that diabetes is associated with a substantial increase in all-cause and CHD 
mortality. For all-cause mortality, the magnitude of excess risk conferred by 
diabetes is similar to that conferred by a history of CHD, for mortality from CHD 
a history of CHD is a more potent predictor of death. The presence of both 
diabetes and CHD, however, identified a particularly high-risk group. 
Manson et al (1990), in a prospective cohort study of over 100,000 female 
nurses, demonstrated a strong positive association between obesity and the 
risk of CHD in women. Adjustment for cigarette smoking increased the 
magnitude of the association. After adjustment for age and smoking, the risk of  
both non-fatal MI and fatal CHD among women in the heaviest weight category 
was more than three times higher than that in the leanest weight category.  
In the Framingham Heart Study, Hubert et al (1983) followed 2,818 women, 28 
to 62 years of age, for a 26-year period and found a strong positive association 
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between relative weight and the incidence of CHD. This association was also 
found amongst men. Yet in the Seven Countries Study (Keys 1980), no 
significant association between body mass index in most regions and CHD 
incidence over 10 years was found. It could be argued that these two studies 
had different levels of baseline obesity and therefore are not comparable. 
However, it highlights the difficulty in assessing the impact of obesity itself, 
versus the impact of obesity on other risk factors such as hypertension, and the 
resulting increase in CHD risk.  
The impact of dietary patterns on CHD has been studied in several areas, 
with varying results. These areas are dietary fats, salt, fruit and vegetables.  
The evidence would appear to be variable across these areas of dietary intake. 
The evidence would appear to be the strongest for a reduction in dietary fats.   
A Cochrane review examined the effect of reduction or modification of dietary 
fats, for at least six months, on reducing serum cholesterol levels and on total 
and CVD mortality and morbidity (Hooper et al 2004). There was no significant 
effect on total mortality, but a trend was identified towards protection from CVD 
mortality and significant protection from CVD events. Trials, with at least two 
years’ of follow up , provided stronger evidence of protection against CVD 
events. The reviewers concluded that there was a small, but potentially 
important, reduction in CVD risk with a reduction or modification of dietary fat 
intake, seen particularly in trials of longer duration. 
A meta-analysis of 28 trials, on the effect of moderate salt reduction on BP, 
demonstrated that a modest reduction in salt intake, for four or more weeks, 
had a significant effect on BP in both hypertensive and normotensive individuals  
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(He and MacGregor 2002). However a Cochrane review found that it was 
difficult to link this with a reduction in CVD events (Jürgens and NA  2004). 
The evidence for the benefits of a diet high in fruit and vegetables is limited. 
The recommendation to eat fruit and vegetables to prevent CHD is mainly 
based on non-randomised studies.  Several cohort studies have examined the 
relationship between fruit and vegetable intake and CHD. Law and Morris 
(1998) found a decrease in cardiac event rates and Shekelle et al (2004) found 
a reduction of 15% of CHD linked to consumption of fruit and vegetables. 
Pereira et al (2004) in their review of cohort studies argue that fruit and 
vegetables may reduce CHD by means of their protective constituents such as 
potassium, folate, vitamins, fibre, and other phenolic compounds. They reported 
an inverse association between intake of fibre from fruit and vegetables and  
CHD risk. In general, studies in this area report a favourable relationship 
between fruit and vegetable consumption and CHD occurrence, however no 
causal link has been shown. 
Alcohol is known to have both beneficial and harmful effects on the 
biochemical basis for CHD and the psychological consequences of the disease 
(Foppa et al 2002). Two cohort studies, on the effects of alcohol consumption in 
secondary prevention sub-groups, confirmed the protective effect of moderate 
drinking (Aguilar et al 2004, Reims et al 2004). In a prospective cohort study, 
Ajani et al (2000) followed up 87, 938 US male physicians for 5.5 years , 2,790 
of these had diabetes.  Their results also suggest that light to moderate alcohol 
consumption is associated with risk reductions in CHD  among diabetic and non-
diabetic men. Conversely, binge drinking is harmful and associated with: a 
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poorer lipid profile, an adverse effect on systolic BP, and increased risk of 
thrombosis (McKee and Britton 1998, Britton and McKee 2000). 
Since 1948, The Framingham Heart Study has been committed to identifying 
the common factors or characteristics that contribute to CVD (D’Agostino et al 
2001). Over the years, careful monitoring of the Framingham Heart Study 
population has led to the identification of the major CVD risk factors as above, 
as well as valuable information on the effects of these risk factors. The 
Framingham Heart Study has informed the development of a risk calculator for 
CHD. The Framingham equation has the advantage of allowing calculations 
over various time periods (4 to 12 years) and for different outcomes: stroke, 
CHD, MI and death from either CHD or CVD. Until recently, the majority of 
people used the Framingham equation for calculating CVD risk. 
A further two risk scoring formulas have been developed within the UK. The 
first is the Joint British Societies (JBS) scoring charts version 2, which are 
published in the British National Formulary (BNF) (JBS 2005). The JBS2 
scoring charts calculate CVD risk, based on the sum of the CHD and stroke 
risks given by Framingham. The Left Ventricular Hypertrophy and Diabetes risk 
factors, originally incorporated in the Framingham equation, are not included in 
the JBS2 charts, as these patients are automatically considered high risk.  
The latest risk calculator is the ASSIGN score which was developed in 
conjunction with SIGN (Woodward et al 2007), to address the issue that the 
Framingham equation may not accurately calculate risk in populations other 
than the US. ASSIGN is tailored to the Scottish population and is based on the 
Scottish Heart Health Extended Cohort, a series of population studies from the 
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1980s and 1990s, followed up until the end of 2005 (Woodward et al 2007).  
ASSIGN calculates risk of CVD, but also includes additional risk factors not 
used by the Framingham equation (family history and social deprivation), which 
are important in a Scottish context. Death rates from CHD are socially patterned 
in Scotland, with people in lower social classes more likely to suffer from CHD 
than those in higher social classes. From 2005-2009 death rates from CHD in 
Scotland were 84% higher in the most deprived decile compared to the least 
deprived decile (BHF 2012b). 
When the health behaviours associated with CHD risk factors are modified 
through activities such as smoking cessation, weight management, lipid 
management, increased physical activity and BP control, CHD can regress and 
progression can be delayed (SIGN 2000). All three risk calculators are used in 
clinical practice, both as a way to highlight the need for behaviour change to an 
individual, and as a tool to decide on treatment options. This has been the 
underpinning framework, for the last twenty years, for much of the prevention 
work in CHD within the UK.  
Yusuf et al (2004) have argued that the modification of currently known risk 
factors has the potential to prevent most premature cases of MI worldwide. 
Deaths and rates of morbidity from CVD fell by at least 50% in most countries 
from about 1980 to 2000 (Capewell and O’Flaherty, 2009) and it has been 
argued that two-thirds of this decline can be attributed to a decrease in adverse 
events and reflects reductions in the prevalence of major risk factors The 
remaining third is attributable to reduced case-fatality rates, owing mainly to 
treatments (Tunstall-Pedoe et al 1999). The changes in medical treatment will 
be discussed further in chapter 2:7.  However it is clear, from the evidence 
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above, that any intervention designed to reduce the highlighted risk factors can 
have a significant impact on the health of the individual with CHD.   
2.7 Improved treatment of Coronary Heart Disease   
In chapter 2:6, the risk factors for CHD were highlighted and the impact that 
changes in the risk profile could bring was discussed. This section will focus on 
changes in treatments within cardiac care that have also contributed to the 
reduction in mortality from CHD since 1980. These are reperfusion therapy, 
secondary prevention and CR. Reperfusion therapy applies mainly to 
individuals who have had a STEMI, or in a small number of cases, those with 
NSTEMI, while secondary prevention and CR can apply to the wider population 
with CHD.  
Reperfusion therapy consists of two distinct treatments: Fibrinolytic Therapy 
(FT) and Primary Percutaneous Coronary Intervention (PPCI). Both treatments 
are designed to clear the coronary arteries following a blockage and reduce 
mortality and morbidity from MI.  This is done using either a drug as in FT, or a 
metal stent in PPCI. During the 1980’s and 90’s FT was the only option for 
treatment, but during the last decade the use of PPCI has increased 
dramatically (SGHD 2009a).  
Nine randomised controlled trials of FT were reviewed by the Fibrinolytic 
Therapy Trialists Collaborative Group (1994). They looked at deaths during the 
first 5 weeks after a MI and major adverse events occurring during 
hospitalisation. This review included 58,600 patients, among whom, 6,177 
(10.5%) deaths, 584 (1.0%) strokes, and 436 (0.7%) major non-cerebral bleeds 
were reported.  This treatment was associated with an excess of deaths during 
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days 0-1, but this was outweighed by a much larger benefit during days 2-35.  
Despite the early hazard, there was a very clear overall survival advantage 
produced by FT.  Benefit was observed among individuals presenting with 
STEMI or bundle branch block (BBB), irrespective of age, sex, BP, heart rate, 
previous history of MI, or diabetes. Among the 45,000 individuals presenting 
with STEMI or BBB, the relationship between benefit and delay from symptom 
onset, indicated highly significant absolute mortality reductions of about 30 per 
1000 for those presenting within 0-6 hours (Fibrinolytic Therapy Trialists 
Collaborative Group 1994). The earlier the drug was given, the higher the 
benefit. The administration of this therapy became commonplace within all 
cardiology units and formed part of the expected standard of care (SIGN 2000).  
Over the last ten years, the concept of opening the artery to improve 
outcome has been expanded to include PPCI. This treatment aims to make the 
blood vessels wider; by the use of a balloon to open the vessel, and a metal 
stent to keep them open. A comprehensive systematic review (Hartwell et al 
2005) and meta-analysis (Keeley et al 2003) of RCT data showed that PPCI is 
superior to FT for the treatment of patients with STEMI. The benefit of PPCI 
over FT was seen in reduced short and long term mortality, stroke, re-infarction, 
recurrent ischaemia and the need for CABG, as well as the combined end point 
of death or non-fatal re-infarction (SIGN 2007a). These benefits were consistent 
across all patient sub-groups and were independent of the drug used.  
The greatest benefit was seen in those patients treated within 12 hours of 
symptom onset (Keeley et al 2003, Hartwell et al 2005). This treatment has 
replaced FT as the treatment of choice for individuals with STEMI, who live 
within a 90 minute radius of the nearest cardiac centre providing this service 
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(SIGN 2007a).   Those who can’t access PPCI in this time frame sti ll receive 
FT. An increase in angioplasty and stenting out-with PPCI, known as 
Percutaneous Coronary Intervention (PCI) has also evolved during the last 
decade. Often individuals with NSTEMI receive this treatment as a planned 
intervention following the index admission. Reperfusion therapy has therefore 
played an important role, over the last three decades, in reducing mortality and 
morbidity from CHD. 
The second area in which improvements have been made in the treatment 
of CHD is that of secondary prevention. Since the publication of SIGN 41 (2000) 
on the secondary prevention of CHD, the use of four groups of medications that 
can reduce mortality and morbidity in individuals with CHD has been 
recommended. These medications include: platelet inhibitors, beta-blockers, 
ace-inhibitors and statins. Meta-analyses of platelet inhibitor therapy 
(Antithrombotic Trialists Collaboration 2002), long term beta-blocker therapy 
after MI (Freemantle et al 1999) and ace-inhibitor therapy (ACE inhibitor MI 
Collaborative Group 1998) have confirmed that these drugs reduce mortality 
following a MI. Several trials have also suggested that the use of statins such as 
simvastatin and pravastatin can reduce mortality by between 20-30%. In the 
Scandinavian Simvastatin Survival Study (1994), total mortality was reduced by 
30% in the intervention group, due to a 42% decrease in CHD deaths.  The 
need for CABG or PCI was also reduced by 37%. These benefits applied to 
older as well as younger patients. In the LIPID study (1998), overall mortality 
was 22% lower in the pravastatin group, with a 24% reduction in deaths from 
CHD and 25% reduction in deaths from other CVD causes. It is now common 
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practice to prescribe all four groups of drugs to individuals with CHD where 
possible. 
The third area where improvements in the treatment of CHD since 1980 can 
be seen is in CR. This intervention was aimed at individuals primarily with MI, 
CABG and PCI and its provision spread rapidly throughout the UK during the 
1990’s. The number of centres providing CR grew from 99 services in 1989 to 
302 services in 2000 (Bethell et al 2007). The evidence base for this 
intervention will be explored in more depth in chapter 3. However it is important 
to note that CR has developed from an exercise only model into a complex 
multi-factorial and multi-disciplinary intervention. The package of care provided 
within CR still has a focus on exercise, but also focuses on the reduction of 
individual risk factors, and the provision of psychosocial support and education.  
2.8 Conclusion  
 Although some important progress has been made in reducing CHD 
mortality in Scotland, and elsewhere, the expected aging population will lead to 
a higher prevalence of CHD across the country, so the goal of disease 
prevention remains. This is dependent, not only on the ability to prevent it 
occurring, but also on the ability to detect disease early, and treat it 
appropriately. Recent changes in diagnostic techniques such as  the use of 
“Troponin T” have changed the way in which the clinical cardiology community 
works. The classification of MI has changed to reflect these developments, 
identifying more people at risk. However, a great deal of debate exists around 
the changed definition of MI. Data from the GRACE registry would suggest that 
individuals with any level of raised troponin have a mortality risk more than 
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twice those with normal levels. Within the UK, only those with levels above one 
are treated as an MI, yet within Europe and the USA any rise would lead to this  
outcome. Despite these differences in diagnosis, the evidence base would 
suggest that it is important to identify those with ACSLT and put in place 
management plans that reduce risk.    
There is a substantial body of evidence from large longitudinal multi -centre 
trials that show what the key contributory risk factors to CHD are: smoking, 
raised blood cholesterol, lack of physical activity, psychosocial factors, 
hypertension, diabetes, poor dietary pattern, obesity and alcohol consumption.  
The effect of these key risk factors on CHD has been shown to be consistent in 
men and women and across different geographic regions. However, the 
importance attached to each risk factor would appear to vary considerably, with 
smoking and high blood cholesterol being viewed as closely linked to the 
development of CHD, and other risk factors varying in importance across the 
world. The evidence base for treatment of risk factors also varies in strength.  
There is a considerable amount of evidence supporting the effectiveness of 
smoking cessation and the lowering of blood cholesterol through medication. 
However the evidence for treating dietary risk factors such as fat, salt or fruit 
and vegetables is limited and trials in this area have shown little impact on total 
mortality.  
Despite the variation in the evidence base, the multi-factorial nature of CHD 
has led to the development of several risk scoring calculators which take the 
level of risk for each factor into consideration when calculating total risk. The 
evidence base would suggest that, within Scotland, death rates are socially 
patterned and that the impact of deprivation on CHD has to be taken in account 
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in any form of risk stratification. ASSIGN is the only risk calculator to do so 
(Woodward et al 2007). There is a substantial body of evidence that altering the 
risk profile of individuals has had an impact on mortality, with two thirds of the 
decrease in worldwide mortality being attributed to reductions in the prevalence 
of major risk factors. The remaining reduction is attributed to changes in 
medical treatment, such as reperfusion therapy and secondary prevention 
(Tunstall-Pedoe et al 1999). The evidence base for these treatments is 
overwhelming and the provision of these services has spread across the world.  
However there is a third element of treatment that has developed and is now 
worldwide and that is CR. This intervention is embedded in the risk reduction 
model and the evidence base for it will be explored in greater depth in  
chapter 3. 
In conclusion this chapter has provided an overview of the evidence base 
that underpins modern cardiac care. This chapter has discussed the incidence 
of CHD worldwide and within the UK and highlighted changes in clinical practice 
within cardiac care that have led to the development of the new diagnostic 
category of ACS and the subcategory of ACSLT.  This chapter has also 
identified the risk factors for CHD and has highlighted the impact on mortality 
from CHD that improvements in the incidence of risk factors and developments 
in treatment have made. These developments include CR, which is a multi -
factorial, multi-professional intervention and is one of a number of interventions 
used to improve outcomes for CHD. 
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Chapter Three Cardiac Rehabilitation 
3.1 Introduction  
Cardiac Rehabilitation, as it is carried out in the modern NHS, is a complex 
intervention. The MRC framework for researching complex interventions a nd its 
importance for this thesis has been explained in chapter 1:7. This has been 
followed in chapter 2, by a description of the background and research base on 
CHD, which demonstrates that CR is one of a number of interventions used to 
improve outcomes for CHD. Chapter 2 has also shown us that CHD is a major 
challenge for the NHS, both nationally and locally. Significant changes in the 
modern management of CHD, as described in chapter 2:7, have highlighted that 
clinical practice can make a substantial impact on morta lity and morbidity.  
Current policy would suggest that CR is a complex intervention that could 
improve outcome in a variety of cardiac diagnoses. This chapter will follow the 
MRC framework for researching complex interventions; by highlighting the 
evidence base for CR and by describing the relative strength of the evidence on 
the exercise, psychological and educational domains (Pre-clinical Phase) and 
by modelling what the intervention should look like (Phase I).  This chapter will 
also examine the strength of the evidence on the components that a CR 
intervention includes, modes of delivery, attendance and adherence, and will 
also consider the gaps in the evidence base. It will identify areas of CR practice 
that require further testing and modelling. This chapter will discuss a new client 
group for CR, those with ACSLT, about whom there is little research within the 
CR evidence base, and will describe the theoretical frameworks on which a CR 
intervention could be based.  
42 | P a g e  
 
In extensive searches of the literature undertaken to review the current 
research base on CR, studies appearing in MEDLINE, PsycLIT, Embase, 
CINAHL, and PsycLIT databases were initially accessed  between 2003 and 
2005, and reviewed regarding objectives, methodological issues, results and 
clinical relevance. The literature review was then ongoing from 2005 until 2012. 
Both electronic and manual searches were conducted, using the key words 
‘patients’, ‘Coronary Heart Disease’ ‘Acute Coronary Syndrome” “Cardiac 
Rehabilitation” These words were coupled with  ‘CHD risk factors’  ‘treatment’, 
“emotional health’, “anxiety”, “depression”, “misconceptions”,  ‘quality of life’, 
‘perceived health status’, ’treatment beliefs’, ‘recovery’, and ‘rehabilitation’’  “self 
regulation” and “uncertainty theory”. Meta-analysis, systematic reviews, RCT’s 
and observational studies were reviewed with respect to the aforementioned 
areas.  
3.2 Background  
CR programmes evolved during the 1980s and 90s from the recognition that 
individuals suffered from physical deconditioning as a result of prolonged bed 
rest, which had been a part of the traditional treatment for MI, and the 
developing evidence that regular exercise was protective against CVD.  There 
has been a steady increase in the centres providing CR over the last thirty 
years. The numbers of programmes in the UK grew from 9 centres in 1969 to 
99 centres in 1989 and to 302 in 2000. The first Scottish programmes started in 
the late 1980’s. By 2000, all NHS hospitals with coronary care units had access 
to CR programmes (Bethell et al 2007).  Within the UK, CR programmes have 
often been developed by enthusiastic nursing staff and physiotherapists with 
limited funding for input from medical staff, clinical psychologists, pharmacists, 
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dieticians, other therapists or exercise physiologists.  Programmes of CR vary 
considerably; in content, in client groups offered the service, length of 
intervention, the type of health professionals involved in their delivery, and the 
setting for that delivery (SNAP 2001). As time has progressed, CR has 
developed into a multi-dimensional package of care that encompasses a holistic 
approach looking at physical, social, and psychological needs to improve the 
individual’s recovery from a cardiac event. The goal of CR is therefore, not only 
to prolong life, but also to improve physical and psychological functioning, 
symptoms, well-being, and HRQoL (SIGN 2002).    
However the research base has not kept up with the developments within 
CR. There are large differences in the quality of the evidence for the various 
components of such a complex intervention. These differences were highlighted 
by the development of the SIGN guideline in 2002 which specifies that 
individuals should be offered an individualised multi-disciplinary comprehensive 
package of care. Within this document, there were several areas where the 
evidence did not reach the level set within SIGN as a gold standard, and 
recommendations were based on expert opinion. In the following sections the 
strength of the evidence in three components of this complex intervention will 
be considered. These areas are the physical, psychological and educational 
domains.   
3.3 Physical domain 
The evidence base for CR spans more than fifty years, with many of the 
initial studies focusing solely on the impact of exercise. This was at a time when 
many of the current treatment strategies for CHD had not been formulated.  
There have been three published and widely cited meta-analyses of the 
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effectiveness of exercise based CR compared to usual care. The first two, by 
Oldridge et al (1988) and O’Connor et al (1989), demonstrated that individuals 
randomised to exercise-based CR after MI had a statistically significant 
reduction in all-cause and cardiac mortality of about 20% to 25%, compared to 
individuals receiving conventional care.  No significant effect on non-fatal re-
infarctions was found.  The trials within these meta-analyses were carried out, 
in the main, during the 1970s and 80s, before the development of CR as it is 
now and before the many changes in medical management that have been 
discussed. The trials included were small and often of poor methodological 
quality. The RCTs used in the reviews focussed almost exclusively on low-risk, 
middle-aged males post MI, thereby excluding women, elderly people and other 
cardiac patient groups, such as individuals with CABG or HF who may also 
benefit from CR. 
The third meta-analysis was the largest review of exercise-based CR and 
included 8940 individuals in 48 RCTs (Taylor et al 2004). This review included 
patients with angina, post MI, CABG or PCI. A total of 19 RCTs assessed 
exercise training only, 30 RCTs combined exercise with other interventions and 
one RCT assessed both exercise only and comprehensive CR. Compared to 
usual care, exercise based CR significantly reduced total mortality by 20% and 
cardiac mortality by 26%. This is in line with the previous reviews. 
Several RCT’s, in individuals with chronic stable angina, have consistently 
shown a significant improvement in exercise tolerance in those in the exercise 
group (Froelicher et al 1984, Sebrechts et al 1986, Todd and Ballantyne 1992).  
Both the study by Froelicher et al (1984) and the study by Todd and Ballantyne 
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(1992) showed a reduction in cardiac symptoms and a reduction in the objective 
measurements of ischaemia. A RCT of exercise training in HF reported 
improvements in exercise capacity, myocardial perfusion, QoL, total mortality 
and hospital admissions (Belardinelli et al 1999).  An overview of RCT’S of CR 
in HF in Europe (European HF training group 1998), that included 134 
individuals concluded that: exercise training improved exercise capacity and 
autonomic indices, training could be conducted either in hospital or at home, 16 
weeks was better than six, and a combination of cycle ergometry and 
callisthenics was better than cycle ergometry alone.  Women did as well as 
men, and elderly individuals were able to train free from complications and with 
benefit to symptoms, although less effectively than younger patients.   
The evidence base for the exercise component of CR, as it is delivered in 
the RCT’s, is therefore comprehensive and compelling. It is this evidence base 
that has ensured the widespread development of CR across the UK.  Within this 
evidence base, although focusing in the main on MI and CABG and PCI, there 
is evidence that CR can have an impact on the physical health of participants, 
with a variety of diagnoses, through exercise.  
3.4 Psychological domain  
The impact of CR on the psychological domain is an area that has interested 
many researchers. The impact that CHD can have on psychological functioning 
has been discussed in chapter 2:7. It has been shown that persistent 
psychological distress and poor social support are powerful predictors of 
outcome following MI, independent of the degree of physical impairment 
(Hemingway and Marmot, 1999). The link between negative perceptions and 
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poor outcome in people with CHD has been studied by several authors 
(Maeland and Havik 1987, Petrie et al 1996, Furze et al 2005).  Yet there is little 
attention paid to cardiac misconceptions in the CR evidence base. 
However, the evidence that psychological treatments within CR will reduce 
psychological distress is ambivalent. Comprehensive CR, based predominantly 
on a cognitive behavioural approach, was evaluated in one randomised trial 
involving 80 patients with angina, and showed improvements in exercise 
capacity, emotional distress, symptoms and disability (Lewin et al 1995).  Lewin 
et al (1992) also showed that significant reductions in anxiety and depression 
can be achieved by a psychological intervention. In his study looking at the 
effect of counselling on anxiety and depression amongst first time MI patients, 
Thompson (1989) found that patients who received in-hospital counselling 
reported statistically significantly less anxiety and depression than those who 
received routine care alone. This effect was sustained for six months after 
leaving hospital. 
A Cochrane review of psychological interventions in CHD (Rees et al 2004a) 
found that, where anxiety was measured (9 trials-2756 patients), there was a 
small, but significant reduction, in anxiety with a psychological intervention. 
Depression was measured in 11 trials and across all the trials there was a 
significant reduction in depression following a behavioural intervention.  
A meta-analysis of 8,988 patients in 37 trials, found that CR programmes 
including psychological and/or educational interventions resulted in a 34% 
reduction in cardiac mortality and a 29% reduction in recurrent MI at 1-10 years 
follow up (Dusseldorp et al 1999). Two meta-analyses support the use of such 
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therapy (Mullen et al 1992, Linden et al 1996).  However two large trials found 
negative results for psychological outcomes (Jones and West 1996, Frasure-
Smith et al 1997). It could be argued that there are several possible 
explanations for the negative outcome in these trials. These include the 
inclusion of subjects with low levels of psychological symptoms, outcome 
measures which were insufficiently sensitive to detect change, provision of a 
uniform treatment for a heterogeneous range of complaints, and a lack of 
appropriate training in cardiac psychological interventions among staff.  
However, it is important that this ambiguity in outcome following a trial of a 
psychological intervention is explored further.  
Modern treatments for CHD need to be considered not only for their impact 
on mortality or morbidity, but also for their impact on the broader aspects of a 
patient’s life. There has therefore been a rapid and significant growth in the 
measurement of HRQoL as an indicator of health outcomes in patients with 
CHD (Thompson and Cheuk-Man 2003). Reaching consensus on a definition of 
HRQoL is problematic because there are so many diverse views. However, 
there is consensus that it is a multi-faceted construct that has physiological, 
psychological, emotional and social components (Roebuck et al 2001). The 
literature suggests that HRQoL and its measurement is poorly understood and 
applied inappropriately (Jenkinson and McGee, 1998) and represents the effect 
of an illness and its treatment as perceived by the patient. Assessing the 
evidence base with regard to HRQoL and CR can be difficult.  Hawkes and 
Mortenson (2003) found that a third of patients have a decline in SF-36 scores 
from baseline to 6 months following CR. However, other studies have 
suggested that CR does improve the HRQoL of patients with CHD  
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(Lavie and Milani 1995, Belardinelli et al 2001, Pasquali et al 2003).   
The difficulty for CR in measuring HRQoL is that a generic instrument may not 
be sensitive enough to detect change over time in the CHD population, yet a 
disease specific instrument may not apply to all the patients within the CR 
programme, who suffer from a wide range of cardiac disorders. Many disease 
specific instruments are designed for a specific subcategory of CHD such as MI 
or HF. The use of individualised instruments for the measurement of HRQoL 
has not been widely utilised within CR. Yet these instruments could bring an 
additional dimension to our understanding of the priorities of individuals with 
CHD. 
In summary, although there is some evidence of benefit from psychological 
interventions, this evidence base is currently ambiguous and there is a need for 
further research into misconceptions, anxiety, depression, and HRQoL. 
3.5 Educational domain 
One of the key components of CR is education on the risk factors for CHD 
and a focus on behaviour change to improve physical well-being. As with the 
evidence base for the psychological domain, the data on the impact of CR on 
these factors is varied. Jolliffe et al (2001) argued that, with a programme of 
comprehensive CR, there were significant reductions in both total blood 
cholesterol and LDL cholesterol. Significant reductions in triglycerides also 
occurred in the comprehensive CR group. Yet they were unable, due to the lack 
of reporting on medication use, to rule out the possibility that this was due, in 
part, to the effects of the widespread use of cholesterol-lowering drugs. 
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Very little data have been collected on the effects of CR on BP 
measurement. Two large trials showed favourable effects of comprehensive 
CR, with reductions in systolic BP of -9mmHg and -6.4mmHg respectively 
(Kallio et al 1979, Haskell et al 1994). Diastolic BP was significantly reduced in 
the comprehensive CR programme. However there is limited data to confirm 
this finding.  
In a study of patients waiting for CABG, McHugh et al (2001) found that after 
a programme of health education and motivational interviewing, according to 
need, patients in the intervention group were more likely to stop smoking, 
reduce obesity, and improve BP. These positive benefits were also found in 
anxiety, depression and physical activity. 
Dusseldorp et al (1999) in a meta-analysis of 37 studies, argued that health 
education programmes such as CR yielded significant positive effects on BP, 
cholesterol, body weight, smoking behaviour, physical exercise and eating 
habits. A randomised trial of health education for individuals with angina in 
primary care, found that it improved exercise, diet and QoL, but did not affect 
smoking rates, lipids or BP levels (O’Neill et al 1996).  
A meta-analysis of education in patients with CHD by Mullen et al (1992) 
demonstrated a significant mortality reduction of 19%, but found no impact on 
re-infarction or hospitalisation. Another meta-analysis by Dusseldorp et al 
(1999) concluded that a health education and stress management programme 
yielded a 34% reduction in cardiac mortality and a 29% reduction in  
re-infarction. However, this meta-analysis included a mix of psycho-social 
interventions and therefore cannot be seen as a review of education alone.  
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Both these reviews included both randomised and non-randomised evidence 
and enrolled white, middle class males. In addition, they were carried out at a 
time prior to the rapid developments within cardiac care previously discussed 
and therefore their applicability to current practice is limited.  
In summary, it would appear that educational interventions as part of CR can 
provide health gain, but that further exploration of the role that education can 
play in a modern individualised programme of CR and the different benefits that 
could bring are required.  
3.6 Impact on under-represented groups    
One of the criticisms of the previously discussed research is that it has 
concentrated mainly on young male MI and cardiac surgery patients. There is 
however some research on the impact comprehensive CR can have on other 
groups such as the elderly, ethnic groups, and women.  
As has been stated earlier, the incidence of CHD rises with age and older 
patients have more modifiable risk factors than younger adults (Fair 2003). 
There is some evidence that CR can have benefits no matter the age. Effective 
rehabilitation services have been shown to reduce cardiac death and improve 
exercise tolerance, functional capacity and QoL in older people (Lavie and 
Milani 2000, Jolliffe et al 2001, Ades et al 2002, Hage et al 2003, Marchionni et 
al 2003). In a study looking at patients, older than eighty, who attended at least 
one session of CR, Muhll et al (2002) demonstrated a 20% increase in 
functional capacity with exercise based CR in this very elderly cohort, without 
any adverse events. Exercise based CR appears to be safe in the elderly and 
studies demonstrate that improvement is similar to younger patients.  
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 A study of patients after MI (Witt et al 2004) found that, although individuals 
older than 70 years old were less likely to participate in CR, overall survival 
benefit was better in CR participants compared with non-participants, along with 
a decrease (28%) in recurrent MI. 
Women are generally older when they develop CHD and this has 
implications for their ability to access and benefit from CR. Issues around 
attendance will be dealt with in chapter 3:7, however the evidence for benefit in 
women is also limited. Most of the meta-analyses mentioned in chapter 3:3 
included mainly men and did not focus on the benefits to women.  
CHD is a major contributor to both morbidity and mortality in ethnic minority 
populations (Mosca et al 1997, Sheth 1999). The prevalence and degree of the 
associated risk factors varies across different cultural, ethnic and racial groups. 
(Yusuf et al 2004, Mosca et al 2004). Yet the evidence base for CR in ethnic 
groups is limited.  
As stated before, it has been recognised that much of the previous CR 
research has been conducted on white middle class males and the focus needs 
to shift to identifying how CR can improve impact across diverse populations.   
3.7 Uptake and adherence  
One of the challenges that has faced CR programmes is the implementation 
of the research. A recent study looking at uptake and adherence in a RCT found 
that 73% of all patients admitted to hospital with MI were eligible for CR. Those 
excluded tended to be older, were more likely to have suffered from previous MI 
and had a more severe presentation of CHD (Beswick et al 2004).  
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However, at least an additional 22% did not attend CR.  This was due to further 
selection by CR staff. There was a clear trend for non-invitation in older age 
groups. Uptake rates amongst older patients can be as low as 14% for women 
and 20% for men over 62 (Ades et al 1992a, 1992b). It has been argued that 
older people desire CR programmes that they perceive as being more 
conducive to their needs (Davidson et al 2003). This could mean 
communicating the benefits of CR in a way that is meaningful to older people, 
such as promoting independence, improving their ability to perform household 
chores and to pursue leisure activities.  
In a trial carried out in the West Midlands of England, Jolly et al (2005) 
found that one reason for the exclusion of ethnic groups in clinical trials was the 
inability to support the range of minority languages required. They found that 
significantly more patients of South Asian ethnicity were excluded and that there 
were large differences between Indian, Pakistani and Bangladeshi patients, with 
Bangladeshi patients being far more likely to be excluded.  However, those who 
met the language criteria were then recruited to the trial in equal numbers. 
Studies that have assessed CR uptake in patients from ethnic backgrounds 
have found that uptake and adherence are especially low in those populations 
with the highest rates of CHD and who would have a lot to gain from CR (Tod et 
al 2001). Webster et al (2003) determined that the needs and experiences of 
the Gujarati Hindu patients, after a cardiac event, were different from those of 
non-asian patients. They suggested that a lack of accessible culturally 
appropriate information about CHD, its management and prognosis, may 
influence South Asian patients post MI behaviour and therefore their adherence 
to CR recommendations.  
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Pell et al (1996) in a study of CR in the West of Scotland found that 
deprivation was associated with an increased risk of MI. Deprived  patients were 
no less likely to be invited to attend CR, but they were significantly less likely to 
start. In addition, deprived patients who did start the programme were less likely 
to complete it. There is a dearth of literature reporting the evaluation of simple 
interventions aimed at improving adherence to CR for all patients or specific 
groups of patients (Beswick et al 2004).  
3.8 Modes of delivery  
The literature on the impact of CR in the physical domains shows definite 
benefits, and in the psychosocial domain, there is some evidence of benefit. 
However, as has been stated earlier, the components of CR, are both multi - 
factorial and multi-disciplinary and need to target a wide range of individuals 
from different backgrounds. There are a number of ways in which CR can be 
delivered. These include: different intensity of exercise, different venues, and 
different start dates following a cardiac event. This makes the gathering of 
evidence of what combination works well and brings the best outcomes difficult. 
The relative importance of each of the components has not been analysed. 
There have been few RCT’s which compare varying types of programmes or 
analyse which components have more impact. Taylor et al (2004) found no 
significant difference in the impact of CR on total mortality when comparing 
trials of exercise only or comprehensive CR or when comparing trials of 
different doses of exercise.  Jolly et al (2005) reviewed the evidence relating to 
different modes of delivery, more particularly with regard to home based CR 
provision. In this review they identified 18 RCT’s that compared home based 
CR to usual care and 6 RCT’s that compared home based CR to  
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centre based CR. In their review they found significant improvements in systolic 
BP and smoking cessation in home CR when compared to usual care, but when 
directly compared to centre based CR, they found the effects on exercise 
tolerance and risk factors to be similar.  Although the research tells us that a CR 
programme can have benefits for a range of people, there is difficulty in 
implementing these trials in clinical practice. Programmes are constrained by 
local resources, access issues and poor referral, take-up and attendance rates 
(Lewin et al 2004). However, none of these trials addressed menu-based 
programmes where the individual’s needs are identified and treated.   
In summary, clinical programmes do not have the ability to restrict the 
participants to specific client groups or specific types of provision, and this has 
led to a gap between research and clinical practice where menu-based CR has 
become the recommended mode of delivery (SIGN 2002). This will be explored 
in greater detail in chapter 3:9.  
3.9 Menu-based Cardiac Rehabilitation 
Current CR provision within the UK has been examined by several  
researchers (Bethell et al 2000, Lewin et al 2004) and there has been some 
progress on developing a benchmark for service provision. In the past, MI was 
seen as an acute event, something that happens and that you recover from and 
don’t allow to interfere with the future.  However in recent years, as secondary 
prevention strategies have developed, there has been a move away from this to 
viewing MI as part of a chronic illness (SGHD 2007). As has been shown 
previously, there are many drugs now that can slow the progression of CHD, in 
addition, there are strategies involving behavioural change that can impact on 
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risk reduction. But, in order for these to work, there needs to be compliance on 
the part of the individual and an understanding by them that this condition will 
be with them for life.  This focus on self-management has been encouraged by 
government with the development of a focus on long term conditions throughout 
the healthcare system (SGHD 2008). There has been a move within CR to 
recommending a menu based approach and standards issued by the BACR 
support this development (BACR 1999).  However the menu-based approach is, 
for the most part, based on expert guidance and not on research.  There is little 
research that evaluates the impact of menu-based CR as it is currently provided 
within the UK.  
The framework for CR provision in the UK (BACR 1999) is divided into four 
phases and each represents a different section of the pathway (see Table 3:1). 
The initial phase covers the stay in hospital and it consists of a full assessment 
of the individual’s needs and the provision of both information and support to 
the individual and their family, with the focus on explaining the diagnosis and 
the context of the recovery. This is often undertaken by either a nurse or a 
physiotherapist in the ward area and is the introduction to the CR programme.  
The second phase, or as it is also known as the ‘post discharge phase’, 
relates to the period of time between discharge and commencing an outpatient 
CR programme of some description. The length of this phase can be anywhere 
from one or two weeks to several months in some programmes, but usually 
lasts about four to six weeks. During this time, a range of activities can take 
place according to local circumstances. These could include telephone follow 
up, home visits from specialist staff, follow up by community nursing teams or 
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practice nurses or the provision of specialist resources such as the Heart 
Manual (Lewin et al 1992). The focus during this period is on returning to 
normal activities and on reducing risk behaviours such as smoking or poor 
eating habits. 
Phase three, or more commonly the ‘outpatient phase’ , relates to the 
provision of a programme of exercise which commences when the individual is 
deemed fit to exercise, usually around four to six weeks post cardiac event.  
The exercise prescription can include home programmes, low or moderate 
intensity exercise, and either hospital or community provision. It can often 
include education and support sessions and on-going assessment of individual 
needs.      
Phase four, or the ‘maintenance phase’, refers to the time following 
discharge from a CR programme for the rest of the individual’s life.  It comprises 
activities designed to reduce risk and help to prevent a further cardiac event. 
These could include exercise classes, smoking cessation, support groups, 
secondary prevention clinics in the community and other supports available 
within the local community.  It is not often within the remit of CR programmes, 
but often falls to local authorities, community services or voluntary groups. 
Across the UK there are a lot of differences in the resources and component 
parts of a local CR programme. Not all phases are provided or supported by all 
programmes. However both phase one and phase three are components of 
most CR programmes in the UK.  
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Table 3:1   Phases of Cardiac Rehabilitation  
Phase one: Inpatient care 
 
Medical assessment, reassurance and education, correction 
of cardiac misconceptions, risk factor assessment, 
mobilisation and discharge planning are the key elements. It 
is customary to involve family and partners from this early 
stage. 
Phase two: Early post discharge period,  Support can be provided by home visiting, telephone contact 
and some programmes use the Heart Manual.  
Phase three: Outpatient exercise training A structured exercise programme in a hospital or community 
setting. A menu-based approach recognises the need to tailor 
the delivery of services to the individual and is likely to include 
specific education to reduce cardiac misconceptions and 
encourage smoking cessation and weight management.  
Phase four: Long term maintenance Involves the maintenance of physical activity and lifestyle 
change. Membership of a local cardiac support group, a gym 
or leisure centre, may help maintain physical activity and 
behavioural change. 
Source: SIGN 2002 
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In summary, the menu-based approach is based on expert guidance and not 
on research. There is little research that evaluates the impact of menu-based 
CR as it is currently provided within the UK.  
3.10 Acute Coronary Syndrome Low Troponin  
As has been discussed in chapter 2:5, the development of new diagnostic 
tests, which identify small amounts of damage to the heart, have led to changes 
in the treatment of MI.  New diagnostic categories have been created (see 
Table 2:1), which classify all admissions to hospital with chest pain according to 
the level of troponin in the bloodstream. There is a large body of evidence on 
the medical management required for individuals with all categories of ACS 
including ACSLT (SIGN 2007a). However, although there is evidence for the 
effectiveness of CR in MI and stable angina, there is little published evidence 
that looks at the impact of CR on patients with ACSLT. These patients have 
traditionally not received CR in the UK and little is known of the impact that CR 
could have on this group. 
3.11 Theoretical framework for Cardiac Rehabilitation  
The increasing focus on individualised care within CR has highlighted that 
CR programmes need to become more effective in addressing the 
psychological needs of the patients as well as their physical needs (Linden et al 
1996, Mayou 1996, Jolliffe et al 2001). Surveys have highlighted that 
psychosocial factors are still poorly assessed (Lewin et al 1998) a nd that the 
measurement of psychological and QoL criteria within programmes is not 
universally carried out (Bethell et al 2000).  
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Professionals, within CR, do not use psychological interventions 
systematically due to limited identification of patient’s il lness beliefs and 
expectations. Programmes do not ground interventions in a specific theory or 
framework. The need to pursue the establishment of a well-grounded theoretical 
framework, to develop models of care that deliver effective CR interventions, 
has been clearly recognised (DOH 2000), and highlighted in guidelines issued 
by the BACR (Coats et al 1995).  
Over the last twenty years, CR has developed from the initial exercise and 
risk factor management model to a broader holistic model of multi -disciplinary 
care. As discussed previously, there are difficulties in implementing evidenced 
based practice in CR, and improving individual compliance with treatment is 
therefore an important element of the design of any CR intervention.  Therefore, 
the theoretical framework underpinning the intervention for this thesis needs to 
have a similar focus.  Without accommodating patient’s individual psychological 
perspectives, when developing and delivering care strategies, research 
indicates that there is a potential for ineffective communication and ultimately a 
failure to provide appropriate rehabilitation strategies that sustain long term 
health behaviour change (NHS CRD 1998).  
The two theories which have been used to underpin individualised care in 
CR are the CSM (Leventhal et al 1980, Leventhal et al 2003) and Self-Efficacy 
(SE) (Bandura 1977). Both theories try to explain why patients with similar 
conditions differ in their response to that condition and how carers can best 
manage these differences. Each theoretical framework argues that it is through 
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the individuals experience, rather than their personality, that patient’s actions 
and perceptions are informed (Lau-Walker, 2004).  
The CSM (Leventhal et al 1980, Leventhal et al 2003) is a commonly used 
model to explain how people interpret current and potential health events or 
threats. The CSM is organized in five dimensions which together make up 
common sense perceptions of an illness episode or health threat.   
The five key elements of this theory are identity, timeline, cause, 
consequences, and control/cure.  Identity refers to the label a person uses or to 
the symptoms that they view as being part of their illness. Timeline refers to an 
individual's beliefs about how long the i llness will last. Cause describes an 
individual’s personal ideas about the cause of the health problem. 
Consequences relate to an individual's beliefs about the likely impact of the 
illness on QoL or functional ability. Control/cure relates to the individuals beliefs 
about whether the condition can be cured or kept under control and the degree 
in which the individual plays a part in achieving this.  
The CSM is particularly suited to understanding and improving patients’ 
management of chronic illness. The theory involves individuals monitoring their 
efforts and outcomes in managing tasks and using this information to regulate 
the process towards achieving desired goals. As a theoretical model it 
describes patients as active problem solvers, who make sense of a threat to 
their health such as physical symptoms or an illness, by developing their own 
cognitive representations of the threat, which in turn, determine how they 
respond (Leventhal et al 1980, Leventhal et al 2003). The model can be 
conceptualised as operating in three stages. The first invo lves the creation of 
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cognitive and emotional representations and thus goals for coping. The second 
stage refers to the development and execution of plans for coping directed 
towards those goals. The third stage of appraisal involves evaluating whether 
the coping response has moved the individual closer to, or further from, the 
goals specified by the representation (Lau-Walker 2004). An individual’s illness 
representation involves both concrete (e.g. chest pains) and abstract features 
(the idea that one is having a heart attack).   
The CSM has been used in a number of studies amongst different 
populations including diabetes (Griva et al 2000), psoriasis (Fortune et al 2002) 
and multiple sclerosis (Vaughan et al  2003). In CHD, one study by Ades et al 
(1992a) found that patients who were judged by staff to view their illness less 
seriously, were less likely to attend CR.   Petrie et al (1996) argue that the 
assessment of illness perceptions may have a valuable role in identifying which 
patients are likely to benefit from CR programmes. Patients who perceived that, 
their heart disease has little hope of being controlled, may benefit from another 
intervention, specifically targeted at changing this perception, before attending 
CR. Whitmarsh et al (2003) argue that people who attend CR differed from 
poor/non-attenders in that they perceived a greater number of symptoms and 
consequences of their illness, greater distress, less strong beliefs that their 
illness had been caused by a germ or virus, and used problem-focused and 
emotion-focused coping more frequently. The best predictors of poor or  
non-attendance were: lower perceptions of symptoms and controllability or 
curability of the i llness, and less frequent use of problem-focused, and more 
frequent use of maladaptive coping strategies. In a further study,  
Petrie et al (2002) showed that a brief intervention, based on the CSM, carried 
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out in hospital, prior to discharge after a MI, caused significant positive changes 
in patients’ views of their MI. Patients in the intervention group also reported 
they were better prepared for leaving hospital and subsequently returned to 
work at a significantly faster rate than the control group. Before leaving hospital, 
patients in the intervention group had significantly modified their perceptions 
about how long their illness would last and the personal consequences of the MI 
on their life compared with the control group. The group reported a significantly 
lower rate of angina symptoms than control subjects, although there were no 
significant differences in CR attendance between the two groups.  
The second theoretical framework that could be used is SE. The leading 
proponent of SE theory is Albert Bandura (1977), who asserts that behaviour is 
the outcome of an interaction between cognitive processes and environmental 
events. People process and synthesise feedback, from sequences of events 
over long intervals, about the situational circumstances and the patterns and 
rates of action that are necessary to produce given outcomes. Perceived SE is 
not a measure of the ski lls one has, but a belief about what one can do under a 
different set of conditions, with whatever skills one possesses. A patient may 
believe that exercise will improve future health, but may still not engage with 
exercise because they do not see themselves as able to start regular exercise 
and sustain it.  
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Bandura (1977) argues that there are four sources of SE with a hierarchy of 
significance for informing behaviour: 
1. Enactive mastery experience which is based on persona l mastery 
experiences 
2. Vicarious experience: seeing others perform activities without adverse 
consequences may generate expectations that they too will improve if 
they persist in their efforts 
3. Verbal persuasion: people are led through suggestion into believing they 
can cope successfully with what has overwhelmed them in the past 
4. Physiological and affective states: an individual’s physiological state 
provides information that can influence efficacy expectation.  
Self-Efficacy makes a difference in how people feel, think and act.  Levels of SE 
can enhance or impede the motivation to act. A key element of CR is the need 
to sustain change over long periods of time and it is here that SE could be seen 
as a suitable theoretical framework.  
Jackson et al (2005) in their review of attendance and adherence in CR 
found that an important factor in attendance was a high level of SE.  
Improvements in SE with a CR intervention have also been found by a number 
of authors (Gardener et al 2003, Lau-Walker, 2004).  Gardener et al (2003) also 
found that SE improved regardless of gender and diagnoses.  
Lau-Walker (2004) in a study on the relationship between CSM and SE 
found that there was a significant relationship between CSM and SE. The 
greater patients’ perceived consequences of the heart condition, the lower was 
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the general SE available to cope with the condition. Further, the longer the 
perceived time the condition will affect the patient, the higher the specific SE to 
maintain a change of diet or exercise regime. Her findings identify that, in the 
initial phase of recovery, nursing practice needs to focus on the key variables of 
the CSM of  ‘consequence’ and ‘timeline’ in order to increase patients’ 
confidence in their ability to cope (SE). 
Research on the CSM tends to be associated with health outcome 
intentions, whereas SE research tends to be associated with predicting long 
term behaviour changes (Petrie and Weinman 1997, Lau-Walker 2004).  Both 
have merits in the field of CR, however this thesis focuses on health outcomes, 
rather than long term behaviour change, so the theoretical framework that will 
be used is the CSM.   
3.12 Need for further research  
The evidence base for the exercise component of CR, as it is delivered in 
RCTs, is compelling. But this is not the case for the psychological and 
educational domains. Although there is some evidence of benefit in 
psychological interventions within CR, there is also a degree of ambiguity in the 
CR literature. Areas such as misconceptions, anxiety, depression and HRQoL 
need further research. Educational interventions in CR can bring health gain, 
but there is a need for further exploration of the role that education can bring to 
a menu-based programme of CR. The difficulties within the literature regarding 
the psychological and education domains are partly due to the difficulty in 
separating out the key components of CR to allow evaluation. Much of the early 
CR research has been conducted on white middle class males, yet clinicians 
working within CR programmes do not have the ability to restrict participants to 
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specific client groups or specific types of provision. The focus needs to shift to 
identifying how CR can improve impact across diverse populations and 
diagnoses.  
There is also a limited evidence base reporting the evaluation of simple 
interventions aimed at improving adherence to CR for all patients or specific 
groups of patients. Professionals within CR do not use psychological 
interventions systematically due to limited identification of patient’s illness 
beliefs and expectations. Programmes do not ground interventions in a specific 
theory or framework which would support better compliance and treatment 
outcomes. 
The research base for menu-based approaches and for some groups such 
as those with ACSLT is very limited. This has led to a gap between research 
and clinical practice, where menu-based CR has become the recommended 
mode of delivery, and CR programmes are being asked to take patients with a 
wider range of cardiac diagnoses. Clinicians need further research to support 
them in the development of menu-based services, based on a theoretical 
framework, particularly in the psychological and educational domain. Despite 
the gaps in the research, CR has become an accepted part of the recovery of 
all patients with MI and CABG. Government strategies (DOH 2000, SIGN 2002) 
have recommended that CR should be available for all patients and this makes 
the need for further research on these issues essential. 
 
 
66 | P a g e  
 
3.13 Conclusion  
In the previous chapter, it was noted that CHD is a major challenge for the 
NHS, both nationally and locally. Significant changes in the modern 
management of CHD have highlighted that clinical practice can make a 
substantial impact on mortality and morbidity. The evidence base would suggest 
that it is important to identify those with a diagnosis of ACSLT and put in place 
management plans that reduce risk and improve outcome. A treatment that is 
not currently provided, to individuals with this diagnosis, is CR, which is a multi-
factorial, multi-professional intervention and is one of a number of interventions 
used to improve outcomes for CHD. 
The goal of CR is not only to prolong life , but also to improve physical and 
psychological functioning, symptoms, well-being, and HRQoL (SIGN 2002).  
In this chapter the evidence base for CR has been reviewed across three 
domains: exercise, psychological and educational and it has been shown that 
there are large differences in the quality of evidence for the various components 
of such a complex intervention. The evidence base for the exercise component 
of CR is comprehensive and compelling. Although focusing in the main on MI, 
CABG, and PCI, there is evidence that CR can have an impact on the physical 
health of participants with a variety of diagnoses through exercise. This is 
confirmed in several meta-analyses, systematic reviews and RCT’s.  
If the psychological domain is considered, it can be seen that there is some 
suggestion of benefit from psychological interventions within CR.  However,  
the findings from this evidence base are currently ambiguous and there is a 
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need for further research into the role of misconceptions, anxiety, depression, 
and HRQoL.  
The final domain is the educational domain and the research base on the 
impact of CR on this area is varied. Several meta-analyses would suggest that 
educational interventions as part of CR can provide health gain. However , there 
are some difficulties in differentiating the impact of education and of 
psychological interventions. There is a need for further exploration of the role 
that education can play in a modern individualised programme of CR.  
This chapter has examined a range of issues that have been highlighted in 
the evidence base for CR, that need to be considered when modelling a CR 
intervention.  These include: the selection of appropriate target groups, uptake, 
adherence, and modes of delivery. In addition the choice of the theoretical 
framework on which to base a CR intervention has been discussed. One of the 
criticisms of the evidence base is that it has concentrated mainly on young male 
MI and cardiac surgery patients, however there is some research on the impact 
comprehensive CR can have on other groups such as the elderly, ethnic 
groups, and women. This evidence base is limited in scope and size and further 
research in this area is needed. There is a large body of evidence on the 
medical management required for individuals with all categories of ACS 
including ACSLT (SIGN 2007a). However, although there is evidence for the 
effectiveness of CR in MI and stable angina, there is little published evidence 
that looks at the impact of CR on patients with ACSLT.  
There is also a dearth of literature reporting the evaluation of simple 
interventions aimed at improving adherence to CR for all patients or specific 
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groups of patients. There have been few RCT’s which compare varying types of 
programmes or analyse which components of CR programmes have more 
impact. Programmes such as menu-based CR have become the recommended 
mode of delivery, yet there is a dearth of evidence of the benefits of this type of 
service delivery. This increasing focus on individualised care within CR has 
highlighted that CR programmes need to have a theoretical framework on which 
to base care. In this chapter, two frameworks have been reviewed, both of 
which have merits in the field of CR. These are CSM and SE. Both theories try 
to explain why patients with similar conditions differ in their response to that 
condition. Research on the CSM tends to be associated with health outcome 
intentions, whereas SE research tends to be associated with the prediction of 
long term behaviour change (Petrie and Weinman 1997, Lau-Walker 2004).  
Both have merits in the field of CR, however the theoretical framework that will 
be used in this thesis is the CSM.   
Despite the gaps in the research, CR has become an accepted part of the 
recovery of all patients with MI and cardiac surgery.  Government strategies 
(DOH 2000, SIGN 2002) have recommended that CR should be available for all 
patients with CHD and this makes the need for further research on CR and 
those with ACSLT essential. 
In summary, this chapter has followed the MRC framework for researching 
complex interventions, by highlighting the evidence base for CR and the relative 
strength of the evidence on the exercise, psychological and educational 
domains  (Pre-clinical Phase) and by modelling what the intervention should 
look like (Phase I).  This chapter has examined the strength of the evidence on 
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the components that a CR intervention would normally include, modes of 
delivery, attendance and adherence, and has described the theoretical 
framework on which the CR intervention will be based. This chapter has also 
identified areas of CR practice that require further testing and modelling and 
has identified a client group for CR (ACSLT) about which little is known    
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Chapter Four  Research aims and design 
4.1 Introduction   
In the previous chapters, following the MRC framework for complex 
interventions, the research base and the underpinning theory have been 
highlighted and the components that could make up the intervention modelled. 
The next step in the framework is that of Phase two; the exploratory trial.  
The thesis contains a feasibility study and an exploratory study. The feasibility 
study aimed to examine the feasibility of a RCT which would test the impact of a 
menu-based CR programme, on individuals diagnosed with ACSLT, against 
standard care. This feasibility study also included staff views. The exploratory 
study aimed to explore the impact that ACSLT and CR can have on this client 
group. The findings of this thesis would inform the design of a RCT (phase 
three) and the progression thereafter to phase four; implementation into 
practice. 
This chapter will describe and discuss the methodology employed to meet 
the aims of this thesis, taking into account the clinical context and information 
from the literature. The design and coordination of the studies will be discussed 
first, followed by ethical considerations and recruitment. The measures and 
process for data collection will then be addressed, and finally, timescales and 
funding. 
4.2 Background 
As has been previously stated, CR is a complex intervention and the design 
and evaluation of complex interventions is problematic. There are a large 
number of diverse components within CR, which act and interact with one 
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another to achieve a range of outcomes for the participant. The evidence base 
for CR has been discussed in chapter 3:2-3:9, however, this evidence base is 
predominantly focused on the post-MI and CABG populations. There is a need 
to examine the impact within a new client group, those with ACSLT.  
4.3 Choice of research methods  
As stated the choice of research methods has been determined by the MRC 
framework, which suggests that a RCT is the gold standard for researching 
complex interventions. However, before developing a RCT, it is important to 
determine whether an intervention is appropriate for further testing, in other 
words, to assess whether or not the ideas and findings can be shaped to be 
relevant and sustainable (Bowen et al 2009).  A feasibility study for a RCT is 
necessary therefore, to test the study design, instruments used, and the 
intervention itself in terms of its acceptability to the participants and staff.  There 
are few previously published studies or existing data on CR in ACSLT. It is 
therefore also important that an exploratory study is carried out to examine the 
experience of participants with ACSLT. For this reason this thesis uses both 
quantitative and qualitative methods in collecting data. This is the first step in 
evaluating the impact that CR can have on this new and novel population.  
4.4 Aim of thesis 
This thesis contains a feasibility study and an exploratory study. The 
feasibility study aimed to examine the feasibility of a RCT which would test the 
impact of a menu-based CR programme, on individuals diagnosed with ACSLT, 
against standard care. This feasibility study also included staff views. The 
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exploratory study aimed to explore the impact that ACSLT and CR can have on 
this client group.  
 
4.5 Research questions 
In attempting to meet the aim of the thesis, specific research questions were 
devised:  
Feasibility Study  
 Would a RCT of a menu-based CR programme for individuals with a 
diagnosis of ACSLT be feasible ? 
 How do staff caring for individuals with ACSLT view the  study and the 
feasibility of a RCT of CR 
 
Exploratory Study 
 What  impact did a menu-based CR programme for individuals with a 
diagnosis of ACSLT have on four areas   
o Cardiac misconceptions  
o Cardiac symptoms 
o Anxiety and depression. 
o HRQoL 
 How do individuals with ACSLT view their illness? 
This thesis includes two studies: a feasibility study and an exploratory study. 
However, these studies used the same group of participants, who were 
recruited while in-patients within the wards, and data were collected from the 
participants throughout the timescale of the studies. The data relating to 
feasibility are reported in the feasibility study and the data gathered from both 
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quantitative and qualitative measures are reported in the exploratory study.  
The term “participant” will be used for the patients who took part in the studies. 
Nursing staff took part in the focus groups as part of the feasibility study and 
they will be referred to as “staff”.  The terms; feasibility study, exploratory study, 
studies, and thesis will be used throughout. In order to avoid confusion, the term 
“feasibility study” will be used when it relates to issues of feasibility. The term 
“exploratory study” will be used when it relates to the data collected from 
participants. The term “studies” will be used when information from both studies 
is being discussed and the term “thesis” will be used to describe the work 
overall. 
4.6 Feasibility study design  
The feasibility study was a exploratory repeated measures longitudinal case-
control study, that examined the feasibility of a RCT, which would test the 
impact of a menu-based CR programme, on individuals diagnosed with ACSLT, 
against standard care. This feasibility study included staff views on issues of 
feasibility and CR through the use of focus groups.  
4.7 Exploratory study design  
The exploratory study was a repeated measures longitudinal case-control 
study that aimed to explore the impact that CR can have on this client group, 
through the use of both standardised questionnaires and qualitative data 
collected at interviews with the participants. This two group study aimed to 
compare patients who received CR (intervention) with patients who did not 
(control). Although it would have been beneficial to randomise participants into 
the two groups, this design was not possible, due to the anticipated impact on 
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the workload for the CR team. The practicalities of organising and delivering an 
intervention meant that a case control design was the better choice, as it 
concentrated the professional resource that was needed into a short time span 
and this allowed the staff to develop and practice the skills required for this 
population.  
4.8 Ethical considerations  
Prior to initiation of the studies, the protocol was submitted to the Ethics 
committee of NHS Ayrshire and Arran and the Research Ethics Committee of 
the School of Nursing and Midwifery at the University of Stirling. The studies 
were conducted within the Research Governance Framework of NHS Ayrshire 
and Arran and run according to internationally agreed Good Clinical Practice 
Guidelines (ICH 1996). A summary of the ethical considerations in these studies 
are considered in the following discussion.  
Admission to hospital with an acute cardiac event is a stressful time for any 
individual and this makes them vulnerable to undue pressure. It was important 
to remind participants that their participation was entirely voluntary and that they 
could decline participation or withdraw at any stage of the study. The researcher 
ensured that all participants were given a full description of what the studies 
entailed. The researcher is a well-known figure within cardiology and has 
worked in this area for 18 years. Often, the influence that the person recruiting 
the individual has, can be crucial. If the researcher is perceived as part of the 
clinical team, then the individual may be more willing to agree, as they may feel 
dependent on the care given during their stay in hospital. The individual may 
also worry over the care they will receive, if they do not take part in the trial, or 
75 | P a g e  
 
they may think that they will get better care if they do. This could have been 
difficult for the researcher, as in her previous role she would be perceived as 
part of the clinical team. During the period of these studies however,  
her only role for this group of participants was as a researcher, and this was 
made clear to all patients. As the researcher has moved into a managerial role 
in the last two years, she has withdrawn from the in-patient clinical area.  
Patients are very vulnerable during a hospital stay and it could have been that, 
by completing the questionnaires, additional concerns were raised. Clear 
guidance was available both in the written information from the researcher and 
from clinical staff who had been updated on the process of the studies and were 
vigilant in looking for signs of distress. In addition, both the cardiologist and 
general practitioner were informed of the patient’s participation in the stud ies. 
There were no instances of distress caused to participants during these studies.  
The guidelines (ICH 1996) state that 48 hours minimum should be given to 
patients to allow them to consider their participation in the studies. As many of 
these patients only spend four or five days in hospital this was quite difficult to 
achieve. It was felt that 24 hours to consider participation was achievable and 
this was agreed to by both ethics committees. The researcher ensured that 
information was available from admission if the patient met the criteria. Patients 
were told that they may be approached or not depending on the diagnosis 
reached and that they should consider if they wished to be involved in the 
research. This allowed the patient time to consider their opinion on participation 
before they were approached. The criteria for entry to the studies were clear 
and concise, so that those not selected, due to a different diagnosis, would be 
aware that this was the reason.  All patients, selected for the research, were 
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approached by the researcher and given full written and verbal information. 
They were then given 24 hours to discuss their participation with their families. 
Another possible area of difficulty is the fact that participants received usual 
care or were part of the intervention arm. As the studies were not randomised, 
the researcher and the ward staff knew beforehand which group the participant 
would be allocated to and this could have influenced the recruitment process.  
It may be that, the staff would not see any benefit for their patient in 
participating in the study, if they were to be in the ‘usual care’ arm. This could 
lead to difficulty in recruitment. In this trial it was agreed therefore to use a 
delayed intervention, in that those in the control arm, who wished to do so, 
would be offered the chance to take part in the intervention following the 
completion of the research.  
All participants in the studies were assessed following the same protocols. 
This includes risk stratification using exercise tolerance testing, which they 
require regardless of participation or not, and assessment by the 
physiotherapist regarding other health problems, which might influence their 
ability to exercise. Where the health of the participant deteriorated , and it was 
felt they were no longer able to cope with the studies, they were withdrawn and 
usual care continued. 
As some participants took part in exercise classes during the intervention 
there was a potential increased risk of a cardiac event. This is calculated as one 
event in six years (SIGN 2002). Exercise classes are standard for CR 
programmes, and protocols were in place to identify the risk for individual 
participants and to place them in the appropriate class. Consultant cardiologists 
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were involved in the assessment of risk, prior to the individual’s attendance at 
class, to ensure safety. Classes were supervised by a specialist nurse and 
emergency arrangements were in place. Should a participant take unwell in 
class or be unable to complete the required number of sessions, plans were in 
place for them to be assessed and treated according to local protocols.  This did 
not in fact happen and there were no withdrawals for this reason. 
As has been stated previously, the researcher was a clinical expert in the 
field and there are clear difficulties in stepping out of this clinical role into that of 
a researcher, particularly if the participant develops health or other problems 
that should be dealt with immediately. The participant may become unwell or be 
suffering from a life threatening deterioration in their illness. The researcher was 
aware that she should not break the confidentiality of the interview without the 
express permission of the participant. In the event that information became 
available to the team, about the health of the participant, that suggested 
continuing would cause them harm, they would have been immediately 
withdrawn. If a participant had received a terminal diagnosis during the period of 
the research, or their cardiac condition had deteriorated quickly, completing the 
studies may have caused them emotional distress. This did not in fact happen, 
but the researcher was aware of the possibility.   
Confidentiality was respected at all times throughout the studies, with 
adherence to the Data Protection Act (DOH 1998) and compliance with the 
NHS Scotland Code of Practice on Protecting Patient Confidentiality (SEHD 
2003, SGHD 2010). The following measures were taken to protect participants’ 
confidentiality: all participants were assigned identification numbers, all data 
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was anonymised as soon as possible. The only information that contained 
demographic data were the registration sheets as this was necessary to 
facilitate the home visits. This was kept in a locked drawer in the consultant 
nurse’s locked office. All other study material was stored in a locked filling 
cabinet in the same office.  Participants were informed that demographic data 
would be collected and were assured of anonymity in the material written up for 
the studies. Any electronic data relating to the studies was only accessible on 
the Principal Investigators password protected PC, and this was kept in a 
locked office. The Caldicott Guardian was informed of the existence of the data 
and it was agreed that the data will be destroyed 15 years after the completion 
of the research. 
4.9 Access to clinical sites  
These studies were carried out in NHS Ayrshire and Arran, serving a local 
population of 375,000.  NHS Ayrshire and Arran has a high incidence of CHD, 
with 22,000 people currently living with CHD. In addition, there are 
approximately 5,000 admissions a year for a CHD related illness and 2500 new 
referrals for outpatient cardiology assessment (ISD 2011). The researcher was 
based within this area and had easy access to the clinical community. The CHD 
Managed Clinical Network (MCN) funded the research and was keen that both 
local hospital sites be included, so that information that would guide future 
service development for individuals with this diagnosis was gathered across the 
health board area. 
A copy of all documentation was submitted to the Research & Development 
(R&D) Department. Full R&D approval was in operation throughout the research 
79 | P a g e  
 
period which included access to the relevant clinical sites. Annual reports were 
submitted to the required R&D department as part of the approval requirements. 
4.10 Sample  
This thesis contains a feasibility study and an exploratory study. The 
feasibility study aimed to examine the feasibility of a RCT which would test the 
impact of a menu-based CR programme, on individuals diagnosed with ACSLT, 
against standard care. This feasibility study also included staff views. There are 
therefore two target groups of recruitment within the feasibility study: patients 
and staff.  
Recruitment within the patient group took place whilst they were in hospital. 
The patients recruited to the feasibility study also took part in the exploratory 
study and the recruitment process for both studies is described in chapter 4:13.  
The staff group, involved in the feasibility study, included 8 participants 
drawn from 60 staff employed within the cardiology wards and 6 staff drawn 
from 15 staff employed within the CR service within NHS Ayrshire and Arran.   
They were recruited to elicit their views on the feasibility of a RCT of CR 
through focus groups.  The inclusion criteria for this element of the feasibility 
study were: 
 Working within cardiology or CR during the full period of the feasibility 
study  
The exclusion criteria were: 
 Having a first degree relative who had been through CR 
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The exploratory study was a repeated measures longitudinal case-control 
study that aimed to explore the impact that CR can have on this client group 
through the use of both standardised questionnaires and qualitative data 
collected at interviews with the participants. This two group study aimed to 
compare patients who received CR (intervention) with patients who did not 
(control). Recruitment within the patient group took place whilst they were in 
hospital. The recruitment process for both studies is described in chapter 4:13. 
 Predicted recruitment was based on current admissions to the two hospitals 
within NHS Ayrshire and Arran. It was anticipated that 100 participants would be 
recruited over the timescale proposed. It was thought that fifty would be 
recruited from site one and fifty from site two. The first twenty five on each site 
were to be in the control group and the rest were to be allocated to the 
treatment arm. It was planned to perform both between group and between site 
analysis. As there was little research in this area a power calculatio n was not 
possible.  It was hoped that this work would inform the power calculation for a 
RCT.  All patients of both sexes, who were admitted to two hospitals sites within 
NHS Ayrshire and Arran and diagnosed with ACSLT, were considered for 
inclusion in these studies.   Participation in these studies was entirely voluntary 
and participants were free to withdraw at any time without prejudicing their 
medical care and without having to justify their reasons for doing so. Diagnosis 
was established by one or more of the following: 
 Clinical History  
 Ischaemic ECG changes  
 Cardiac troponin release or raised serum Creatinine Kinase-MB(CK-
MB) enzyme demonstrated at any time during admission 
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As a key element of the studies was the CR intervention, it was important 
that patients who would normally be referred for CR and who had previous 
experience of CR were not included.  
The inclusion criteria for patients within both studies were: 
 Patients who are living in NHS Ayrshire and Arran 
 Able to speak, read and understand English  
 Aged 16 or over 
 Diagnosed as ACSLT by criteria above  
The exclusion criteria for patients within both studies were: 
 Classified as MI as they would normally receive CR follow-up 
 Housebound 
 Previous attendance at CR  
 Currently receiving treatment for a terminal illness 
 
4.11 Cardiac Rehabilitation in NHS Ayrshire and Arran  
The CR programme within NHS Ayrshire and Arran was established in 1990 
with the appointment of a specialist nurse to provide care at site two for 400 
individuals with MI.  Since then it has expanded to include both hospitals, and 
those who have had a cardiac event such as CABG, valve surgery, PCI, HF, or 
are referred from a rapid access chest pain clinic, as well as the original 
population of post MI. The CR team is managed by a consultant nurse and all 
the staff within the team have had more than ten years experience in cardiac 
care, with at least five years experience within CR.  
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Currently, the staff within the team support 1400 individuals with CHD 
following an acute event. They provide 12 exercise classes and 4 nurse led 
clinics across the area in both hospital and community sites. In addition, the 
team is supported as required by: cardiologists, pharmacists, dieticians, 
smoking cessation specialists, and social workers.  The team consists of the 
following permanent staff as noted in Table 4:1. 
Table 4:1 CR staffing  
Title Band WTE 
Consultant Nurse  8b 1 
Advanced Specialist Nurse  7 2 
Specialist Nurse 6 2.5 
Specialist Physiotherapist 7 2 
Physiotherapist 6 1 
Physiotherapy assistant  2 1 
Psychologist  7 0.5 
Medical secretary  4 1.5 
 
4.12 A Menu-based Cardiac Rehabilitation intervention 
As has been described in chapter 3:9, CR, as it is provided across the UK, 
varies widely from service to service due to funding constraints and local 
arrangements. This is in contrast to the evidence base which has focused on 
studies, with clearly defined interventions, for specific timescales. A key element 
of the feasibility study was to examine the feasibility of a RCT of a menu-based 
CR intervention for the participants, which was the same as that which would be 
given to any other individual referred to this CR service. For this reason the 
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intervention was not prescribed for the participants (group one), but was in fact 
agreed between the specialist staff and the participant at the assessment stage.  
Group one (CR programme)  
Following allocation to the intervention group, the participant was assessed 
by a specialist nurse in hospital and a programme of care agreed that would 
span from phase one to three of the CR phases (see Table 3:1).  During phase 
one, for all the participants, this involved input from a specialist nurse, 
physiotherapist, and other members of the multi-disciplinary team on the ward. 
These discussions included family members where appropriate. The topics that 
were covered were: 
 Structure of the heart and the process that causes ACS 
 Identifying and modifying risk factors 
 Behaviour change 
 Gradual return to activities  
 Goal setting and pacing 
 Psychological assessment 
 Medication advice 
Before discharge, an assessment of the individual’s physical, psychological and 
social needs was carried out and a care plan was agreed. The types of activities 
that could be prescribed during phase two included:  
 Home visits 
 Outpatient clinic visits  
 Telephone support 
 
The types of activities that could be prescribed during phase three included:  
84 | P a g e  
 
 Moderate intensity exercise rehabilitation for 13 weeks in a class setting  
 Low intensity exercise rehabilitation for 13 weeks in a class setting  
 Home exercise plan 
At any time during the CR programme, additional support could be sought from 
topic experts dependent on participant need. These could include: 
 Referral to psychologist  
 Referral to specialist smoking cessation advisor  
 Referral to dietician 
 Referral to social work  
Following completion of the programme, participants were referred onto local 
voluntary providers of phase four that aimed to reinforce the behaviours gained 
through the CR programme. 
Group two (standard care):  
Participants in this group received the same medical care as the 
intervention group. They were in hospital for similar lengths of time and received 
routine input from ward nursing staff during their stay. The clinical care, 
information and support provided by the nursing staff were similar for both 
groups and included information on the disease process, risk factor 
management and recovery. The input all participants received varied depending 
on ward allocation, skill mix and workload at that time. The standard care group 
however, did not receive input from the specialist CR team.   
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4.13 Recruitment of participants for feasibility and exploratory studies 
The ward nurse in charge provided information to all patients admitted to the 
coronary care units in both hospitals. Potential subjects were then identified to 
the researcher. As soon as the ward nurse was able to confirm the diagnosis 
and that the individual met the inclusion/exclusion criteria set by the studies, 
she approached the individual and asked for consent to contact the researcher. 
The researcher provided an information pack on the studies which was 
developed according to requirements of the NHS Ayrshire and Arran Research 
Ethics Committee in relation to format and content. She discussed the studies 
with the individual and allowed time for questions and feedback. The researcher 
reinforced that the individual could withdraw at any time and that whatever their 
decision, the clinical care that they received would not be affected. The patients 
were given 24 hours to consult with their families and to consider if they wished 
to be involved. They were informed that the protocols for the studies required us 
to inform their general practitioner and asked for their permission to do so. Once 
the patient had time to consider and if they agreed, consent to take part was 
completed by the patient and written information sent to general practitioner and 
cardiologist. 
During the year of the studies, as shown in Figure 4:1, there were 396 
individuals admitted to hospital with ACSLT. Only 118 patients were eligible for 
the studies. The reasons for this are documented in Figure 4:1. Of these 118, 
only 40 patients were referred, three refused and four were unable to complete 
consent. 33 participants consented to take part. The reasons for the large 
number of missed participants will be discussed in chapter 5:2-5:3.  
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During the course of the studies, eight participants withdrew.  This included one 
participant who went on to have a MI, one whose diagnosis was changed, one 
who developed HF and did not feel well enough to take part and two who died 
prior to their final assessment.  Three participants were lost to follow up at the 
final review appointment and could not be contacted.  In addition three 
participants who were allocated to the control group then returned with a further 
cardiac event which meant they automatically received CR.  
4.14 Recruitment of staff for feasibility study 
Invitations were sent to all staff within the cardiology wards and the CR team 
and two focus groups were held with those who accepted the invitation. The first 
focus group contained six CR professionals involved in the provision of care for 
the participants in the intervention group. This included two senior nurses, two 
senior physiotherapists and two physiotherapy assistants . The second focus 
group consisted of eight ward staff, from both sites and from cardiology wards.  
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Figure 4:1 Flow Chart of patient recruitment  
 
Admitted with 
ACS (n=396) 
Not meeting inclusion 
criteria (n=278) 
Missed (n=78) 
Refused to participate 
(n=3) 
Unable to complete 
consent (n=4) 
Entered into study (n=33) 
Allocated to control 
(n=22) 
Allocated to treatment 
(n=11) 
No intervention 
(n=19) 
Intervention after 
admission (n =3) 
Intervention (n=11) 
Completed 
assessments 
T1 n=11 
T2 n=4 
T3 n=8 
 
Completed 
asessments 
T1 n=19 
T2 n=16 
T3 n=14 
Completed 
assessments 
T1n=3 
T2 n=3 
T3 n=3 
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4.15 Data collection  
This thesis contains a feasibility study and an exploratory study. A range of 
data was collected over the period of the research which was utilised within 
both studies. An appropriate data collection sheet was designed to collate this 
data. The data collection instruments are documented in Table 4:2. The 
participants were assessed at four time points:  
 T1-On entry to the study during hospital admission 
 T2-eight weeks after their discharge  
 T3-nine months after their discharge 
 T4-A case-note only review took place at two years 
There were three types of data collected: baseline, feasibility, and outcome. 
Baseline data, as shown in table 4:1, included demographic data, clinical data 
and risk stratification. Demographic data were collected from the participants at 
the time that they consented to participate in the studies. This was important 
since this information was used to describe the samples and was also used in 
the comparative analysis between the groups. These data were easily accessed 
through the case-notes. Ethnic origin was that stated by the participant on 
admission and deprivation category was established using the participants’ 
postcode and was determined according to deprivation categories measured by 
the Carstairs scores for Scottish postcode sectors (Carstairs and Morris 1991) 
using data from the 2001 census (McLoone 2004). Data on risk factors for CHD 
were collected at T1 from both case-notes and self-reporting by participants. 
Blood pressure, smoking status and activity scores were  collected at each 
assessment. Cholesterol levels were only collected at T1. It was intended that 
information on dietary habits and weekly activity would also be collected 
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through diaries and pedometers, however participants found it difficult to comply 
with this aspect of the data collection and the data that were collected was 
limited in its use, therefore it is not reported in this thesis.  
Clinical factors and risk stratification data were accessed through the case-
notes and through case-notes and self-report in the case of readmissions.  
Risk of future events was calculated using the GRACE score at time of 
discharge.  This is a widely accepted method of determining risk and has been 
discussed previously in chapter 2:5.  
Feasibility data were collected to identify how acceptable the research 
design and the intervention were to the participants and staff. Feedback on 
content and acceptability of methods was assessed using a questionnaire.  
In addition two focus groups were carried out with staff. The first focus group 
included CR specialist staff and the second took place with staff from the 
cardiology wards.  Outcome data as described in Table 4:2 were also collected. 
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Table 4:2 Data collection instruments 
Type of data 
 
Data item  Source Questionnaire No 
Baseline  Demographic 
details  
Casenotes  n/a 
 Clinical factors  Casenotes 
 
n/a 
 Risk stratification Casenotes 
 
n/a 
Feasibility  design of studies  Acceptability 
questionnaire 
Staff focus groups 
Exit discussion with 
participants 
6   
 
 
 
Outcome  Misconceptions  York angina belief 
questionnaire v2 
(YABQv2) 
1 
 Symptoms Cardiac Limitations 
and Symptoms 
Profile (CLASP) 
2 
 Anxiety and 
depression 
Hospital and 
Anxiety Scale 
(HADS) 
3 
 HRQoL Schedule for the 
Evaluation of 
Quality of Life-
Direct Weighing 
(SEIQoL-DW) 
Medical Outcomes 
Trust Short Form 
(SF36v2) 
4 
 
 
 
 
5 
 
 Patient 
perceptions 
discussion with 
participants at T2 
and T3 
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In chapter 3:12, the researcher identified key outcomes that would be 
necessary to measure. These are: cardiac misconceptions, symptoms, anxiety, 
depression and HRQoL. In addition, data on the experiences of the participants 
were collected at two data collection points . Information was gathered using 
open questions during interviews and this is documented in Appendix one.  
Within the feasibility study, options for instruments that could be used 
successfully in a large RCT were examined and piloted. These included both 
quantitative and qualitative instruments and these will be examined in greater 
detail in chapter 4:15-4:16. 
4.16 Quantitative data  
The key areas that were identified as important to measure within this 
section were cardiac misconceptions, symptoms, anxiety,depression and 
HRQoL. The choice of questionnaire for each section involved a review of the 
instruments available and their suitability for the population being studied.  
If we consider the area of cardiac misconceptions, individuals can hold 
misconceived or maladaptive beliefs regarding the impact of CHD on their life 
and this can have a negative impact on their HRQoL.  However, as documented 
in chapter 3:4, very little attention has been paid to misconceptions in the CR 
literature. Yet, if we are to utilise a theoretical framework as documented in 
chapter 3:11, it is important to address the misconceptions that are held by the 
individual. When deciding on a tool to measure this within the exploratory study, 
two instruments were considered, the Cardiac Misconception Scale (CMS), 
(Maeland and Havik 1988) and York Angina Beliefs Questionnaire v2 (YABQv2) 
(Furze 2003).  
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The CMS is a 10 item questionnaire which details common misconceptions  
about MI. It has been used to demonstrate the potential effect that 
misconceptions about MI can have on recovery (Maeland and Havik, 1987, 
1988, 1989).  The participants within these studies have ACSLT and are not 
classified as having a MI. So to use the CMS would suggest to the participants 
that they have had an MI. This left the YABQv2, which was designed as a quick 
tool to assist in identifying misconceptions about CHD in clinical practice. Furze 
et al (2003) argue that beliefs about angina are significantly associated with 
functional and psychological status. People with more misconceived or 
maladaptive beliefs are more anxious and physically limited than are people 
with fewer such beliefs (Furze et al 2003).  
The YABQv2 was developed from belief statements elicited in an interview 
study by Furze et al (2001). They were used to form a pilot version of the 
questionnaire which was completed by 105 angina sufferers and was factor 
analysed. Two items were removed following this pilot and the 14 item 
questionnaire was formed (YABQv2).  
This questionnaire, which produces an overall score plus two sub-scales 
scores, which measure coping and threat, has been validated in the stable 
angina population (Furze et al 2003).  The perception of threat sub-scale and 
total score was shown to have good internal consistency, while that of the 
coping sub-scale was deemed adequate. Test–retest reliability for both sub-
scales and total score was good. Face validity was established by using items 
directly derived from the patient i nterviews and checked by presenting the items 
to an expert panel. Construct validity appeared to be reasonable as there were 
moderate, but significant, correlations between the sub-scales and total scores 
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of the YABQ2 with both sub-scales of the HADS and the physical limitations 
sub-scale of the SAQ.  Discriminant validity was demonstrated by the ability of 
the sub-scales and total score to discriminate between those who had 
undergone education about misconceptions and those who had not.  The 
correlations were as predicted, that is, people who scored more highly on the 
perception of anginal threat sub-scale were more anxious and/or depressed; 
people who held more misconceived coping beliefs were more physically 
limited. The results from the psychometric analysis showed that the total 
YABQ2 score has good internal consistency, test–retest reliability and 
discriminant validity. Subsequent reviews of this questionnaire found that the 
YABQv2 had good internal reliability, with a Cronbach’s alpha score of 0.81 and  
stability (r = 0.85) in a study of British people waiting for CABG surgery (Furze & 
Lewin 2006) and among Taiwanese cardiac patients with a Cronbach’s alpha 
score of 0.73 (Lin et al 2009). The questions contained within the YABQv2 were 
also appropriate for the population to be studied. The focus on perception of 
threat and coping were considered to be valuable to the understanding of 
individuals with ACSLT. It was therefore decided to utilise the YABQv2 . 
The measurement of symptoms was also an important clinical outcome. 
Many questionnaires have been devised to assess a specific cardiac condition 
such as angina, MI, or HF. The Cardiac Limitations And Symptoms Profile 
(CLASP) is unique in that it can be used across all these cardiac conditions 
(Lewin et al 2002). The 37 questions that comprise CLASP yield four symptom 
subscales (angina, shortness of breath, ankle swelling, tiredness) and five 
subscales focused on functional limitations (mobility, social life and leisure 
activities, activities within the home, concerns and worries, gender). Each 
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domain is represented by a subscale with four to six questions. Each subscale 
can be categorised as mild, moderate, severe. It can serve as an outcome 
measure indicating the burden of symptoms. The questionnaire was validated in 
a cohort of patients undergoing angiography at two large hospitals. The 
reliability of the CLASP was assessed with a Cronbach’s alpha score of 0.80 
(Lewin et al  2002).  However in this thesis, only three of the sub-scales of the 
CLASP are used. These sub-scales were: angina, breathlessness and oedema. 
These sub-scales are very simple and are a quick method of clinically 
assessing a patient. These sub-scales are recommended for general clinical 
use (SIGN 2002), but further research in different populations was required with 
this instrument.   
Within the study by Lewin et al (2002), pearson correlation coefficents were 
calculated for the symptom subscales at T1. The angina subscales were 
significantly co-related with the number of angina episodes, and the shortness 
of breath and ankle swelling subscale scores were significantly correlated with 
total treadmill time. Sensitivity was measured looking at 3 groups over  
2 time-points and observation of significant time interactions (p<0.001).  
This showed that the measure was highly sensitive to treatment effects as a 
function of group type. The CLASP was therefore shown to be a reliable, valid, 
and sensitive, disease specific measure in patients with stable angina (Lewin et 
al 2002).  
The impact of anxiety and depression on individuals with CHD has been 
discussed in chapter 2:6 and the possible impact of CR in this area has been 
discussed in chapter 3:4. There are several well established self-report 
measures available for assessing anxiety and depression. The most commonly 
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utilised within CR research are the State-Trait Anxiety Inventory (STAI) 
(Spielberger 1983), The Beck Depression Inventory II (BDI) (Beck et al 1996) 
and the Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith 
1983). The BDI and STAI have been identified as appropriate instruments for 
assessing the psychological status of hospital patients (Kocovski et al 2004), 
despite being developed to assess symptoms in psychiatric patients. However, 
the HADS was specifically developed to detect anxiety and depression in 
hospital and outpatient settings. Recommendations from SIGN suggest that 
HADS has been well validated for use in the cardiac population and it is used 
extensively as an assessment tool within CR (SIGN 2002). It is a 14 item self-
report questionnaire which contains 7 items measuring depression and 7 
measuring anxiety. Scores of 0-7 are considered normal with 8-10 considered 
borderline and 11 and over indicating either anxiety or depression. HADS does 
not include items of a somatic nature that could be caused by physical disease 
as much as mood disturbance (Bjelland et al 2002).  
A psychometric evaluation of the HADS in a post-MI population by Martin 
and Thompson (2000) found that the levels of anxiety and depression reported, 
using the recommended cut-off points, would suggest that the HADS and, in 
particular, the HADS-A and HADS-D sub-scales provide a clinically useful and 
quick to administer measure of affective state. Cronbach’s alpha estimations of 
the HADS (all items) and the HADS-A and HADS-D sub-scales were all 
adequate and provide a statistically robust corroborative account of the HADS 
as an internally reliable affective state assessment tool. 
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In a review of the HADS by Bjelland et al (2002), the authors argue that 
HADS, despite its brevity, exhibited similar sensitivity and specificity to longer 
versions of the General Health Questionnaire. When compared to other 
questionnaires for anxiety and depression in common use, such as the STAI, 
and the BDI, the correlation of the BDI to HADS-D and the STAI to HADS-A, 
respectively, were between 0.60 and 0.80, which should be characterised as 
medium to strong correlations. The conclusion they reached was that the 
concurrent validity of HADS was good to very good. It was therefore decided to 
utilise the HADS, as this would be quick and easy to use within this popula tion 
and it would measure both anxiety and depression on the same questionnaire. 
In addition, it had been used extensively with the MI population in NHS Ayrshire 
and Arran for more than eight years, which would allow for comparative data 
with other populations. 
As discussed previously HRQoL represents the effect of an illness and its 
treatment as perceived by the patient. The measurement of HRQoL can be 
achieved by using a disease specific, generic, or an individualised instrument. 
However, since this thesis looked at a new and novel population that had not 
been studied before, it was felt that a full review of the tools available should be 
carried out to decide which tool would be most appropriate for the RCT.  
As there is no disease specific tool designed for ACSLT, the nearest disease 
specific tools would be the Quality of Life after MI (QLMI-2) (Hillers et al 1994),  
Seattle Angina Questionnaire (SAQ) (Garratt et al 2001), and the CLASP 
(Lewin et al 2002). The QLMI-2 is divided into three different domains, social 
functioning, physical function and emotional functioning.  Dempster et al (2002) 
in their review of this measure found that two out of three of the QLMI-2 scales 
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lacked evidence of sensitivity or reliability. It was also designed to be used in 
the post MI population. 
The SAQ has been assessed as a good disease specific instrument 
designed to assess the functional status of patients with angina, in five cli nically 
relevant domains: physical limitations, angina stability, angina frequency, 
treatment satisfaction, disease perception and QoL (Garratt et al 2001, 
Thompson and Cheuk-Man 2003).   
As discussed previously, the CLASP has been shown to be a reliable , valid, 
sensitive, disease specific measure of HRQoL in patients with stable angina 
(Lewin et al 2002). However it was also unique in that it could be used across 
all cardiac conditions (Lewin et al 2002). Further research was required with this 
tool in different populations and it was decided that this population would be a 
useful population to further research its utility. So the CLASP was chosen as a 
disease specific measure.  Difficulties did arise within the studies regarding this 
measure. There was a great deal of similarity between the CLASP and the 
SF36v2 and the timescales were different. The CLASP is over two weeks and 
the SF36v2 looks at the last four weeks. This caused some difficulty for the 
participants and therefore data relating to HRQoL is not presented, only those 
relating to symptoms.  
Three commonly used generic instruments in CHD were reviewed by 
Dempster and Donnolly (2000). They found that the Nottingham Health Profile 
(Hunt et al 1980) had major floor and ceiling effects, (bias by respo ndents 
answering in the top or bottom few categories of an instrument) and poor 
responsiveness to change in part one of the instrument. The Sickness Impact 
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Profile (Bergner et al 1976) had few floor or ceiling effects, but data concerning 
its 12 separate sub-scales were limited, therefore only total domain scores 
could be achieved.  This has the potential to reduce the instruments ability to 
detect a change in health status. The Short Form 36 v2 (SF36v2) Health Survey 
(Ware and Sherbourne 1992) achieved the best results, but demonstrated 
reduced sensitivity in the mental health and general health scales, and ceiling 
effects in the role emotional and role physical scales.   
The development of the SF36v2 relies on a long history of health surveys 
and the need to develop a questionnaire that could collect useful data without 
an unnecessary burden on the respondent. The SF36v2 aims to assess the 
following concepts: physical functioning, role-physical, bodily pain, general 
health, vitality, social functioning, role-emotional, and mental health.  This 
comprehensive short-form with only 36 questions yields an 8-scale health 
profile as well as measures of HRQoL. The scales of each question are coded 
summarised and transformed into a scale of 0 (the worst possible QoL) to 100 
(the best possible). The SF36v2 also provides a summary of several of the 
scales to two components: physical summary and mental health summary.  
Internal reliability testing of the SF36v2 has been reported in 14 studies 
involving more than 20,000 patients (Ware and Sherbourne 1992). Cronbach’s 
alpha reliabilities ranged from 0.65 to 0.96 on all subscales. The SF36v2 has 
been validated against the National Survey of Functional Health Status and the 
General Social Survey in diverse populations of indi viduals with chronic health 
problems, including heart disease, and in healthy individuals (Dougherty et al 
1998). Normative levels have been established for patients with both physical 
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and mental health problems, including hypertension, HF, Type II diabetes, 
recent MI, and clinical depression.   
A questionnaire containing the SF36v2 was administered to a cohort of over 
10,000 civil servants (Roberts et al 1997). Administration was repeated on a 
subset of 289 civil servants four weeks later. Clinical groups were distinguished 
by self-report measures of health. Data showed high internal consistency (alpha 
0.75-0.35). Test-reset reliability was poor for role limitations due to physical 
problems (0.38), though acceptable for all other scales (range 0.60-0.89).  
Validation of the scales against criterion groups, defined on the basis of self-
reported health, indicated that physical functioning, social functioning and 
general mental health had good discriminant validity. 
The SF36v2 has also been tested across different ethnic backgrounds, with 
the Chinese version being tested for its psychometric properties (Yang et al 
2012). The Chinese version was evaluated by indicators such as validity and 
reliability. Test-retest reliability coefficients for all domains were higher than 
0.80.  Five of the eight domains, as well as the physical and mental health 
subscale summaries, all had statistically significant changes after treatment. 
The authors concluded the Chinese SF36v2 showed good validity and 
reliability, but small responsiveness when used in patients.  
The SF36v2 has been used in a wide variety of cardiac populations when 
assessing HRQoL (Lavie and Milani 1995, Morrin et al 2000, Mendes de Leon 
et al 2001). The reliability and validity of the SF36v2 in cardiac populations and 
in CR has also been extensively well tested (Ware et al 1993, DeVon and 
Ferrans 2003, Brown 2003).  It has proven useful in monitoring general and 
specific populations, comparing the burden of different diseases, differentiating 
100 | P a g e  
 
the health benefits produced by different treatments, and in screening individual 
patients. Dempster and Donnelly (2000) came to the conclusion that the 
SF36v2 is the most appropriate generic instrument to assess HRQoL of cardiac 
populations. The SF36v2 was therefore chosen as the generic measure for 
measuring HRQoL.  
As has been stated, individuals with this diagnosis have not been studied in 
this way before and it was therefore decided to add an individual measure that 
looks at global QoL. This would further explore the issues around QoL for this 
group of participants. It was intended to carry out this measure on a subset of 
the participants, but due to the small numbers recruited, most participants 
completed the measure at T1 and T3.  The measure chosen was the Schedule 
for the Evaluation of Individual Quality of Life (SEIQoL-DW) by Hickey et al 
(1996). This is a QoL measure which is derived from the Schedule for the 
Evaluation of Individual Quality of Life (SEIQoL) (O’Boyle et al 1993). It is a 
short form of the original and was validated against the original by Hickey et al 
(1996).  It provides both quantitative and qualitative data, as it gives both an 
overall score on QoL, but also identifies areas that contribute to this outcome. 
The practicality and brevity of this measure make it useful in clinical situations 
where QoL is important.  It has been shown to have high levels of consistency 
and validity with older medical patients, stroke, cancer and palliative care 
patients, and has been found to be acceptable and practical to use with these 
patient populations (Hickey et al 1996, O’Boyle and Waldron 1997, Waldron et 
al 1999, Campbell and Whyte 1999, LeVasseur et al 2005). The measure 
allows respondents to nominate the areas of life which are most important, rate 
their level of functioning or satisfaction with each, and indicate the relative 
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importance of each to their overall QoL. An overall QoL score can then be 
calculated.  In a review of published studies regarding the use, feasibility and 
psychometric performance of SEIQoL-DW by Wettergren et al (2009), the 
authors conclude that the SEIQoL-DW is a feasible and valid complement to 
standardised measures for use in clinical research. However, they also argue 
that some aspects, such as responsiveness over time, require further 
investigation. The total number of reviewed papers is small (n = 39), reflecting 
the overall limited number of studies using the SEIQoL-DW compared to 
traditional measures. The individual nature of this measure appeared to offer 
another dimension to the understanding of QoL and to give insight into personal 
differences between patients that might influence the success of CR.   
The questionnaires chosen were therefore: YABv2, CLASP, HADS, SF36v2 
and SEIQoL-DW.  The statistical analysis of this data will be discussed in 4.18. 
4.17 Qualitative data  
Qualitative research is suitable for exploring new areas of inquiry. It can help to 
gather information and generate hypotheses for the main quantitative phase. 
Qualitative research can also add detail and depth to  the understanding of any 
issue, as it strives for holistic and detailed descriptions. Within this study, two 
types of qualitative research were carried out. These were focus groups with the 
staff and interviews with the participants.  
As part of the design of the feasibility study, two focus groups were planned 
with staff working within cardiology and the CR team. The focus group protocol 
is included in Appendix 1.1. The use of focus groups as a tool within nursing 
research is becoming increasingly popular (Doody et al 2013). Focus groups 
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can be used on their own as the primary method of data collection or with other 
methodologies (Stewart et al 2007) as is the case here. In nursing, focus groups 
can be used to explore a range of issues. The purpose is to understand rather 
than infer, to determine the range rather than generalise and to gain insight into 
how people in the groups perceive situations rather than make statements 
about the population ( Krueger 1994). 
There are several advantages to using focus groups. They are useful in 
obtaining detailed information about personal and group feelings, perceptions 
and opinions, they can provide a broader range of information, and give 
opportunity for clarification. However, as they are self-selecting, they may not 
be representative of the broader staff group.  The staff focus groups in this 
research took place at the end of the feasibility study. 
The focus groups needed to have enough staff to provide meaningful 
information, yet not so many that the researcher became overwhelmed by 
cumbersome data. The two focus groups, within the feasibility study, aimed to 
have 6-8 staff. They were led by the researcher and moderated alone, without 
an assistant. This enabled staff to feel at ease during the discussions. Staff 
were assured that the entire discussion would be confidential and no-one would 
be identified by name within any of the written documentation. Each focus group 
lasted approximately 60 minutes and refreshments were provided during this 
time. 
Each focus group was structured in three stages. The first stage introduced 
the participants to the study. The second stage involved asking the participants 
questions and generating discussion, and the third stage examined the 
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conclusions reached. There were also opportunities at the end of each meeting 
for participants to make more specific inquiries about the project. Each focus 
group was recorded and subsequently transcribed.  
A group of themes for the focus groups was devised to stimulate discussion 
and to inform the feasibility study. The themes chosen were: 
 Expectations of the research process 
 Barriers to participation 
 Perceived impact of CR on the participants 
 Provision of the CR programme (CR focus group only)  
The data gathered during the focus groups was analysed using thematic 
analysis as described in Chapter 4.19 and is reported in Chapter 5.4  
Within the exploratory study, qualitative data was collected through 
interviews with participants. The protocol for the semi-structured interview is 
included in Appendix 1.2.  Interview data was collected from 17 participants at 
two home visits (T2 and T3), and from eight participants at one home visit only 
(T3).  Time was taken to facilitate participants trust and confidence rather than 
distrust in the researchers intentions. The researcher stressed to participants 
there was no intention to judge performance or report ‘bad’ practice within the 
healthcare system, but purely to understand the experiences that they had had. 
Any initial tensions appeared to resolve as the participants started to answer the 
questions. Interviews were transcribed verbatim. The interviews consisted of 
open ended questions, with further discussion led by the participants. These 
data added depth to the understanding of the experiences of the participants.  
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The data gathered during the interviews was analysed using thematic analysis 
as described in Chapter 4.19 and is reported in Chapter 6.6  
4.18 Data handling  
The participants were assessed at four time points:  
 T1-On entry to the studies during hospital admission 
 T2-eight weeks after their discharge  
 T3-nine months after their discharge 
 T4-A case-note only review took place at two years 
The schedule for which assessment tools were used at each time point is 
documented in Figure 4:2. These time-points were chosen to reflect the 
pathway that the participants would experience.  Baseline (T1) was during their 
index admission and T2 would be the time-point at which the individual would 
be expected to have recovered from their illness. By then they would be 
discharged from medical follow up and would be looking to go back to work. 
Those who were receiving the intervention would have been assessed and a 
package of care would be well underway. The third time point (T3) was chosen 
to reflect a time beyond which CR would have finished, but not too soon that the 
impact of the intervention was still at the forefront of the participants thoughts.  
It is important to review the longer term impact of a complex intervention such 
as CR and if six months had been chosen, then it is possible that some 
participants would have still been under the care of the CR team. There is also 
the possibility that participants would still be receiving further investigations and 
treatment for their condition at this point. This was in fact the case for three of 
the participants. Nine months (T3) was therefore chosen as long enough from 
the initial event to ensure treatment was complete, but not so long that 
105 | P a g e  
 
participants would be lost to follow up. It was also intended to review the 
outcomes for participants at two years (T4). Data collection were carried out, in 
both groups, while the participants were still in hospital, prior to the 
commencement of the CR programme at T1. The CR team then started a 
package of care for those participants in the intervention group prior to their 
discharge from hospital.  The assessments at T2 and T3 were carried out in the 
participants’ home at a time suitable to them. Recruitment took place over a 12 
month period between November 2006 and November 2007. Follow-up 
questionnaires were completed by September 2008. Each participant was 
identified only by a number, which identified the site and the order in which they 
were recruited. The first number referred to the site and the second and third 
number referred to the participant.  The researcher, following manual collation 
and tabulation of the results, entered the data. All data fields were numbered 
according to a predetermined coding system. Following data entry, checks were 
made to ensure accuracy. 
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Figure 4:2   Data collection timescales 
 
 
  
T1 baseline data + questionnaire 1-5  
 
phase one and two intervention as per 
standard CR  protocol 
CR  assessment at  four weeks 
and commencement of phase three CR 
intervention 
 
eight weeks=T2 
questionnaire 1-5 
discussion 
 
eight weeks=T2 
questionnaire 1-5 
discussion 
 
completion of CR intervention 
at 4-6 months 
control group 
Moderate CR low CR  home 
program
me 
intervention Group 
nine month=T3 
questionnaire 1-6 Exit 
discussion 
 
two years =T4 
casenote review 
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4.19 Data analysis  
There were two elements of data analysis within these studies: quantitative 
and qualitative. Quantitative data consisted of data from the registration form, 
record sheets and participant questionnaires, which were entered into SPSS  
(version 15). The planned approach was to report on each of the variables 
using frequency distributions and graphical displays, as appropriate and to 
report the composition of the sample highlighting characteristics such as age, 
sex, marital status, clinical variables etc. Summary statistics included measures 
of central tendency such as means and medians, and measures of variability 
such as the range, variance and standard deviation and confidence intervals.  
A variety of parametric and non-parametric statistical tests were planned: the 
paired-sample t-test, pearson’s correlation, and chi-squared, which allowed for 
exploration of differences between the groups and to test the effect of time.  
To explore whether socio-demographics, clinical characteristics, HRQoL and 
social and psychological variables were associated with the outcomes, a series 
of correlation matrixes were constructed to test the inter-relationships among 
variables. Statistical tests therefore included exploration of the differences and 
similarities between and within the groups. Statistical significance was set at 
p=0.05. However, due to the small numbers within the exploratory study, limited 
parametric data analysis is presented.  
Qualitative data was collected from staff focus groups and participant 
interviews and the method of analysis for both was thematic analysis. It has 
been argued by Braun and Clarke (2006) that although thematic analysis is 
widely used, there is no clear agreement about what thematic analysis is and 
how you go about doing it. It could be seen as a very poorly “branded‟ method, 
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in that it does not appear to exist as a “named‟ analysis in the same way that 
other methods do (e.g., narrative analysis, grounded theory). Braun and Clarke 
(2006) however argue that thematic analysis should be a method in its own right 
and can and should be used for identifying, analysing and reporting patterns or 
themes within data. One of the advantages of this type of analysis is its 
theoretical freedom and flexibility.  Thematic analysis can be used to analyse 
classifications and present themes that relate to the data. It illustrates the data 
in great detail and deals with diverse subjects via interpretation (Boysatzis 
1998). Thematic analysis gives an opportunity to understand the potential of 
any issue more widely (Marks and Yardley 2004).  As thematic analysis does 
not require the detailed theoretical and technological knowledge of approaches 
such as grounded theory, it was considered a more suitable form of analysis for 
the qualitative element of this thesis. 
Braun and Clarke (2006) argue that a rigorous thematic approach can 
produce an insightful analysis that answers particular research questions. They 
provide guidelines for researchers to undertake thematic analysis that is 
theoretically and methodologically sound (Appendix 1.3.) These guidelines were 
used as the basis for the thematic analyses carried out within these studies on 
both the focus group and interview data.  
The set up and content of the focus groups have been described in Chapter 
4:17.  The data collected was recorded and the transcribing of each focus group 
recording took between two to three hours and was carried out by secretarial 
support staff. Each transcript was then audited against the original recording to 
ensure accuracy.  As part of the analysis of the focus group data, written notes 
and information collected on the day were also read through.  A preliminary 
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analysis was undertaken, the transcriptions were reviewed and initial codes 
were generated and analysed manually.  The two focus groups were then 
compared to identify shared and differing approaches to the themes that had 
been set for the focus groups. A graphic representation of the themes and their 
interconnections was drawn (Appendix 1.4). These themes were then used as 
the basis for describing the results: 
 Expectations of the research process 
 Barriers to participation 
 Perceived impact of CR on the patient participants  
 Provision of the CR programme (CR focus group only)  
As the researcher, it was important that my own preconceived ideas were 
acknowledged by myself and that the difference between, what I expected to be 
said, and what was actually said, was recognised. I attended staff meetings 
following the focus groups to provide staff with the opportunity to raise any 
questions or issues of concern regarding the results. 
 
As part of the exploratory study interview data was collected from 17 
participants at two home visits (T2 and T3), and from eight participants at one 
home visit only (T3). The data collected was recorded and transcribed. This 
took between one to two hours and was carried out by secretarial support staff. 
Each transcript was then audited by the researcher against the original data. 
Apart from ensuring that transcripts represented what had been said, the 
auditing helped the researcher to gain a close contact and familiarity with the 
data (Boyatzis 1998).  Following transcription, participants were invited to check 
transcripts. All of the participants declined.  After each transcript was 
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transcribed and audited, it was given an identity marker representing participant 
identity (e.g. Male/Female, control/treatment, age)  
  A preliminary analysis was undertaken and initial codes were generated 
and analysed manually.  An example of a preliminary coding of an interview can 
be seen in Figure 4:3. The results were reviewed by an independent researcher 
within the department.  After the initial coding, codes were merged into larger 
units that were similar in meaning. This merging of codes into larger units 
persisted until only a few remained. However, the next step in the analysis - 
integrating codes into themes- proved to be more difficult. A theme was defined 
in this research as the smallest unit that could express the codes that were 
included in it in a meaningful way. At the end, four themes were formed, 
highlighting how the participants described their experiences. A graphic 
representation of the themes and their interconnections was drawn (Appendix 
1.5).  Finally, data extracts were chosen to illustrate the resulting themes. Thematic 
analysis is flexible and the importance of a theme is not necessarily dependent 
on prevalence, but can be determined by its relevance to the research question 
and by researcher judgment (Braun & Clarke, 2006). In the current studies 
repetitions of the themes across individual transcripts were taken to indicate 
their relevance in the experience of the participants in relation to the topic under 
investigation. In line with Braun and Clarke (2006) the inclusion of a theme was 
also based on the researcher’s judgement of its relevance to the research 
question and to future practice. This approach emphasises the participant’s 
perceptions, feelings and experiences as the object of s tudy.   
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Figure 4:3 Coding process  
Data extract from Participant 203 T2 Coded for 
Quite well really, the GP came out and sorted out my 
tablets, although there was a little bit of a debate about 
what I should be on as I wasn’t very sure and they had 
stopped some and restarted others.   
1. Feeling fine 
2. Uncertainty 
3. Lack of knowledge 
4. Communication  
But I haven’t had any pain which is a bonus.  I don’t 
have to back to the hospital so that’s a good thing, just 
see my GP. 
1. Relief  
2. Well  
They thought at first it had been a heart attack and I 
wouldn’t have been surprised if it was as the pain was 
bad but they said the blood tests came back negative so 
I can just get back to normal.   
3. Relief 
4. Return to normal 
5. Pain 
 
I haven’t been very well for a while and I didn’t really 
know what was wrong with me, but the doctors say I 
have angina and it is nothing to worry about. 
1. Unwell  
2. Lack of knowledge  
I don’t really feel normal. I am very tired.   I haven’t been 
far from the house as I am not really sure what I am able 
to do.    
1. Unwell 
2. Lack of confidence 
3. Lack of knowledge  
Well I suppose things were a bit confused for a while but 
I didn’t know what to expect when I came home and it 
was a bit scary  
1. Uncertainty  
2. Lack of knowledge  
3. Fear 
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4.20 Funding 
This thesis was funded by NHS Ayrshire and Arran, who paid for the 
researcher to undertake a clinical doctorate at the University of Stirling, through 
the learning and development fund, but who also supported the research 
through the MCN for CHD, which bought any resources required, and funded 
backfill to allow the researcher to undertake some of the work.  
4.21 Conclusion  
In summary, CR is a complex intervention and the design and evaluation of 
complex interventions is problematic. There are a large number of diverse 
components within CR, which act, and interact, with one another to achieve a 
range of outcomes for the participant. The choice of research methods has 
been determined by the MRC framework, which suggests that a RCT is the gold 
standard for researching complex interventions. A feasibility study for a RCT is 
necessary to test the design, instruments used, and the intervention itself, in 
terms of its acceptability to the participants and staff. The exploratory study is 
also necessary to explore the experience of participants. There are few 
previously published studies or existing data on CR in ACSLT.  
Full Ethics and R&D approval was in operation throughout the period of the 
studies, which included access to the relevant clinical sites. All patients of both 
sexes, who were admitted to two hospitals sites within NHS Ayrshire and Arran 
and diagnosed with ACSLT, were considered for inclusion in the feasibility and 
exploratory studies. A menu-based CR programme was provided for the 
participants in the intervention group 
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The feasibility study design was an exploratory repeated measures 
longitudinal case-control study which included staff views on issues of feasibility 
and CR through the use of focus groups. The exploratory study aimed to 
explore the impact that CR can have on this client group; through the use of 
both the standardised questionnaires being used within the feasibility study, and 
qualitative data collected at interviews with the participants. The questionnaires 
chosen for both studies were: YABv2, CLASP, HADS, SF36v2 and SEIQoL-DW 
as they were assessed as being valid and reliable. Data analysis was planned 
using both statistical analysis of the quantitative data and thematic analysis of 
the qualitative data.  
In conclusion this chapter has described the methodology employed to meet 
the aims of the studies, taking into account the MRC framework for complex 
interventions, the clinical context and information from the literature. The design 
of the studies has been discussed. This was followed by a description of the 
ethical considerations, recruitment, and the rational for the choice of 
instruments. The process for data collection and analysis has been discussed 
along with timescales and funding. 
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Chapter Five Feasibility study   
5.1 Introduction 
This thesis contains a feasibility study and an exploratory study. The 
feasibility study aimed to examine the feasibility of a RCT which would test the 
impact of a menu-based CR programme, on individuals diagnosed with ACSLT, 
against standard care. This feasibility study also included staff views. The 
exploratory study aimed to explore the impact that ACSLT and CR can have on 
this client group.  
In the previous chapter, the methodology to meet the stated aims of this 
thesis has been outlined. In this chapter, the results of the feasibility study will 
be examined and chapter six will focus on the results of the exploratory study.   
The four areas of feasibility that will be discussed are: participants, the CR 
intervention, staff, and measures. 
5.2 Participants 
When considering the participants, there are three areas that need to be 
examined, the ability to recruit, being able to retain the participants, and having 
a sample that is reflective of the population from which it is drawn. The initial 
target for recruitment set within the studies was 100 participants as described in 
chapter 4:10. This was a large target number for a feasibility study, but was 
based on the number of current admissions to the two hospitals in NHS 
Ayrshire and Arran. The CHD MCN that was funding the studies, was keen that 
both hospital sites were included, as they wanted information that would guide 
future service development for individuals with this diagnosis.   
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During the period November 2006 to October 2007, 396 individuals were 
admitted to hospital in NHS Ayrshire and Arran with ACSLT.  From local data it 
was established that 128 of these had previously been under the care of the CR 
team. In addition, 150 patients were diagnosed as having a MI and were 
referred for CR during their admission. This left 118 potential recruits for the 
studies of whom only 40 patients were approached. Time was spent with each 
participant explaining the process and the impact of the studies. Every 
participant was given 24 hours to discuss their participation with family. Three 
patients decided on reflection, and on discussion with their family, not to 
proceed with the studies. A further four patients had pain and could not 
complete the consent process. This left 33 participants who were consented 
and completed the initial assessments at T1.  This included 22 participants in 
the control group and 11 participants in the intervention group at T1. The 
majority of potentially eligible ward patients (78 out of a potential 118) were sti ll 
not identified and referred. It is difficult to know why this was the case, but it 
could have been because the ward staff were busy with priorities related to 
patient care. Often there was a delay in making a diagnosis and the time left 
before discharge was not long enough to complete the consent protocol. It is 
recognised that the presence of the researcher on the ward may have helped to 
identify potential patients. This was, however, not possible due to the short time 
the patient spent in hospital, on average two to three days , and the increasing 
work commitments of the researcher. An additional problem was the need to 
visit two separate hospitals to recruit. A potential participant could be in site one 
and the researcher in site two.  
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There appear to be several key linked issues within this that need to be 
mentioned: 
 Availability of a researcher to check wards daily 
 Patients short stay in hospital 
 Difficulties of obtaining a diagnosis of ACSLT  in time to start the consent 
process 
Initially, ward staff were meant to contact the researcher when a suitable patient 
was identified. However, it soon became apparent that ward staff were not 
remembering to contact the researcher when a suitable patient was admitted. 
The two site model meant that recruitment at the site one was even more 
difficult as the researcher was based at the site two and it takes more than 30 
minutes to travel between hospitals. Of 33 participants to enter the studies, only 
seven were from site one. The nursing and medical staff were aware that if 
participants were recruited during the contro l phase, they would receive no 
intervention from the CR team. This meant that, where some debate arose over 
diagnosis, the ward staff preferred to wait to see if patients would be eligible for 
CR, rather than enter them into research which would ensure they did not 
receive CR for nine months. Many of the patients were only in hospital for two 
or three days. During this time ward staff had clinical priorities in terms of 
diagnosis and care. Often the diagnosis was delayed until Troponin T results 
were obtained and this could be at least 24 hours after the index admission.  
Even then the patient might only be told their diagnosis just prior to discharge, 
making it impossible to approach them for consent. In addition, no patients were 
recruited from the first site from February 2007 due to changes in protocols for 
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the diagnosis of ACSLT at that hospital site. This will be discussed further on 
pages 113-114.  
The combination of these factors meant that recruitment was very limited in the 
first six months compared to the number eligible as can be seen in Table 5:1.  
Table 5:1   Participants recruited from Nov 2006 till Oct 2007 
06-07 Nov Dec Jan Feb Mar Apr  Ma Jun  Jul  Aug  Sep Oct tot 
Admit   15 14   16   15   12 8 9 7     5     5   7   5 118 
Refer 3 4 2 2 4 3 1 6 3 4 4 4 40 
Decline  0 0 0 0 1 1 0 1 0 0 0 0 3 
Unfit 1 0 0 0 0 1 0 1 0 0 1 0 4 
Recruit  2 4 2 2 3 1 1 4 3 4 3 4 33 
 
Despite education and awareness-raising sessions for ward staff, 
recruitment remained slow. In an attempt to improve recruitment, two nurses 
already working within the department, one each site, were tasked with the job 
of identifying individuals that would be suitable for the trial and assisting with the 
consent process. There was a slight improvement during the next six months in 
the numbers that were recruited for the studies compared to the number eligible 
(Table 5:1).  
By the time the nurses were in place, a new problem for recruitment had 
arisen. The researcher wanted to look at a group of patients who did not qualify 
for CR under the referral criteria at that time. This was those with ACSLT. 
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Diagnosis of ACSLT was established by one or more of the following: 
 Clinical History  
 Ischaemic ECG changes,  
 Cardiac troponin release or raised CK-MB enzyme demonstrated at 
any time during admission 
 
The key difference between patients eligible for the studies and patients 
diagnosed as MI and therefore eligible for CR related to the level of cardiac 
troponin release.  According to BCS guidelines (see Table 2.1), at the time of 
the commencement of the studies in 2006, if the level of Troponin T was equal 
to or greater than one, the patient was diagnosed as having a MI. If it was 
greater than 0.01 and less than 1.0 the patient would have ACSLT and would 
be eligible for the studies. However, there was a lot of debate amongst 
clinicians. This was fueled by ESC/ACC guidelines which argued that any rise in 
troponin meant that the individual had sustained an MI, as the risk of death at 
six months was similar (see Table 2:1). By Feb 2007 clinicians at site one had 
started using the ESC/ACC guidelines, while site two started using these 
guidelines by November 2007.   
Many medical and nursing staff were confused by these changing opinions. 
Consultants were applying different criteria for the diagnosis of MI, some were 
using the ESC/ACC definitions and some were using the BCS definitions. Some 
patients who met the criteria for the studies, with a Troponin T release of less 
than 1.0, were being diagnosed as having a MI. Referral protocols for CR stated 
that patients diagnosed as MI should be referred to the service. This 
automatically made them ineligible for the studies. Consultants and ward staff 
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were aware of this and of the fact that, during the control phase, patients would 
not receive any input from the team. This made them reluctant to make a 
diagnosis which made individuals ineligible for CR. In addition, the diagnosis 
would often change depending on who was doing the ward round and this made 
it difficult for ward staff to know whether to refer to the studies or not.  By the 
time the decision was made, it was often too late to complete the recruitment 
process, particularly in terms of informed consent.  Allowing for the extra time to 
speak to their families meant that some went home before they could be seen 
again and informed consent completed.  
By Nov 2007 the BCS had changed the definition of MI to be used 
throughout the NHS to bring it in line with the ESC/ACC guidelines. This meant 
that recruitment to the studies had to stop as all patients were now eligible for 
CR. 
 There are therefore three key issues with regards to the feasibility of 
recruiting a sample which are: if a different researcher had been used it could 
have been possible to recruit enough participants, if recruitment had continued 
after discharge then numbers could have been increased, and the changes in 
definition make it now unlikely that a suitable sample could be recruited for a 
RCT.   
If we now consider retention, we can see that 33 participants agreed to take 
part, of whom, 25 completed the final assessments. Eight were lost to follow up 
between T1 and T3, the reasons for which are clarified below.  
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The control group lost five out of 22 to follow up (22%), the intervention 
group lost three out of 11 (27%) to follow-up. In addition, three participants from 
the control group received a CR intervention due to a further cardiac event.  
Of the eight who withdrew, three withdrew due to further health problems 
(1c, 2int), two died (1c, 1int), and three (3c) could not be contacted for further 
assessment. Several phone calls and a written letter received no response from 
this last group of participants. All three were in the control group. The time lag 
between T2 and T3 was felt to be a key reason for the three participants who 
dropped out from the control group. There was no contact with the research 
team for seven months.  The intervention group did not have the same drop-out 
rate and they would have had a longer contact with the healthcare system.  
As can be seen from Table 5:2, assessments were completed at three time 
points (T1, T2, T3). Seventeen participants in the control group completed all 
three assessments (T1,T2,T3). In the intervention group, 2 participants 
completed all 3 assessments (T1,T2,T3) and an additional six completed both 
T1 and T3 but not T2. This was not due to lack of interest on the part of the 
participants. The second questionnaire had to be completed during a short time 
scale at eight weeks and the researcher was unable to make this deadline for 
this group of participants. If a researcher had been employed to undertake the 
research, or the timescale set for the data collection had been broader, it is 
likely that all questionnaires would have been completed at this time-point. Over 
the period of the studies, as documented previously, 5 participants were 
withdrawn due to health reasons (see Figure 5:1).    
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Table 5:2  Drop-out rates and stage of drop out 
 Control Intervention Total 
Identification 25 15 40 
Consented 22 11 33 
Completed 1st assessment 22 11 33 
Completed 2nd assessment 20 2* 22 
Completed 3rd assessment 17 8 25 
Dropout/withdrawn 5(22%) 3 (27%) 8 (24%) 
Received CR following event 3 8 (+3 from control) 11 
Final group totals 14 11 25 
          *researcher on leave of absence 
An additional three of the participants within the control arm actually 
received a CR intervention between T1 and T3 due to another cardiac event. 
One participant had CABG and two participants had PCI. Within the intervention 
arm, this incidence of a further cardiac event was also seen with one participant 
having CABG and one participant having PCI. This meant that of 25 participants 
to complete the studies (17 control and 8 intervention) there were  
14 participants in the studies who received no intervention and 11 who did.    
There are therefore three issues with regards to the feasibility of retaining 
this sample. Firstly, the drop-out rate from the studies due to ill health was 
higher than expected. Secondly, there was crossover between the groups due 
to further cardiac events.  Thirdly, the time span of the studies and timing of the 
questionnaires, with limited contact with participants in between, could have 
reduced the willingness of individuals to continue.   
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Figure 5:1  Flow chart of withdrawals 
 
Entry to Study (n=33) 
 
Allocated to 
control (n=22) 
Baseline 
completed (N=22) 
 
Allocated to 
Intervention (n=11) 
Baseline 
completed (N=11) 
T2 (n=21) 
Withdrawn T2 
Health problems (1c 2int)  
T2 (n=9) 
Missed (n=6) 
Completed 
assessments 
T3  (n=8)+3 
from control  
 
 
T2 n= 
Completed 
assessments 
T3 (n=17)-3  
to intervention 
Withdrawn 
Failed to respond (3c) 
Died (1c 1int) 
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The issues of recruitment and retention have been considered and the final 
issue relating to the participants is; how representative was the sample of the 
population from which it was drawn. Data on individuals admitted with ACSLT 
during this time period, and available through medical records, was analysed to 
define the wider population that the sample was drawn from and the results are 
displayed in Table 5:3.  It would appear that the sample recruited within the 
studies were younger, more likely to be male, married and on sickness benefits 
than the population they were representing. If this was replicated in a RCT, it 
would have obvious implications for the applicability of the results.  
An additional issue that need to be considered is the impact of the dropout 
rate. There appears to be limited differences between the participants who 
completed the assessments at T3 (25) and the participants at T1 (33). The key 
differences were that the final sample at T3 contained: more women, more over 
70, less deprived, more married, more retired. The numbers recruited are small, 
but if this change in the participant population, due to drop outs, was reflected in 
a RCT, then there would implications for the applicability of any results.  
In summary, if we consider the participants, in terms of the feasibility of a 
RCT, we can see that, if a different researcher had been used, it could have 
been possible to recruit enough participants. If recruitment had continued after 
discharge, then numbers could also have been increased. The drop-out rate 
from the studies due to ill health was higher than expected and there was also 
crossover between the groups due to further cardiac events. This is useful 
information that would inform any future RCT.  
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Table 5:3  A comparison of  participants and population from which they were drawn 
  Study Sample 
N=33 
 ACSLT  Sample 
N=396 
  % Count  % Count 
Gender  M 72.7% 24  66% 263 
 F 27.3% 9  33% 133 
Group total    33   396 
Age group <50 19% 6  9.6% 38 
 50-59 38% 13  18% 70 
 60-69 25% 8  25.6% 101 
 >70 18% 6  47% 187 
Group total   33   396 
Marital status Single 
/divorced/wid 
27.3% 9  39% 155 
 Married  72.7% 24  61% 241 
Group total   33   396 
Employment  Working  33.3% 11  29% 115 
 Sick  30.3% 10  5% 20 
 Unemployed 3% 1  5% 20 
 Retired 33.3% 11  61% 241 
Group total    33   396 
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The time span of the studies and timing of the questionnaires, with limited 
contact with participants in between, could have reduced the willingness of 
individuals to continue and this would need to be altered to reduce the drop-out 
rate. It would appear that the sample recruited were younger, more likely to be 
male, married and on sickness benefits than the population they were 
representing. If this was replicated in a RCT it would have obvious implications 
for the applicability of the results. But the changes in definition of ACSLT make 
it now unlikely that a suitable sample could be recruited for a RCT.   
5.3 Cardiac Rehabilitation intervention 
The second element of feasibility to be considered is that of the CR 
intervention itself. It is important to ensure that the intervention reflects menu-
based practice and to assess how acceptable this part of the feasibility study 
was to participants. The CR intervention, that was used in the feasibility study, 
is described in detail earlier in chapter 4:11, however it was designed to 
replicate real life practice of menu based CR, and to use the skills of staff 
already experienced in this field. The intervention was delivered by a  
multi-disciplinary team comprising of a nurse, physiotherapist, dietician, 
pharmacist and clinical psychologist. Individuals allocated to the intervention 
group were reviewed by the CR team and interventions appropriate to their 
condition were prescribed by the relevant member of staff. Eight participants, 
originally assigned to the intervention group, and three, who were in the control 
group, but received a package of CR due to a further cardiac event, were 
included in this analysis. The CR intervention spanned the first three phases of 
CR as described in chapter 3:9 and onward referral was made for phase four to 
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voluntary and local authority providers. The elements that each participant 
received are documented in Table 5:4. 
This table shows that all participants received an education package on their 
illness and the implications for them as individuals  but, in addition, if they 
needed specialist smoking cessation advice or a psychological intervention this 
was provided. Individuals assessed as requiring an exercise component were 
offered this element.   
Of eleven participants in the intervention group, all received input in hospital 
from the specialist nursing staff and physiotherapists. All participants felt they 
had received a lot of useful information while in hospital, while one felt he hadn’ t 
received enough input. The provision of the programme within hospital was 
simple to organise and carry out. The additional elements of the programme, 
and in particular the exercise component was more complex to deliver and had 
more variability in compliance. Of eleven participants, three were not offered an 
exercise class because of health problems and eight participants were offered 
the exercise component.  Of this eight, two received a home programme, one 
refused to attend, two attended for part of the class and three completed the 
exercise component. The reasons given for not completing the exercise 
component of the programme were mainly due to family circumstances.  
One participant had returned to work, one had a family illness and one 
participant refused to attend as he did not feel like travelling to the hospital. 
Although only five of the eleven participants can be said to have completed a 
full CR programme, the mixture of input does reflect practice within menu-based 
CR programmes in Scotland (ISD 2012).  
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5:4 Cardiac Rehabilitation interventions  
Participant code/Intervention group 219 220 222 223 224 225 106 107 108 109 110 
Education (nurse)            
Risk factor management (nurse)            
Exercise advice (physio)             
Medication advice (nurse/pharmacist)            
Healthy eating (nurse/dietician)            
Specialist smoking cessation advice (smoking cessation 
advisor) 
           
Outpatient programme or Home programme     1/2    1/2    
Number of interventions carried out per participant 5 7 5 6 6 4 6 6 6 5 5 
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The CR intervention can be seen to have replicated usual clinical practice of 
menu-based CR as was a stated aim of the thesis.  
All participants, who completed the feasibility study, were given an 
acceptability questionnaire at the T3 assessment. This asked a number of 
questions around the feasibility study and its acceptability for participants. They 
were asked to assess the usefulness and clarity of the informatio n and to 
expand on any issues they felt had been difficult. However, all participants were 
very positive and felt that they had been happy to be involved. There was  
no-one who expressed any concern about taking part.  At this point, participants 
in the control group, were offered a CR intervention. One participant took this 
offer up.  Participants in the intervention group were asked several additional 
questions. They were asked if the intervention had been acceptable and had 
provided benefit. They all agreed that this was the case.   
In summary, the CR intervention within this feasibility study reflects clinical 
practice and was acceptable to the participants within the intervention group. In 
addition, participants within the control group found taking part in the feasibility 
study acceptable.  
5.4 Staff  
As part of this feasibility study, focus groups were conducted with two 
separate groups of staff to elicit their views on the feasibility of a RCT of CR.  
The process for this has been documented in 4:13 and 4:18. The first focus 
group contained six CR professionals involved in the provision of care for the 
participants in the intervention group. This included two senior nurses, two 
senior physiotherapists and two physiotherapy assistants. The second focus 
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group consisted of eight ward staff, from both sites and from cardiology wards. 
Both focus groups were asked to consider the following topics:  
 Expectations of the research process 
 Barriers to participation 
 Perceived impact of CR on this group 
In addition the CR focus group were asked to consider  
 The provision of the CR programme  
Expectations of the research process 
The CR focus group appeared to have a clear understanding of the research 
process and the reasons behind the design that had been chosen. They were 
familiar with the evidence base for the topic and with previous studies that had 
been conducted. This is likely due to the fact that they had been more involved 
in the discussions relating to the feasibility study. The second focus group on 
the other hand were not familiar with research methodology and had had little 
previous involvement in research. They did recognise that they had bee n given 
information on the feasibility study and its aims, but did not identify themselves 
as being involved in the process.  
Barriers to participation 
The CR focus group did not identify any barriers to participation in research. 
They did, however, raise the issue of low rates of referral from the ward staff to 
CR. This made it more difficult for them to gain consistent experience with this 
population. The second focus group expressed the view that, the time that 
participants were in hospital was too short to facilitate recruitment, and that they 
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had so much to do during this time, that it was difficult to remember the needs 
of the feasibility study. The difficulties with diagnosis were also raised as an 
issue. They were confused by the problems with definition that have been 
described previously and by the different opinions of the cardiologists across 
the two sites. Although supportive of the intervention, they expressed the view 
that, by carrying out a RCT, we would be preventing participants who could 
benefit from receiving CR. They seemed to have little understanding of the 
resource implications or professional challenges that this would bring to the CR 
team. They did not appear to value the feasibility study, as they felt that there 
was no need for further research to prove the benefits of CR.  
Perceived impact of CR on this group  
Both focus groups identified CR as important to the well-being of this client 
group. The second focus group were convinced that CR was needed for this 
group of participants and that it should be provided. They felt that the 
participants would benefit from the intervention, even if they had not had an MI.  
In contrast, the CR staff were concerned over what to tell the participants . This 
was not something that worried the ward staff. They assumed that the 
information would be the same and that it would be provided by the CR staff.  
Provision of the CR programme 
 
Discussions had taken place prior to the commencement of the intervention 
to clarify how the diagnosis would be explained and what care would be 
provided. The CR staff were asked to discuss how they felt this had worked in 
practice. The CR staff felt that they had provided care in exactly the way that  
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they would have for the usual caseload.  They had assessed individual need 
and implemented a programme of care which had been different for each 
individual. This was based on the theoretical framework. However, they did 
identify several issues for further discussion. These included; problems with 
explaining the diagnosis, difficulties in giving advice on specific issues such as 
work and exercise, due to the lack of evidence in these areas, and variation in 
follow-up arrangements.  The team found that participants were very confused 
about their diagnosis, many expressing that there was nothing wrong with them, 
while others thought they had had a heart attack. This was difficult for the staff 
to deal with and to explain to participants.  As stated, a clear strategy for this 
had been agreed prior to the commencement of the intervention, and the staff 
had been prepared for it. However, they felt it had caused more difficulties than 
expected.  At the time of the feasibility study there was no official advice 
available on issues such as returning to work and driving, and the staff felt they 
had to rely on their own expertise in assessing the capabilities of the individual.  
As this was a small feasibility study, the provision and timing of medical follow-
up could not be altered, and the staff had no control over when or where this 
took place.  This was different to the provision of CR in the MI population where 
the team control the follow-up. The staff reported that this led to delays in 
getting agreement for participants to attend the exercise component of the 
programme. The staff were supportive of the feasibility study and felt that it was 
important to gather more information on this population. They had struggled to 
provide evidenced based care for the participants and had to rely on their 
clinical judgement. They also expressed concern about the changing definitions 
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and what it could mean in terms of workload for the team. They were worried 
about a large increase in referrals and how they would cope.  
In summary, the CR staff were supportive of the feasibility study and felt that 
it was important to gather more information on this population, as they had 
struggled to provide evidenced based care for the participants and had to rely 
on their clinical judgement.  The ward staff were supportive of the intervention, 
but felt that a RCT wasn’t necessary as they believed this client group should 
already be receiving CR.  
5.5 Measures  
Further discussion of the data collected using the outcome measures will 
take place in the next chapter. However it is important to consider whether the 
measures chosen were suitable to be used in any future RCT. Data from these 
outcome measures was collected at three assessments. Five validated 
measures were utilised, in addition to, self-reported measures on risk factors, 
health service utilisation and medication (see Table 4:1). The completion rate of 
each assessment is included in Figure 5:1. An acceptability questionnaire  was 
also filled out at completion of the studies and this was discussed in chapter 
5.3.  
The YABQv2 was completed at all assessments with participants appearing 
to understand the questions. However, on several occasions, it was necessary 
to reinforce that ‘don’t know’ was a valid answer. Participants felt that it was 
important to choose an answer even when they weren’t sure. This was then 
included in the verbal instructions given prior to completion of the questionnaire.  
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All participants appeared to understand the questions and answer fully. The 
questionnaire took about five minutes to complete. 
The CLASP asked questions about symptoms that the participant had 
experienced in the previous two weeks, including chest pain,  breathlessness, 
oedema, and physical functioning. Each question was scored and a total score 
for each symptom calculated. Some of the questions were very similar to 
questions within the physical functioning section of the SF36v2. The main 
difference was the timescale involved. The SF36v2 asks questions about the 
last four weeks, while the CLASP uses the last two weeks as a reference . This 
caused difficulties as the studies progressed with participants feeling that they 
were answering the same questions twice. Most declined to answer the section 
on sexual habits and it was decided to use only the chest pain, breathlessness 
and oedema sub-scales of the CLASP in the data analysis.  
The HADS was completed with few difficulties by the participants . It was 
clearly explained prior to completion and assistance given to those who 
required it, due to poor eyesight or difficulty in reading. The time taken was 
usually between five to ten minutes. 
There were no unforeseen problems in the completion of the SF36v2.  There 
was some cross-over in questions with the CLASP as previously mentioned, 
which caused some weariness during the initial assessments. The researcher 
then ensured that the SF36v2 was administered first, to guarantee that these 
data were complete and accurate, and could be compared, and contrasted, with 
that of the SEIQoL-DW. This instrument took about 10-15 minutes to complete.  
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SEIQoL-DW requires a lot more explanation for participants than the others, 
as it requires the participant to identify five key elements of their QoL.   
Then they rate their level of functioning or satisfaction with each, on a scale of 
0-100 with 100 being totally satisfied and 0 being totally unsatisfied. 
The participant then indicated the relative importance of each to their overall 
QoL. They have 100 points to divide between the five factors, in order of their 
importance.  An overall QoL score can then be calculated. The administration of 
SEIQoL-DW took between 20-30 minutes and the whole procedure had to be 
completed at each assessment. There were four occasions when this was not 
possible out of 81 assessments. In all cases this was due to the health of the 
participant. They were unable to concentrate fully on the process and it was 
decided to abandon it rather than to put them through additional stress and 
collect information that would not be a true reflection of their current QoL.  
Once the concept had been explained to the rest of the participants, there did 
not seem to be any real difficulty in coping with the task. Many were quickly able 
to identify five parts of their life which affected their QoL. However some 
participants found it difficult to identify as many as five items. They could think 
of three without too much difficulty, these were often, family, health or work. 
However the last two sometimes took a bit longer to identify. If they were unable 
to think of anything, then there were prompts that could be used to encourage  
them. At each assessment, participants were asked to identify again five areas 
of their life, and only if they were having difficulty, were they prompted with the 
list from previous assessments. In the main, there was a lot of consistency with 
the categories that they identified and their ability to carry out the allotted task.  
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Table 5:5 is an example of one participant’s score on SEIQoL-DW. This shows 
that family and holidays were the two most important factors in determining this 
individual’s QoL and accounted for 70% of the score.  
Table 5:5 Worked Example of SEIQoL-DW  
Factor  Score  Weighting  
out of 100  
Score out of 100  
Family  80 50 40 
Holidays  40 20 8 
Driving  60 15 9 
Health  20 10 2 
Pets  90 5 4.5 
Total score    63.5 
Participants were asked to complete weekly diaries which monitored their 
dietary intake and activity levels. However the completion rate for this part of the 
exploratory study was very poor.  They were given diaries at each intervention 
and asked to post them back after a week.  However participants had problems 
using the pedometers and frequently forgot to keep their food diaries up to date. 
This part of the data collection then had to be abandoned as no reliable 
information was being produced.  
In conclusion all the measures, with the exception of the self-reporting 
diaries were easily used and accepted by the participants. However the use of 
three HRQoL measures was not feasible for the participants and SF36v2 and 
CLASP appeared very similar. The choice of SF36v2 would allow for 
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comparisons with other populations. SEIQoL-DW took the longest time to 
complete, but was interesting to the participants and most were able to carry out 
the exercise.  
5.6 Conclusion  
In summary, the feasibility study was designed to examine the feasibility of a 
RCT which would test the impact of a menu-based CR programme, on 
individuals diagnosed with ACSLT, against standard care. This includes the 
staff views on issues of feasibility. The feasibility study was successful in its aim 
of testing the CR intervention and protocols for a further RCT. Information 
gathered within the feasibility study has shown that recruitment to the studies 
was problematic. Withdrawals were also more than expected.  
If we consider the participants, in terms of the feasibility of a RCT, we can 
see that, if a different researcher had been used, it could have been possible to 
recruit enough participants. If recruitment had continued after discharge, then 
numbers could also have been increased. The drop-out rate from the studies 
due to ill health was higher than expected and there was also crossover 
between the groups due to further cardiac events. This is useful information that 
would inform any future RCT. The time span of the studies and the timing of the 
questionnaires, with limited contact with participants in between, could have 
reduced the willingness of individuals to continue and this would need to be 
altered to reduce the drop-out rate. It would appear that the sample recruited 
within the studies were younger, more likely to be male, married and on 
sickness benefits than the population they were representing. If this was 
replicated in a RCT it would have obvious implications for the applicability of the 
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results. But the changes in definition of ACSLT make it now unlikely that a 
suitable sample could be recruited for a RCT.  
The CR intervention, within this feasibility study, reflects clinical practice and 
was acceptable to the participants within the intervention group. In addition 
participants within the control group found taking part in the studies acceptable. 
The menu based application of the interventions led to a degree of variability in 
the programme, provided to individuals, as had been expected. This would have 
implications for the sample size needed to detect differences between groups in 
any RCT. The CR staff were supportive of the research and felt that it was 
important to gather more information on this population as they had struggled to 
provide evidenced based care for the participants and had to rely on their 
clinical judgement. The ward staff were supportive of the intervention, but felt 
that a RCT wasn’t necessary, as they believed this client group should already 
be receiving CR.  
All the measures, with the exception of the self-reporting diaries were easily 
used and accepted by the participants. However the use of three HRQoL 
measures was not feasible for the participants and SF36v2 and CLASP 
appeared very similar. The choice of SF36v2 would allow for comparisons with 
other populations. SEIQoL-DW took the longest time to complete, but was 
interesting to the participants and most were able to carry out the exercise. Data 
obtained from these measures will be discussed in chapter 6:5. However, the 
changes in diagnostic categories led by government and clinical expert 
agencies means that a RCT is no longer feasible. Recruitment would no longer 
be possible for ethical reasons as has been described. 
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In conclusion, the feasibility study was successful in its aim of testing the CR 
intervention and protocols for a further RCT. However due to changes in 
diagnostic categories a RCT is no longer possible.  
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Chapter Six Exploratory study  
6.1 Introduction 
As has been discussed in previous chapters, individuals with ACSLT are a 
novel population for CR and there is limited data about the impact the CR might 
have on this group. In chapter 5:2-5:5, we discussed the first aim of this thesis, 
which was to examine the feasibility of a RCT which would test the impact of a 
menu-based CR programme, on individuals diagnosed with ACSLT, against 
standard care. This feasibility study also included staff views. The conclusion 
was that, although a RCT of CR in ACSLT was feasible, current healthcare 
policy made it no longer possible.  
A secondary aim of this thesis was to carry out an exploratory study that 
aimed to explore the impact that ACSLT and CR can have on this client group. 
A wealth of data was collected on the participants over a two year period which, 
although only exploratory in nature, does point to areas that require further 
study. Significant problems in recruitment and retention were experienced and 
therefore the numbers of participants who completed the exploratory study was 
small. The data must therefore be treated with caution and can only be seen as 
exploratory in nature. 
This chapter will explore the data collected on the 25 participants who 
completed the exploratory study. Due to the problems with data collection at T2, 
these outcome data will not be presented here, although some information 
obtained at T2 in the interviews will be presented.  However the data obtained 
using clinical outcome questionnaires at T1 and T3 and from the case-notes at 
T4 will be discussed.   
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As discussed previously in chapter 5:2, 33 participants started the 
exploratory study, eight participants were withdrawn, and 25 participants 
completed. Initially, 17 were allocated to the control group and eight to the 
intervention group. However, three of the control group participants received 
input from the CR team following a further admission. The data could have been 
analysed on an ‘intention to treat basis’, which would have given groups as 
above. However, the exploratory study was exploring the impact of a CR 
programme, as it is delivered in real life, and this issue of crossover in groups is 
one that often happens in real-life practice. It was felt that, by including 
participants who received CR later in their care, a clearer picture would be seen 
of the impact that CR has in real life programmes. Therefore, in the data 
explored in chapter 6:3-6:7, the 14 who received no additional input to usual 
care are described as the control group. The eight who received input from the 
CR team during their initial event, and the three who received input from the CR 
team following a second cardiac event, are described as the intervention group. 
The data will therefore be analysed on the basis of 14 participants in the control 
group and 11 in the intervention group.  
6.2 Participants demographic data 
All participants in the studies were of white Scottish ethnic origin. 
The baseline demographic factors can be seen in Table 6:1 and there were no 
statistically significant differences between the control and intervention groups 
in any of the variables. The expected gender balance in the sample would be 
2:1 male to female, as this would reflect the incidence of CHD in Scotland (ISD 
2010).    
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Table 6:1 Baseline demographic factors on admission 
 Study groups Overall total 
 Control group  Intervention 
group 
 total sig 
 % count % count % Count  
Gender 
M 78.5 11 63.6 7 72 18 ns 
F 
 
21.5 3 36.4 4 28 7  
Age group 
<50 7.1 1 27.2 3 16 4 ns 
50-59 42.8 6 36.4 4 40 10  
60-69 28.5 4 18.2 2 24 6  
70-79 7.1 1 9.1 1 8 2  
>79 14.2 2 9.1 1 12 3  
Mean age   61.7  57.2  59.7  
Marital status 
Living alone  21.4 3 9.1 1 16 4 ns 
Married/with partner  78.6 11 91 10 84 21  
Employment status 
Working  28.6 4 45.4 5 36 9 ns 
On Sick  35.7 5 9.2 1 24 6  
Retired 35.7 5 45.4 5 40 10  
Depcat class 
1-2 
3-4 
5-6 
14.3 2 18.2 2 16 4 ns 
3-4 28.6 4 27.3 3 28 7  
5-6 57.1 8 54.5 6 56 14  
Age at leaving full-time education 
16 or under  
17-18 
>18  
85.8 12 63.6 7 76 19 ns 
17-18 0.0 0 36.4 4 16 4  
Over 18 14.2 2 0 0 8 2  
 
142 | P a g e  
 
However, the control group had more men than expected, whereas the 
intervention group reflected the national average. The mean age of the control 
group was slightly older than the mean age of the intervention group.   
The majority of the participants were married or living with a partner. In this 
sample no participants were unemployed, which does not reflect the local 
population, where unemployment rates are currently 8% (Office of National 
Statistics, 2012). As the mean age of the sample was 59.7 years, it is not 
unexpected that 40% were retired and an additional 24% had ill health and were 
unable to work. The occupations most noted were skilled tradesmen, and 
administrative and clerical staff. Only two participants were professionals.  
The incidence of sickness benefit was higher in the control group and the 
numbers working full-time was higher in the intervention group. The majority of 
the sample (92%) left school at 16 or younger, with only two participants going 
on to further education. The intervention group had four participants who stayed 
on at school for a fifth or sixth year and none who went on to further education. 
The control group had two who went to further education, but none who left 
after fifth or sixth year.  
Deprivation status was determined according to deprivation categories 
measured by the Carstairs scores for Scottish postcodes (Carstairs and Morris 
1991).  Each postcode is classified as one of seven categories.  Categories 1-2 
are classified as affluent, 3-4 as middle category and 5-7 as deprived. Currently 
the Ayrshire population is classified as having 14% in the affluent group, 46% in 
the middle group and 40% in the deprived group (ONS, 2012). In this sample 
the groupings were: affluent 16%, middle 28% and deprived 56%.  
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The larger number of participants within the deprived grouping as compared 
to the Ayrshire population was not an unexpected finding as CHD is more 
prevalent in deprived populations (BHF 2012a).  
6.3 Baseline clinical factors 
The sample was assessed using standardised measures for a wide range of 
clinical factors at baseline. As can be seen in Table 6:2, both control and 
intervention groups were similar for: co-morbidities, BMI, Systolic BP, number of 
cigarettes per day, activity score and levels of cholesterol.  The GRACE score  
gives an indication of a % clinical risk of future cardiac events and that the risk 
score is low for both groups and there are no statistically significant differences 
between them.  
Table: 6:2 Baseline clinical factors  
 Study groups  
 Control  
group  
Intervention 
group 
Sig 
Total N=25 N=14 N=11  
 Mean(SD) Mean(SD)  
Co-morbidity  2.0(1.69) 1.9(1.1) ns 
BMI 30.8(5.3) 29.6(5.25) ns  
Diastolic BP  80.08(14.38) 71.4(13.43) ns  
Systolic BP  136.75(23.16) 134.4(30.85) ns  
Cigarette/day 8.35(8.05) 9.54(11.92)) ns  
Active 5.2(0.89) 5.9(1.7) ns  
Cholesterol 5.13(0.58) 5.62(1.7) ns  
TropT 0.33(0.27) 0.31(0.25) ns  
GRACE  
(risk of further events 
within 6 months) 
5.9%(6.68)) 8.75%(12.0) ns  
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6.4 Medical treatment  
The medical treatment for CHD consists of five main groups of drugs and 
these are highlighted in Table 6:3 below. The discharge prescriptions for the 
sample were exactly as would be expected from local discharge data and from 
clinical practice. The control and intervention groups discharge drugs are similar 
across all prescribing data. The follow-up data would appear to show a lower 
rate of follow-up and a higher rate of investigations within the intervention 
group. Three participants from the control group moved to the intervention 
group and all three had further investigations. This accounts for the higher 
investigation rate in the intervention group. However, if we exclude the three 
participants who were moved into the intervention group, due to a further event, 
the groups are similar.  
Table 6:3   Medical treatment  
                                                  Study groups Overall 
total 
sig 
 Control 
group 
Intervention 
group 
Total  
 % count % count % count  
Aspirin  100 14 100 11 100 25 ns 
Clopidogrel 85 12 100 11 92 23 ns 
Ace-inhibitor 64 9 64 7 64 16 ns 
Betablocker  85 12 81 9 84 21 ns 
Statin  92 13 90 10 92 23 ns 
Cardiac  outpatients 78 11 55 6 68 17 ns 
Cardiac Investigations 21 3 45 5 32 8 ns 
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6.5 Outcome measures  
The choice of outcome measures and the rationale for these has been 
described in chapter 4:16 and the feasibility of their use in a RCT has been 
outlined in chapter 5:5. This section will outline the results obtained at T1 and 
T3 on the five outcome measures: 
 YABQv2 
 CLASP 
 HADS 
 SEIQoL-DW 
 SF36v2 
A high score on the YABQv2 relates to a high level of misconceptions. 
Within the participants (both control and intervention), the range of scores on 
misconceptions was 30%-71% at T1 and 21%-71% at T3 (see Table 6:4). This 
indicates quite a wide range of misunderstanding amongst the participants. In 
Table 6:4, we can see that there was only a slight change in the misconceptions 
score for the control group over the exploratory study, with a slightly larger 
change in the intervention group.  
This slight gap between the two groups is also reflected in both the coping 
and perception of anginal threat sub-scales. A high score on these scales 
denotes poor coping or high levels of perceived anginal threat. If we consider 
coping first, we see that the range of scores in the control group varies very little 
from T1 to T3, however in the intervention group, there is a reduction in the 
range of scores between T1 and T3 and a change of mean scores of -2.57 in 
the control group compared to -8.36 in the intervention group.  
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Table 6:4 Outcome measures 
 Control group N=14  Intervention group N=11   
 T1 T3  T1 T3   
         mean (SD) mean (SD) change 
(+/-) 
mean (SD) mean(SD) 
 
change 
(+/-) 
significance 
YABQv2 (Benefit=Reduction) 
Misconceptions  53.78(11.46) 51.15(9.6) -2.63 47.85(8.02) 41.78(14.81) -6.07 ns 
Anginal threat 50.50(14.18) 50.17(13.08) +0.33 45.39(14.01) 39.08(17.33)  -5.3 ns 
Coping 57.14(11.55) 55.71(12.06) -2.57 55.45(14.01) 46.81(13.65) -8.36 ns 
CLASP (benefit=reduction) 
Angina 7.43(3.1) 2.43(3.52) -5 9.18(2.82) 1.91(2.70) -7.27 ns 
Breathlessness 7.29(4.4) 5.64(4.1) -1.65 7.09(5.33) 3.11(3.01) -3.98 ns 
Oedema 1.57(2.62) 1.00(2.1) -0.57 1.82(3.1) 0.89(1.833) -0.93 ns 
HADS (benefit=reduction) 
Anxiety  7.29(4.69) 7.21(5.01) -0.08 8.18(3.06) 5.45(4.22)    -2.73 ns 
Depression  6.57(4.8) 5.85(4.24) -0.72 4.73(2.49) 3.36(3.13) -1.37 ns 
SEIQoL-DW (benefit =increase) 
Global QoL  64.88(16.46) 70.23(14.70) +5.35 69.20(15.34) 77.67(11.53) +8.47 ns 
SF36 v2 (benefit =increase) 
SF36v2 Physical 39.88(10.45) 39.75(14.03) -0.13 36.09(8.09) 44.09(10.36) +8.0 ns 
SF36v2 Mental 
Health 
39.05(15.98) 43.99(14.03) +4.94 48.97(8.17) 51.63(10.74) +3.64 ns 
T1=at baseline T3=at nine month
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We can see from Figure 6:1 below that seven participants (5 control and 2 
intervention) had a deterioration in their coping scores over the period of the 
study.   
 Figure 6:1 Change in coping score  
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The picture of greater reduction in the intervention group continues, on the 
subscale looking at anginal threat, with mean scores (-0.33 v -5.3) reducing 
more in the intervention group. Across all three scales of this questionnaire , we 
see a similar picture of small amounts of improvement between T1 and T3 in 
the control group, with larger changes in the intervention group (see Table 6:4).   
The elements of the CLASP that measured clinical symptoms, including 
angina, breathlessness and oedema are presented in Table 6:4.  A score is 
calculated according to the frequency and severity of symptoms, the higher the 
score, the higher the level of symptoms, with the maximum score obtainable 
being 20. Angina is a key symptom for patients with this clinical diagnosis and it 
can be seen that the scores across both groups reduced from T1 to T3, with a 
change of 5.0 in the control group compared to 7.27 in the intervention group.  
Only one participant suffered deterioration in their pain score and this 
respondent was undergoing further investigations and treatment.  
Breathlessness can be linked to angina, and both groups reported moderate 
levels of breathlessness at T1 and at T3. There is a reduction in both groups 
with changes of -1.65 in the control group compared to -3.98 in the intervention 
group.   
Oedema in the cardiac population is usually related to the presence of HF 
and would not be routinely expected in this population. This is reflected in the 
low incidence at both T1 and T3 with changes in both groups of 0.57 and 0.93 
respectively.  
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The HADS measures two key psychological factors, namely anxiety and 
depression.  The results are displayed in Table 6:4.  If we consider anxiety first, 
we can see that there is little change in mean anxiety levels between T1 and T3 
in the control group. However, the intervention group had higher levels of mean 
anxiety at T1 and this had reversed at T3.  The relative change between the two 
time points was 0.08 in the control group and 2.73 in the intervention group. We 
can see from Figure 6:2 below that there is a wide variation in individual scores 
in the control group between T1 and T3, with half the control group showing a 
worsening of anxiety levels and half showing improvement, therefore leading to 
little mean change. 
Figure 6:2 Change in anxiety score  
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The picture is however different if we consider the intervention group, here 
we see that all the scores across the group improved, and it is this that is 
responsible for the differences noted in the mean scores above. 
If we then consider depression, we see a slightly different picture.  
The relative change between T1 and T3 was 0.73 in the control group and 1.4 
in the intervention group (see Table 6:4). In Figure 6:3 we can see that both 
groups have individuals whose scores deteriorate over the period from T1 to T3.  
Figure 6:3 Change in depression score  
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From Table 6:5, we can see that the control group was more depressed at 
T1 and at T3. It is important to note that within the control group there were four 
participants who presented with scores greater than nine . This level of 
depression would be treated as clinically significant. Of these four participants, 
two had reduced their score below nine and the other two continued to score 
high levels of depression at T3. In addition, one respondent within the control 
group developed a significant depression score between T1 and T3, with no 
corresponding deterioration in health. Within the intervention group there were 
no individual scores above nine at T1 and only one at T3.  This individual had 
suffered additional serious health problems in the intervening time.  
Table: 6:5      Depression Scores by category at T1 and T3 
 Control intervention 
 T1  T3  T1  T3  
         % count % count % count % count 
0<7 57 8 57 8 82 9 91 10 
7-9 14 2 21.5 3 18 2 0 0 
>9 29 4 21.5 3 0 0 9 1 
 
Quality of life was measured using two validated instruments, the SEIQoL-
DW and SF36v2. Twenty four participants completed a SEIQoL-DW at T1 and 
T3. They had to identify five variables that made a difference to their QoL.  
Of these, 19 stated that their family was the main contributing variable to their 
QoL, rising to 21 at T3, with most suggesting that it represented around 50% of 
the total score. Three participants at T1 stated that their health was the main 
contributor to their QoL, with an additional one stating faith and one work.  
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The second most important contributor was often defined as health with 11 
participants identifying this and three picking work. The five who had not picked 
family as variable one, did choose it as variable two. In many cases, the second 
variable represented around 20-30% of the total score.  
The last three variables picked by the participants varied quite a lot, but can 
be summarised as social arrangements. These could be holidays, pets, hobbies 
or a range of other items which related to entertainment. These often had 
values of between 5-15% of the total score.  
Any differences between the groups at T1 and T3 did not reach statistical 
significance. However, we can see that both groups had an improvement in 
their QoL as measured by SEIQoL-DW across the time of the exploratory study, 
with the mean change being 5.35 in the control group and 8.47 in the 
intervention group (Table 6:4).  
The second instrument to be used was the SF36v2. This instrument has 
several different components and can be analysed compared to a variety of 
populations. Two key scales are the physical care summary and mental health 
care summary scales.  The small improvement in QoL noted by the SEIQoL-
DW in both groups is also reflected in the mental health scale of the SF36v2, 
with the control group improving slightly more than the intervention.  
However, the control group started from a lower baseline on this scale.  
This may reflect the results found on the HADS scale that showed a higher level 
of depression in the control group. The results, on the physical summary scale, 
show a slightly different picture, here the control group stay the same and the 
intervention group improve by 8. 
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There are eight sub-scales of the SF36v2 and these are laid out in Table 
6:6. If we consider the control group, we see a mixed picture of improvement 
and deterioration. Physical functioning, role physical, and general health seem 
to deteriorate, and vitality, social functioning and role emotional improve. In the 
intervention group only general health appears to deteriorate. All other factors 
appear to improve.  
Information on norms within different groups is available for the SF3v2.  
If we consider the two groups against the CHD norms, we can see that at T1 
the control group was worse than the norms on all factors except role physical. 
The intervention group was worse than the norm on everything except general 
health, role emotional and physical functioning. At T3 the control group is below 
the norm on all factors except bodily pain, role emotional and the physical 
summary scale. The intervention group is consistently above the norms across 
all factors.  
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Table 6:6   HRQoL  
SF36v2    
Norm based scoring   Control  Intervention    
Total N=25  N=14   N=11   CHD norm  sig 
  T1 T3 change  T1 T3 change    
  Mean(SD) Mean(SD)  Mean(SD) Mean(SD)    
Physical functioning  38.89(11.55) 38.54(10.41) -0.34 39.81(11.08) 46.12(11.74) +6.31 38.87(11.24) ns 
Role physical  41.46(12.82) 40.06(11.07) -1.4 37.26(10.15) 45.05(9.59) +7.79 40.09(10.74) ns 
Bodily pain  38.42(10.1) 47.93(12.63) +9.51 37.22(7.79) 50.32(8.91) +13.1 43.54(9.85) ns 
General health  37.47(8.88) 36.72(9.44) -0.75 43.57(9.1) 41.10(10.07) -2.47 40.86(9.86) ns 
Vitality  37.59(13.5) 37.81(12.1) +0.22 39.88(11.20) 45.84(10.44) +5.96 45.36(9.52) ns 
Social functioning  37.76(13.98) 42.02(13.98) +4.26 41.97(10.37) 51.39(12.19) +9.43 44.16(11.38) ns 
Role emotional  39.49(15.85) 45.05(11.52) +5.56 47.39(13.10) 50.57(11.12) +3.18 43.59(12.67) ns 
Mental health  39.95(14.68) 43.57(13.72) +2.62 48.72(6.46) 50.77(11.12) +2.05 48.48(10.13) ns 
Physical summary  39.88(10.45) 39.75(14.03) -0.13 36.09(8.09) 44.09(10.36) +8 38.91(10.05) ns 
Mental health summary  39.05(15.98) 43.99(14.03) +4.94 48.97(8.17) 51.63(10.74) +2.66 48.34(10.68) ns 
T1=at baseline T3=at nine months
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6.6 Participant interviews  
As described in chapter 4:16, as part of the follow-up at T2 and T3, 
participants took part in a semi-structured interview. The interview protocol is 
included in Appendix 1.2. The process of data analysis is documented in 
Chapter 4.19. There was no overarching theme which joined all the participants, 
but several themes did present themselves within the two groups. These are 
displayed in a thematic map in Appendix 1:5  
The control group consisted of 14 participants. The key themes within this 
group appeared to be; difficulties in making the diagnosis, lack of information on 
what to expect, and feeling as if their life was on hold.  
If we consider the issue of diagnosis first, many of the participants in the 
control group expressed concerns around their diagnosis. They seemed to have 
been given different diagnoses at various stages of their recovery. They had 
been told by one healthcare professional that their admission was due to angina 
and then by another healthcare professional that it was due to an MI.  
‘They told me in the hospital that I had had an angina attack and my GP told me 
last week that the letter says it was a heart attack,’ (participant 204)  
‘one doctor says one thing and another doctor says something else, it was a 
heart attack and then it wasn’t’  (participant 207)  
This uncertainty amongst staff appears to have affected more than one 
hospital and department and also to have impacted on the care from primary 
care teams. There was no consistency in the information being given to the 
participants. For some, this lack of clarity and explanation, was taken to mean 
that there was nothing to worry about.  If the doctors didn’t know for sure , then it 
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couldn’t be anything serious.  This led to some participants not taking tablets, or 
following advice, as they minimised the impact of their illness. These 
participants distanced the event from what they saw as a true serious event 
 i.e. a heart attack.  
‘It’s not like a heart attack or anything’ (participant 102)  
‘It was only an angina attack and I have not had any more (pain) so I don’t see 
the point in taking more tablets’  (participant 104)  
This lack of information made it difficult for many to move forward and many 
of the participants at T3 continue to describe a sense of confusion as to what to 
do now. They expressed concerns about not understanding what they were 
dealing with.   
Many of the participants described a feeling of putting their life on hold, not 
going on holiday, or avoiding their usual hobbies.  This was especially difficult 
for those waiting on tests, who describe living in limbo until the next hospital 
appointment, or the next test, and not knowing what to expect.  
‘I am kind of in limbo, I’m not sure what I should be doing or if I am doing too 
much.  I mean I have had health problems before and If it was my chest or my 
bones, I would know what to do but the heart is different, you only have one 
heart and I don’t want to do anything wrong’ (participant 101).  
The interviews appeared to suggest that, in the control group, not only was 
there a lot of uncertainty among staff about the diagnosis, but this led to the 
participants struggling to make sense of what they had suffered as well.  
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The intervention group consisted of 11 participants, five of whom had either 
PCI or CABG during the period of the exploratory study. Of these, three had 
originally been in the control group before their procedure. They expressed no 
uncertainty around their diagnosis. It is possible that by having another 
procedure this uncertainty was minimised for these individuals. For the 
remaining six participants within the intervention group, this concept of 
uncertainty around diagnosis also doesn’t appear to have been a concern. Only 
one participant in this group expressed concerns around diagnosis.  
‘I didn’t really remember what the CR team said, I have a lot of unanswered 
questions’ (Participant 225). 
For the intervention group the key theme was the future and what it would be 
like. Those who had undergone cardiac intervention were worried about 
whether it would work. The focus for many others, within this group was the 
need to get back to normal and the belief that they could. There was a lot of 
discussion around what they could achieve and how they were managing their 
life.  The impression was of looking forward instead of back.  
Another theme to emerge, from the interviews with the intervention group 
participants, was the benefit that had been perceived in the CR intervention.  
This focused in some cases on the provision of information around how to 
manage their illness or on the recognition of the need for active management of 
issues around their illness that were on-going and required expertise to solve.  
 ‘The specialist nurse came out when I got home and went over everything 
for me, so I kind of knew what to do.’  (participant  220) 
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The interviews appear to suggest that in the intervention group the 
participants were making sense of their i llness, but were still trying to deal with 
uncertainty around the future and what it would bring. They identified the 
intervention as helping them to come to terms with the situation.  
6.7 Two year follow-up 
All 25 participants, who remained in the exploratory study at T3, had their 
case-notes reviewed at two years following admission. Information was 
gathered on readmissions, and any additional health problems. Two of the 
participants (1C, 1INT) had died, both from complications of heart disease.  
Mr (104) was an elderly man who had suffered a further heart attack and Mr 
(108) had suffered extensively from HF.  These two participants had the highest 
GRACE score at T1. Four participants had developed cancer (3C 1INT) and this 
accounts for many of the readmissions to hospital. An additional four 
participants had further investigations and treatment for CHD and two 
participants had suffered from gallbladder and stomach problems.  
Five participants had one admission, two had two admissions, four participants 
had between five and nine admissions, and one participant had 20 admissions.  
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Table 6:7  Readmissions at two years since index admission 
 Control 
 
Intervention Sig 
Total N=25 N=14 N=11  
 Mean(SD) Mean(SD)  
Number of  all cause 
readmissions 
3.09 (6.68) 2.87 (3.35) ns 
Total days 12.0 (25.83 ) 14.50 (21.68) ns 
 
 If we compare the two groups, there would appear to be no significant 
differences, either in number of readmissions or total number of days spent in 
hospital in two years.  However there seems to have been more than expected 
ill health within the participants in both groups. 
6.8 Conclusion 
A secondary aim of this thesis was to explore the impact that ACSLT and 
CR can have on this client group. A wealth of data was collected on the 
participants over a two year period which, although only exploratory in nature, 
does point to areas that require further s tudy. Significant problems in 
recruitment and retention were found and therefore the numbers of participants 
who completed the studies was small. The data must therefore be treated with 
caution and can only be seen as exploratory in nature. 
There were no statistically significant differences between the control and 
intervention groups on any of the demographic variables. Both control and 
intervention group scores were similar for: co-morbidities, BMI, Systolic BP, 
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number of cigarettes per day, activity score and levels of cholesterol.  The risk 
score for future cardiac events is low for both groups and they received similar 
medical treatment.  
Within the participants (both control and intervention), the range of scores on 
misconceptions indicates quite a wide range of misunderstanding. There was 
only a slight change in the misconceptions score for the control group, with a 
slightly larger change in the intervention group. This slight gap between the two 
groups is also reflected in both the coping and perception of anginal threat sub-
scales. Across all three scales of this questionnaire , we see a similar picture of 
small amounts of improvement between T1 and T3 in the control group, with 
larger changes in the intervention group. 
Angina is a key symptom for participants with this clinical diagnosis and it 
can be seen that the scores across both groups reduced, with a slightly larger 
reduction in the intervention group. This pattern is reflected in both 
breathlessness and oedema scores.  
If we consider anxiety and depression, we can see that there is little change 
in mean anxiety levels between T1 and T3 in the control group. However , the 
intervention group had higher levels of mean anxiety at T1 and this had 
reversed at T3.  All the scores across the intervention group improved. The 
control group was more depressed at T1 and at T3, but the relative change 
between T1 and T3 favoured the intervention group. However 30% of all the 
participants had clinically significant depression scores.  
Quality of life was measured using two validated instruments, the SEIQoL-
DW and SF36v2. Both groups had an improvement in their QoL as measured 
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by SEIQoL-DW, across the time of the exploratory study, with the mean change 
being 5.35 in the control group and 8.47 in the intervention group. This is 
reflected in the SF36v2. If we consider the two groups against the CHD norms, 
we can see that, at T1 the control group was worse than the norms on all 
factors except role physical, and the intervention group was worse than the 
norm on everything except general health, role emotional and physical 
functioning. At T3, the control group is below the norm on all factors except 
bodily pain, role emotional and the physical summary scale and the intervention 
group is consistently above the norms across all factors.  
The interviews with participants appear to suggest that the key themes 
within the control group appeared to be; difficulties in making the diagnosis, lack 
of information on what to expect, and feeling as if their life was on hold. In the 
intervention group, the participants were making sense of their illness, but were 
still trying to deal with uncertainty around the future and what it would bring.  
They identified the intervention as helping them to come to terms with the 
situation.  
At the two year follow-up there would appear to be no significant differences, 
either in number of readmissions, or total number of days spent in hospital.  
However, there seems to have been more than expected ill health within the 
participants in both groups. 
In conclusion, outcome data was collected, at four time points, on a new and 
novel population, that has not been studied within the CR evidence base 
previously.  There were significant problems in recruitment and retention and  
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this meant that the number of participants who completed the studies was 
small. There were no significant differences between the groups at T1 and no 
statistically significant benefit can be detected across the clinical outcome 
indicators, due to the small numbers. Any data must therefore be treated with 
caution and can only be seen as exploratory in nature. However , a wealth of 
data was collected on the participants over a two year period and it does 
suggest areas that require further investigation. The data obtained using clinical 
outcome questionnaires at T1 and T3 and from the case-notes at T4 have been 
explored and it can be seen that, although the numbers within the exploratory 
study were small, the intervention group do appear to have improved more than 
the control group across almost all indicators. This warrants further study. 
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Chapter Seven Discussion 
7.1 Introduction 
This thesis contains a feasibility study and an exploratory study. The 
feasibility study aimed to examine the feasibility of a RCT, which would test the 
impact of a menu-based CR programme, on individuals diagnosed with ACSLT, 
against standard care. This feasibility study included staff views. The 
exploratory study aimed to explore the impact that ACSLT and CR can have on 
this client group.  
The impetus for this thesis was the growing pressure on CR teams to 
provide care for a wide range of individuals with varying diagnoses, but 
particularly for those with ACSLT. There was however, a lack of evidence on 
the impact, and the best method of provision of menu-based CR, for this 
population.  The preceding chapters have reviewed the theoretical basis, have 
modeled the intervention, and have documented the outcome of the overall 
aims of the research stated above. This chapter aims to discuss the limitations 
of the studies and the three main findings in depth. The three main findings that 
require further discussion are as follows: firstly, that the feasibility study was 
successful in its aim of testing the protocols and the CR intervention for a 
further RCT. Several improvements were identified that could enhance the 
design of the studies. However the feasibility study also highlighted that, due to 
changes in healthcare policy and service provision, a RCT of menu-based CR 
in ACSLT would no longer be possible within the UK.  
Secondly, this thesis has explored the impact of menu-based CR on a 
unique population, that of ACSLT, and although the exploratory study was not 
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powered to detect statistically significant differences between groups, there 
appears to be a tendency to benefit that would warrant further study in this area.  
Finally, this thesis has highlighted the degree of uncertainty experienced by 
participants during this time of change within cardiac services. The confusion 
over the changing definitions of MI was a unique situation and the impact that 
this had on participants has been documented within the exploratory study.  
However, the wider implications of the concept of uncertainty and its impact on 
the theoretical framework need further consideration.   
The chapter will then discuss changes in the CR evidence base, the 
implications of the thesis for clinical practice, and make suggestions for further 
research.    
7.2 Limitations of the studies 
This thesis contains a feasibility study and an exploratory study which 
involved only 33 participants. The feasibility study also involved 14 staff. 
Although the studies provide useful information for practice, their limitations 
must be acknowledged.  The small size of the sample made it unlikely that 
significant results could be found. Previously, little data existed on this 
population. However, there are several interesting trends within the data that 
require exploration in a further study.  
The studies were carried out by a single researcher with limited additional 
funding.  This had implications for the design. It is possible that if this had been 
a funded project, then decisions taken on the design would have been different. 
One example was the choice of a case-control rather than a randomised 
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design.  If a randomised design had been chosen, it may have strengthened the 
studies, however the practicalities of organising and delivering an intervention 
meant that a case control design was the better choice, as it concentrated the 
professional resource that was needed into a short time span and this allowed 
the staff to develop and practice the skills required for this population.  
Another example of practical issues influencing design choices was the 
choice of time-points. It is possible that, if an additional time point had been 
introduced at 6 months; different data would have been obtained, as it would 
have been closer to the end of the intervention. In addition, at T4 only data from 
the case-notes was obtained and if a further interview had been carried out at 
this point, utilising standardised questionnaires and qualitative methods, then 
this could have strengthened the exploratory study.  
The use of standardised questionnaires was a strength of the exploratory 
study, as this allowed comparisons with previous work to take place.  
However, the use of both CLASP and SF36v2 was too challenging for the 
participants and it would have been better to have focused on one instrument. If 
a pilot study of these HRQoL measures had been carried out, this difficulty 
could have been avoided. 
These studies were carried out at two hospitals in the west coast of 
Scotland and the findings may not generalise to areas where clinical practice is 
different. If the studies had been carried out at one hospital, then it is possible 
that recruitment would have been better. However, the use of two hospitals was 
at the request of NHS Ayrshire and Arran, who wished to explore the service 
issues.  
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Due to the difficulties with recruitment and retention, the participants may 
not have been representative of the population from which they were drawn. 
The sample was small and no significant differences were found. If the sample 
had been larger this may not have been the case.  The participants included a 
high number of males versus females. The experiences of the women may not 
have been adequately reflected within the data that was collected. In addition, 
all the participants came from a white Scottish ethnic background. This reflects 
the local population, but limits the applicability of the results to other ethnic 
populations.    
The control and intervention groups had substantial drop outs throughout 
the course of the research due to ill health. There were also three participants, 
who crossed from the control to intervention group, due to further cardiac 
events. This was a useful finding for any future study, but was one that had not 
been anticipated at the design stage. 
The use of focus groups and interviews was an additional element of the 
studies and was limited in its scope. Only two focus groups were held with staff 
and if further focus groups had been carried out, it is possible that the data 
would have given more understanding of the issues. However, it is also possible 
that similar views would have been expressed.  
The interview data was limited in its scope, as it took place as part of the 
session involving the completion of the standardised questionnaires, and the 
participants may have been tired of answering questions at this point. In 
addition, it focused on a small number of questions due to the limited time 
available. A deeper understanding of the experiences of this group of 
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participants could have been achieved by making the qualitative approach a key 
element of the design. 
The issue of uncertainty, especially around diagnosis, had not been 
anticipated and its impact on the results is unknown. This is an area that has 
not been studied within the CHD population, to any great extent, and these 
studies were not designed to do so. However, this is an interesting area for 
future research. 
In summary, the studies provide useful information for practice, but their 
limitations must be acknowledged. The small size of the sample made it unlikely 
that statistically significant results could be found. The studies were carried out 
at two hospitals in the west coast of Scotland and the findings may not 
generalise to areas where clinical practice is different. Due to the difficulties with 
recruitment and retention, the participants may not have been representative of 
the population from which they were drawn. The participants consisted of a high 
number of males versus females and the experiences of the women may not 
have been adequately reflected within the data that was collected. In addition, 
all the participants came from a white Scottish ethnic background. This limits 
the applicability of the results to other ethnic populations. The design itself had 
limitations due to funding and staffing and the qualitative aspect of the studies 
needed to be expanded. The issue of uncertainty was unexpected within the 
exploratory study and is an area for further research. These studies do however 
contribute to the evidence base on a population about which little is known and 
do provide information on areas that require further study.  
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7.3 Feasibility of a randomised controlled trial  
The rationale behind carrying out a feasibility study for a RCT has been 
explained in chapter 4:3 and follows the original MRC framework for complex 
interventions (MRC 2000). As stated previously, the feasibility study was 
successful in its aim of testing the CR intervention and the protocols for a 
further RCT.  
The strengths of the feasibility study design included the acceptability of the 
CR intervention, commitment from the specialist CR staff to the process, the 
use of validated tools that were easy to administer and which the participants 
found acceptable, and the collection of a wide range of data on a group not 
previously studied.   
A core component of the design was the CR intervention itself. As described 
in chapter 3:8-3:9, CR has developed rapidly over the last two decades and has 
extended beyond the exercise-only models that form much of the initial 
evidence for CR, to a multi-disciplinary menu-based model that addresses a 
wide range of need within the individual treated. This menu-based approach 
has not been studied in the same depth as exercise based CR.   
This feasibility study aimed to test a menu-based intervention used in 
everyday practice, and see how feasible it would be to replicate the intervention 
in a further trial. The participants received input throughout the four phases of 
menu-based CR, as described in table 5:4. This reflects current practice within 
the specialist CR team. A recently published audit of all Scottish CR 
programmes shows that current CR practice across Scotland is multi-
dimensional and includes all the elements that were included in the  
170 | P a g e  
 
CR intervention provided in this research (ISD 2012).  At T3, no participants 
from the intervention group expressed any concerns about the CR intervention 
and this established the acceptability of the intervention to ACSLT participants.  
Another strength of the feasibility study was the commitment expressed by 
the specialist staff to providing an appropriate CR intervention for ACSLT. They 
were keen to provide the intervention and to take part in the feasibility study. 
They had no difficulty with providing health behaviour change interventions and 
the exercise prescription advice. However, there was uncertainty amongst the 
CR staff on what advice to give on issues relating to recovery. There was 
limited advice available on issues such as driving, holidays and work. The CR 
staff were concerned about the information on these topics that they were 
providing and the lack of an evidence base in this population. They were not 
convinced that they could advise the participants in the same manner as 
individuals with MI and they were keen for evidence-based information to be 
developed.   
The challenges found within the design of the studies were around 
recruitment and retention of the participants. If we consider recruitment first, this 
is seen as one of the key hurdles for any research and in these studies it was 
not possible to recruit an appropriate sample. The researcher had 
underestimated the number of patients with ACSLT, who had participated in CR 
in the past, and this excluded a large number of potential participants.  
Although, the CR team had information on all previous participants at CR, it was 
not possible to access data on individuals admitted with ACSLT due to coding 
difficulties.  Therefore this data could not be cross-referenced to give a reliable 
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estimate. The information gathered within the feasibility study, on the number of 
patients admitted with ACSLT, who had a previous history of CHD, would help 
to inform any future calculations on recruitment. The key issues affecting 
recruitment would appear to have been related to the wider healthcare 
community. The issues were: clinical gatekeeping, diagnostic difficulties, and 
timescales. 
If we consider clinical gatekeeping first, this has been defined as the process 
whereby healthcare providers prevent access to eligible patients for research 
recruitment (Hudson et al 2005). The concept of clinical gate-keeping as a 
barrier to recruitment has been raised in two studies (Hudson 2005, Fayter et al 
2007). Recruiting participants to studies like these requires collaboration 
between researchers and clinical staff. The eligibility criteria included defined 
physiological criteria, i.e. Troponin T level and the cardiologist had to make a 
clear diagnosis, which fitted with the research protocol, before the patient could 
be approached. This criterion was approved by the ethics committee. In a 
systematic review of barriers to recruitment, Ross et al (1999) noted eight 
barriers for clinicians that prevented recruitment to a RCT. Four of these 
barriers were identified in the studies. These were: time constraints, lack of staff 
and training, concern for patients, and an insufficiently interesting question. The 
barriers identified by Ross et al (1999) not found within the studies were: worry 
about the doctor/patient relationship, loss of autonomy, difficulties with consent 
procedure, lack of rewards or recognition.  
An important issue was the time constraints for recruitment and for consent. 
Many patients were only in hospital two or three days and it took some time to 
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reach a diagnosis. Healthcare staff within the wards did not notify the 
researcher of suitable patients and many patients were missed prior to consent. 
Without the ward staff identifying suitable patients and making the initial 
approach, recruitment was difficult. The researcher’s time was certainly an area 
of difficulty and the inability to be around, when suitable participants were in the 
wards, was problematic. The ward staff were busy and this client group was 
only one of many that they were dealing with. This could have made it difficult 
for them to remember the inclusion criteria.  
Training had been carried out at the beginning of recruitment, but this was 
not repeated while the studies were running. The ward staff expressed support 
for CR during the focus groups, but also expressed a feeling that further 
research was not needed. They felt that all patients should receive it, regardless 
of the lack of an evidence base. This translated into a delay in assessing 
patients, particularly during the control group phase. The staff felt that, if they 
waited long enough, the diagnosis would be changed and the patient would be 
eligible for CR. This is not surprising given the difficulties in diagnosis that will 
be discussed in the next section. The research questions held particular interest 
for the CR clinicians, but were not important to the other clinicians within the 
team as it would have no impact on their workload.    
Sharkey et al (2010) suggest that this issue of clinician gate keeping can be 
minimised by the appointment of a professional researcher to solve the 
difficulties with the recruitment processes. This would reduce the demands on 
the staff. In an attempt to improve recruitment, two nurses were tasked with 
visiting the wards every day to check for potential participants.   
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This did start to improve recruitment, and it is possible that, if this had been built 
in from the beginning, then the anticipated recruitment would have been 
possible. Also, if the studies had taken place on one site, this would have 
reduced the available pool of suitable participants, but could have improved the 
pickup rate, as it would have concentrated resources in one place. 
The ward staff were not aware that participants would receive CR regardless 
of which group they were allocated to. Those in the control group were offered 
CR following the completion of the studies. If more had been made of this fact, 
recruitment might have been improved.  
The lack of an understanding of the importance of the research question 
was another area in which improvements could have been made. The training 
undertaken with the staff could have emphasised the importance of the studies 
to clinical practice and to issues such as service development and funding.  
These issues would need to be addressed in a further study.  
Hudson (2005) argues that it is collaboration in research design that is likely 
to solve the problem of lack of interest. Where professionals have been 
involved, in the formulation and development of a study, they are more likely to 
commit to that study. No clinicians apart from the researcher were involved in 
the design stage and this may be why the cardiologists and cardiac nurses did 
not feel involved in the research, or in the recruitment of participants.  
Diagnostic difficulty was the second area of concern relating to recruitment. 
In the early stages of the studies, when the control group was being recruited, if 
the patient was diagnosed as a MI, they would automatically receive a package 
of care from CR. If they were diagnosed as meeting the research protocol, they 
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wouldn’t. There were examples of staff not being keen to approach a patient 
about the research, as they were hoping that Troponin T levels would make 
them eligible for the routine CR programme. There were also examples of 
differing opinions amongst the cardiologists, about diagnostic criteria, prior to 
the implementation of governmental policy. Only 11 participants were recruited 
at site 1 and 22 at site 2. This does not reflect the workload of the two hospitals, 
but does reflect the diagnostic preferences of the cardiologists and therefore the 
available pool of potential participants. It is possible that, if more education 
around the basis for the research had been undertaken with all the healthcare 
staff in the department, they would have understood the rationale and benefit to 
both the participants and the organisation.  
The timescales built into the design also caused problems for recruitment, 
with many patients not being in hospital long enough after the diagnosis was 
reached to ensure informed consent. The ability to recruit after discharge would 
have given more time for obtaining consent and could have increased the 
available pool of participants. However, this would have changed the 
implementation of the CR intervention which commences prior to discharge.  
As a key element of the exploratory study was to examine menu-based CR, as 
it is usually provided, recruitment following discharge was not considered in the 
design of the studies. 
Following on from recruitment, it is important to ensure that participants stay 
in both studies. The researcher had several problems, with retention of 
participants, that had not been adequately predicted. A key element was the 
difficulty in retaining participants due to i ll health. Of eight participants (24%) 
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withdrawn from the studies, two died, three withdrew due to further health 
problems, and three withdrew for personal reasons. In addition there was also 
crossover between the groups as three participants (9%) had a further cardiac 
event and received CR.  However, the small number of participants meant that 
every drop-out had a large impact on the total percentage. There is little that the 
researcher could have done to change the level of ill health within the 
participants, as this level of ill health is consistent with a serious illness such as 
ACSLT, however these data are useful in determining recruitment numbers for 
any RCT.  
The impact of losses to follow up, or drop out, has only been examined in a 
few trials of CR. Jolly et al (2009) looked at 1207 patients who were eligible for 
home exercise and consented 525. They had an attrition rate of 8.5% and an 
additional 11 patients (4%) crossed over from the home to a hospital 
programme. This is well below the attrition rate within these studies.  In a paper 
by Zwisler et al (2008), looking at a RCT of CR in Denmark, a 16% drop out rate 
was noted, but no description of the reasons for drop out was given. In a 
Cochrane review of exercise rehabilitation by Jolliffe et al (2001), it was noted 
that losses to follow up within many trials were high, but often not adequately 
described. This was also noted in a systematic review of home -based CR 
versus hospital, where losses to follow up varied considerably across all the 
studies (Taylor et al 2010). The issue of crossover was dealt with in many 
studies by appearing to undertake an intention to treat analysis, in that groups 
were analysed according to initial random allocation. In the feasibility study a 
final group design was used, in that the data was analysed by the final outcome 
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for the individual, control or treatment.  The reasons for  this are explained in 
chapter 6:2.  
An additional problem for the studies was the timing of the questionnaires. 
Three participants chose not to continue between T1 and T3. There was limited 
contact with participants in between the assessment periods and this could 
have reduced the willingness of individuals to continue. It is possible that if 
contact with the participants had been made, at regular intervals, by phone, or 
letter, that these three withdrawals could have been avoided.  
There are several lessons that can be learnt from this feasibility study when 
designing a future RCT. This feasibility study could have been more successful, 
if a researcher had been employed to recruit participants and if more training 
had been carried out with the healthcare staff on the wards. If these staff had 
been included in the development of the proposal, they would possibly have 
been more open to assisting with recruitment. If time had been taken to keep in 
contact with the control participants, then the attrition rate within this group 
might have been smaller. Information was collected within the feasibility study 
on: the high mortality and morbidity within the participants, the crossover 
between groups, the limited time span for consent and the difficulties with 
diagnosis. These data will contribute to the revision of the design for any further 
study.  
Healthcare policy and service provision had an overriding impact on this 
thesis, as recruitment was halted at 25 participants due to changes in the 
diagnostic categories. The debate about the definition of MI was one that 
caused uncertainty throughout the life of the studies. This was a debate that 
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had arisen as early as 2000 with the publication of a new definition of MI (Table 
2:1). The BCS however, did not agree with this definition of MI. This was due in 
part to a belief that the change in definition would affect comparisons with 
previous reference studies and epidemiological cohorts (Fox et al 2004).  
This change in definition, it was believed by the BCS (Fox et al 2004), would 
have important implications for patients who could be given unjustifiable 
prognostic information based on historical comparisons, be barred from certain 
occupations, and be inappropriately penalised or rewarded by financial and 
insurance institutions. Fox et al (2004) argued that the term “clinical MI” should 
be reserved for patients who would previously have been diagnosed as MI and 
also had an increase in Troponin T above a threshold set at 1.0 ng/ml. They 
argued that the ESC/ACC guidelines were overly dependent on troponin 
assays, which were not reliable enough. Fox et al (2004) also argued that the 
term ‘‘ACS with myocyte necrosis’’, or ACSLT as defined within this thesis, 
should be reserved for patients with a typical clinical syndrome plus an 
increased troponin concentration below the diagnostic threshold (that is, 
Troponin T< 1.0 ng/ml). This meant that a group of patients with Troponin T 
results between 0.01 and 0.99 would be classed as MI in Europe and America 
but not in the UK, where they would be diagnosed as ACSLT.  It was on this 
basis that the inclusion criteria were set.  
As the research progressed, the gap between the BCS criteria and 
ESC/ACC criteria produced a lot of confusion for clinicians across the UK. This 
continuing debate was clear, even as late as the beginning of  2007, with the 
publication of the SIGN guideline for ACS (SIGN 2007). This continued to show 
the differing definitions in the evidence and highlighted the mortality risk of all 
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groups as seen in Table 2:1. A cornerstone of the differing opinion was the 
belief that the lower range of troponin rises meant less  risk.  However, in their 
study of 2499 patients, Das et al (2006) had found this not to be the case. They 
found that at six months, mortality rates for patients with ACSLT, had risen to 
the same level as those for patients with clinical MI.  Das et al (2006) also found 
significant differences in the treatment of patients with ACSLT, with less 
prescription of recommended drugs such as beta-blockers, ace-inhibitors and 
statins. The relatively limited use of interventional strategies and of short term 
and secondary prevention drugs further suggested that patients with ACSLT 
could benefit both from early identification and from being treated more 
aggressively. Their findings supported the value of the revised ACC/ESC 
definition of MI, as the additional cohort of patients identified by the new 
diagnosis of MI had a prognosis identical to those covered by the old definition. 
By late 2007, the Scottish Government had issued guidance to health boards 
stating that any troponin rise was to be treated as an MI and they followed this 
up in the publication of the CHD and Stroke strategy (SGHD, 2009).  
This strategy argued that, although a diagnosis of MI has a range of potentially 
significant implications for patients and their families, with respect to 
psychological effects, life insurance, careers and lifestyle, a more precise 
diagnosis, and recognition that even minor elevation in troponin is associated 
with poorer prognosis, means that more appropriate initial and long term 
treatment can be offered. This definition of MI became standard practice within 
the research centres at the end of 2007. The decision to classify this group of 
patients (ACSLT) as having suffered an MI, in line with ESC/ACC guidelines, 
meant however that CR had to be routinely offered, to patients  with ASCLT 
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within NHS Scotland.  Therefore, it would no longer be ethical to withdraw this 
intervention as part of a RCT.  
The rationale behind carrying out a feasibility study for a RCT has been 
explained in chapter 4:3 and follows the MRC framework for complex 
interventions (MRC 2000). The results of the feasibility study have been 
documented in chapter 5:2-5:5 and the strengths and challenges have been 
further discussed in this chapter. However, since the original studies were 
designed, a number of limitations in the MRC framework have been identified 
and a revised framework has been published (MRC 2008). One limitation, 
identified in the original framework, was the use of a linear model that had 
traditionally been used to evaluate the effects of medicines. Other limitations 
identified included the fact that there was little guidance in the original  MRC 
framework (2000) on how to approach developmental and implementation 
phase studies, which this was, and an assumption that conventional trials 
provided a template for different approaches to evaluation.  The authors of the 
revised framework made the point that there had been a lack of guidance on 
how to tackle highly complex interventions. There was also a lack of attention to 
the social, political and geographical context in which interventions take place. 
All these limitations of the framework had implications for the design of this 
thesis. The new framework (see Figure 7:1) no longer places reliance on the 
linear model of research and on the gold standard o f RCT. It considers differing 
options for research methods and guides researchers on which method to 
choose and at what stage of the developmental process. It is possible that , if 
this thesis had been designed according to the new framework, then some of 
the difficulties it encountered could have been avoided.  
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Figure 7:1 New MRC Framework for evaluation of Complex interventions 
 
MRC (2008) 
The focus in the previous MRC framework was that a RCT was the gold 
standard. However, a lot of the issues within these studies, especially with 
regards to recruitment, related to the need to have a control group. If the studies 
had not required a control group, but instead had considered a comparative 
study of CR outcomes for ACSLT and for MI, then some of the issues related to 
recruitment would not have occurred. Participants would all have been receiving 
the intervention as routine clinical practice and healthcare staff could have been 
more amenable to approaching potential participants. The diagnosis issues 
would no longer have made any difference, in the initial stages, as all 
participants would receive CR, and the focus of the research would have been 
on delivering the intervention and on the outcomes it could achieve, in both 
groups. 
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One of the elements of the new MRC framework is the attention paid to 
changing circumstances and the recognition that circumstances may change 
after a study has begun. The new framework recognises the need to develop a 
good understanding of the context in which a study is being carried out, and to 
monitor and document any significant changes. Examples of significant 
changes could be the introduction of some new policy or, in the case of trials 
with long-term follow-up, more fundamental changes in the economic or political 
context.  
In summary, a key finding of this thesis is that the feasibility study was 
successful in its aim of testing the CR intervention and the protocols for a 
further RCT. The strengths of the feasibility study included the acceptability of 
the CR intervention, commitment from the specialist CR staff to the process, the 
use of validated tools that were easy to administer and which the participants 
found acceptable, and the collection of a wide range of data on a group not 
previously studied.  The challenges the feasibility study faced were recruitment, 
retention, and changes in healthcare policy and provision. This feasibility study 
could have been more successful, if the healthcare staff had been active 
partners and if a researcher had been employed to recruit participants. If time 
had been taken to keep in contact with the control participants , then the attrition 
rate within this group might have been smaller. The information collected within 
the feasibility study on mortality and morbidity and crossover between groups, 
could inform any further calculations of sample sizes for a RCT. The 
implications of changes in healthcare policy and service provision mean that a 
RCT of menu-based CR in ACSLT is no longer possible within the UK.  
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However the new MRC framework offers opportunities for evaluating CR in 
ACSLT in a different way.  
7.4 Cardiac Rehabilitation and Acute Coronary Syndrome with Low 
Troponin  
This thesis contains a feasibility study and an exploratory study. The 
feasibility study has been discussed in chapter 7:3. The second element was 
the exploratory study, which aimed to explore the impact that ACSLT and CR 
can have on this client group. 
As has been stated previously, the exploratory study did not achieve 
statistically significant results in any of the key outcome measures of 
misconceptions, symptoms, anxiety, depression and HRQoL. However a 
tendency to benefit was noted that favoured the intervention group. This finding 
must be treated with caution due to the limitations of this thesis noted earlier in 
chapter 7:2. This trend does however, reflect the evidence that has been found 
in previous studies of CR in non-standard populations. 
In this exploratory study, the YABQv2 was used to examine misconceptions, 
anginal threat and coping.  As documented in Table 6:4, across all three scales 
of this questionnaire, a picture of small amounts of change can be seen 
between T1 and T3 in the control group with larger changes in the intervention 
group.  None of these changes were statistically significant.  
The YABQv2 has previously been used by Furze et al (2003) in a study of 
133 participants comparing a control group, with a group who received the 
Angina Plan, a cognitive behavioural intervention. Following the intervention, 
statistically significant differences between the groups were found.  
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The scores on the questionnaire were 48 in the control group and 40 in the 
intervention group as compared to 51 and 41 respectively in this exploratory 
study. 
The scores found by Furze et al (2003) on the two sub-scales are also 
similar to the results found within this exploratory study. The coping subscale 
scores were 48 in the control group and 37 in the intervention group. In this 
exploratory study, the corresponding scores were 55 and 46. This similarity is 
continued if we look at the perception of threat subscale. Here the scores were 
47 in the control group and 37 in the intervention group as compared to 50 and 
39 respectively in this exploratory study. 
As had been stated previously, both control and intervention groups in this 
exploratory study had high scores across all the scales of misconceptions, 
anginal threat and coping at T1 (Table 6:5) and the intervention group had a 
greater reduction in these scores than the control group at T3. This could 
indicate a change in misconceptions over the timescale of the exploratory study 
and would certainly merit further investigation, particularly given the similarity to 
the scores within Furze et al (2003).  
A high prevalence of psychological symptoms and disorders in patients with 
CHD has been documented in several papers (Rugulies 2002, Carney and 
Shibeshi 2007, Freedland 2008).  In a recent meta-analysis, looking at anxiety 
as a predictor of medical prognosis after MI, Roest et al (2010) found that post 
MI anxiety is consistently related to adverse cardiac events. Within this 
exploratory study, several participants reported high levels of anxiety and 
depression. As part of the CR intervention, participants in the intervention group 
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had access to a psychologist, if necessary, and received an intervention that 
used the CSM as its guiding framework. This exploratory study found that mean 
scores, in both control and intervention groups, were mildly anxious at T1 and 
that in the control group they remained mildly anxious at T3. Anxiety levels in 
the intervention group had fallen to within normal ranges at T3 (Table 6:5). 
Changes in anxiety levels, with the addition of a CR programme, have been 
noted in other studies, as shown in a recent Cochrane review of psychological 
interventions in CHD. Whalley et al (2010) found that where anxiety was 
measured, a small but significant reduction in anxiety was associated with a 
psychological intervention.  
A study by Yohannes et al (2010) used the HADS to measure anxiety and 
depression in participants attending a CR programme. The authors found that 
mean scores at baseline for anxiety were 7.87. The corresponding scores within 
the exploratory study were 6.35 (c) and 7.87 (I).  Yohannes et al (2010) also 
found that scores dropped over the course of the intervention and that anxiety 
scores were 6.35 at six months and 6.51 at 12 months. Within the exploratory 
study, anxiety was measured at nine months and scores were 6.51(c) and 5.71 
(I) respectively.  
In a review of outcomes within a CR programme, Turner et al (2002) found 
that mean anxiety scores, measured by the HADS, fell from 6 to 4.9 over the 
course of the programme.  In a comparison of home versus hospital CR, Dalal 
et al (2007) found baseline anxiety scores of between 5.67 and 7.46 and a 
reduction in both groups of approximately 1.0 at nine months. The results, 
within this exploratory study, are therefore similar to the results found in 
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previous studies. Across the timescale of this exploratory study, there was a 
reduction in anxiety in both groups, with the tendency to benefit favouring the 
intervention group. It is possible that, if a larger sample had been recruited, 
significant results may have been found.    
Between 31-45% of patients with CHD, including those with stable and UA 
or MI, suffer from clinically significant depressive symptoms (Lesperance 2000, 
Carney 2008, Thombs 2008). Depression was measured in this exploratory 
study and the mean scores do not indicate significant levels of depression.  
They do reflect scores found in previous studies utilising the HADS.  
Dalal et al (2007) found baseline depression scores of between 2.84 and 4.12, 
with a reduction over the study of 0.23 in both groups. Turner et al (2002) found 
mean scores of 3.8 with a reduction of 1.3 after CR and Yohannes et al (2010)  
found baseline scores of 7.35 with a reduction of 2.08 after six months. This 
exploratory study reported levels of depression at T1 of 6.57 in the control 
group and 4.73 in the intervention group, with a corresponding reduction at nine 
months of 0.72 and 1.37 respectively. Although there are a wide range of 
scores within these papers, all are within normal limits and all report reductions 
in scores across the period of CR. 
If however, we consider the individual scores within this exploratory study, 
we can see that four participants in the control group had clinically significant 
levels of depression and approximately 21-25% of the participants had some 
degree of depression throughout the period of the studies (Table 6:4).  Whalley 
et al (2011) in their review argued that psychological interventions appear to be 
effective in reducing psychological symptoms in patients with CHD.  
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This was despite the fact that many of the patients treated were not diagnosed 
with any specific psychological condition, and many may not have met 
conventional diagnostic criteria for depression. Within this exploratory study, we 
have found comparable levels of anxiety and depression and a suggestion of 
benefit for a CR intervention that is mirrored in the studies reviewed by Whalley 
et al (2011).   
HRQoL was an important area of interest within this exploratory study. Frank 
et al (2011) argue that the factors that are most predicative of change in HRQoL 
within CR are primarily clinical and functional in nature; those with the poorest 
exercise capacities at entrance to CR make the greatest gains in HRQoL over 
the length of the programme. If we consider that clinical symptoms may play a 
part in the level of HRQoL, then it is important to consider the results obtained 
on angina using the CLASP.  Angina is a key symptom for individuals with 
ACSLT. It would be expected that angina symptoms would improve, as the 
participant recovered, and it can be seen (Table 6:4) that the scores across 
both groups improved from T1 to T3, with a slightly larger change in the 
intervention group.   
The CLASP was utilised by Zetta et al (2011) in a trial of the Angina Plan, a 
cognitive behavioural, nurse-facilitated, self-help intervention. The authors 
found scores of 9.4-9.5 on the angina subscale reducing to 8.2-8.7 at six 
months. Within this exploratory study, the corresponding scores were 7.43-9.18 
reducing to 2.43-1.91 at nine months. Breathlessness shows a similar picture 
with Zetta et al (2011) reporting scores of 8.7-9.6 at baseline and 8.51-8.33 at  
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six months. The exploratory study reported scores of 7.29-5.64 at T1 and 7.09 - 
3.22 at T3.  Any comparison of the study of angina by Zetta et al (2011) and this 
exploratory study of ACSLT has to take in account the different time scales for 
data collection. However it does highlight that more work is needed to 
understand the experiences of individuals with ACSLT. The improvement in 
scores in this exploratory study compared to Zetta et al (2011) may be due to 
the intervention or it may simply be a result of dif ferences in the clinical 
condition.  Individuals with ACSLT would be considered to have had a more 
serious illness, when in hospital, compared to those with angina, but the results 
here show that the individuals in this exploratory study had fewer symptoms of 
angina and breathlessness and improved more over the timescale than those in 
the study by Zetta et al (2011).   
Some research studies have suggested that participation in CR improves 
the HRQoL of patients with CHD (Belardinelli et al 2001, Pasquali et al 2003). 
Within this exploratory study, the main instruments used to measure HRQoL 
were SEIQoL-DW and SF36v2. It had been intended to also use CLASP, but 
this proved impractical as discussed in chapter 4:15 and 5:5. If we consider 
SEIQoL-DW first, we can see that the areas identified by the participants as 
most important were family and health, followed by social activities. Family is 
mentioned by all patients and ranked highly. This reflects the literature (O'Boyle 
et al 1993, Hickey et al 1996). This pattern of family, health, followed by social 
activities has also been noted in patients with cancer (Campbell and Whyte 
1999, Willner and Hantikainen 2005), and diabetes (Walker and Bradley 2002).  
 The results from this exploratory study show that both groups had an 
improvement in their global QoL as measured by SEIQoL-DW, across the time 
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of the exploratory study, with slightly larger changes in the intervention group 
(Table 6:5). The mean scores were 64.8-69.2 at T1 and 70.2-77.6 at T3. 
If we compare this to the study by Campbell and Whyte (1999) in a group of 
cancer patients, we find that the mean index score for this group of patients was 
58.4 (SD 21.59).   
There are limited studies utilising SEIQoL-DW within cardiology. However, 
Dempster et al (2010), in a study looking at patients attending CR, found that 
the five key areas were family, leisure, social life, health and work. This reflects 
the information found within this exploratory study. Dempster et al (2010) argue 
that, when asked to retrospectively rate their functioning at baseline, patients 
rated their functioning to be significantly lower than their original rating at 
baseline, indicating that a response shift had occurred. It would appear that 
patients may have changed their internal standards and perhaps had higher 
goals than they did at pre-test. Dempster et al (2010) argue that, when patients 
who have completed a CR programme look back on their QoL before CR, they 
believe they were functioning at a lower level than they reported at that time. It 
is therefore important that future research and clinical evaluations of CR 
programmes consider an assessment of response shift, in order to accurately 
estimate the effect of a CR intervention. 
An improvement in the participants HRQoL is reflected in the scores on the 
SF36v2. The use of the SF36v2 is advantageous in allowing comparisons 
across disease states. In a recent review of exercise in the HF population, 
Davies et al (2010a) argued that regardless of the measure used, there is 
evidence of a significant improvement in HRQoL in patients with HF following 
an exercise programme. The scores presented in Table 6:6 show that, in this 
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exploratory study, the intervention group had lower scores than the CHD norm 
at T1 and higher scores than the CHD norm at T3. The control group scored 
lower than the CHD norm at T1 and T3 on 7 out of 10 scales.  
Chan et al (2005) examined HRQoL in a group of 182 CR participants that 
included patients with ACSLT. They found highly significant differences were 
found in SF-36v2 scores for all eight sub-scales at the 6-month assessment, as 
compared with baseline data for those who received an intervention.  The range  
of scores, on the SF36v2 at baseline, were 35-76 compared to 52-89 at six 
months. The lowest score at baseline was bodily pain and this was also the 
domain with the largest improvement, increasing to 89 at six months.  
The lowest score at six months was general health, which also had the smallest 
change (8) from baseline.  The range of improvement across the scores was 
from 8-21, with bodily pain being an outlier with an improvement of 64.  
In a study looking at scores on the SF36v2 following phase three CR, 
McKee (2009) found positive increases, six months following CR, of between 1 
to 20 from baseline. The lowest score at baseline was physical role and this 
was also the domain with the largest improvement. The lowest score at six 
months was vitality, while the smallest domain improvement was for general 
health. The group studied by McKee (2009) had scores ranging from 63-83 at 
six months post intervention.  
Within this exploratory study, the improvements noted within the intervention 
group ranged from 2 to 13.1, with a reduction in general health of -2.47 and with 
the biggest improvement being in bodily pain (13.1).  The score range at T3 was 
41-51. There are therefore several similarities in scores on the SF36v2 across 
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all three studies with the general health domain showing little improvement. 
Both the study by Chan et al (2005) and this exploratory study noted 
improvements across bodily pain.  
A key difference in the results within this exploratory study is that; the level 
of scores both at T1 and at T3 seems to be at least 10-20 points lower than 
those in the other two studies. Only some of the intervention group within this 
exploratory study took part in phase three CR, so this could explain the different 
focus for the improvements. However, given the small numbers in this 
exploratory study and the lack of data on those with ACSLT, it is an area that 
requires further study. 
The results found within this exploratory study support the findings that have 
been described above. Despite the difficulties in assessing the evidence base, 
HRQoL has become one of the outcomes measures recommended for 
everyday use in measuring the effectiveness of CR programmes (BACR 2007).  
In summary, as has been stated previously, this exploratory study did not 
achieve statistically significant results in any of the key outcome measures, 
however a tendency to benefit was noted that favours the intervention group. 
Although this exploratory study had small numbers and the data has to be 
treated with a great deal of caution, it does reflect the evidence found in other 
studies on the impact of CR within different cardiac populations. 
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7.5 Cardiac Rehabilitation and uncertainty  
These studies were conducted at a time of great change within cardiac 
services and an additional finding within the exploratory study related to the 
concept of uncertainty. As previously noted in chapter 6:6, the majority of 
participants highlighted the level of uncertainty that they had experienced 
following their admission to hospital. The uncertainty they experienced was both 
around the diagnosis itself and the implications for them as individuals. In this 
section, these two areas of uncertainty will be discussed, along with the impact 
of uncertainty on the theoretical framework underpinning the CR intervention.    
Nevi lle (2003), in her review of uncertainty theory, argues that professional 
uncertainty is based on real difficulties in diagnosis and prognosis (Davis 1960, 
McIntosh 1974). Jette and Jette (1997) argue that the consequence of 
professional uncertainty in clinical care is a broad variation in treatments. 
Professional uncertainty around the diagnosis itself was evident due to differing 
opinions within cardiology worldwide on the diagnosis of ACSLT. During the 
period of the research, participants received a wide variety of information from 
clinicians and this information was often contradictory in nature. The impact this 
had on the participants has been highlighted previously in chapter 6:6.  
Since the diagnosis of ACSLT has disappeared, due to its amalgamation with 
the diagnosis of MI, it could be argued that the lack of an evidence base for 
ACSLT, outwith medical treatment, is no longer a problem.  However this would 
be to assume that outcomes of CR for those with ACSLT are the same as for 
those with the traditional diagnosis of MI. Yet there is little evidence to support 
this.     
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The second theme within uncertainty was the impact of the illness itself on 
the participants. The theme of uncertainty and its impact on recovery has been 
reported to be a common experience of people experiencing illness or receiving 
medical treatment (McCormick 2002). Uncertainty can be seen as major 
component of the illness experience and can dramatically affect psychosocial 
adaptation and outcomes of disease states (McCormick 2002). There has been 
extensive research into experiences with uncertainty in both acute and chronic 
illnesses.  Much of the research base looks at uncertainty in cancer, particularly 
in two patient populations: breast and prostate cancer (Nelson 1996, Germino 
et al 1998, Wonghongkul et al 2000, Gill et al 2004). This research suggests 
that uncertainty undermines the patients ability to sustain an acceptable HRQoL 
(Germino et al 1998, Sammarco & Konecny 2008). Breast cancer survivors face 
uncertainty, as a result of living daily with a pre-existing disease and the 
possibility of recurrence, and this affects their ability to  plan for the future 
(Nelson, 1996, Wonghongkul et al 2000). The inability to distinguish symptoms 
of their i llness, or recurrence from normal bodily changes, has also been 
reported as a source of uncertainty in this cancer population (Hilton 1988).  
The causes of uncertainty have also been studied in populations with 
rheumatoid arthritis, asthma, and AIDS. It has been shown that the erratic 
nature of symptom onset and disease progression and the inability to 
distinguish symptoms from normal bodily changes were sources of anxiety for 
patients (Weitz 1989, Braden 1990). However, there has been limited focus on 
the impact that uncertainty has on people living with CHD and it has largely 
been ignored in the CR literature.  
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In their study of Chinese men undergoing angiography, Taylor-Piliae & 
Molassiotis (2001) found that the participants experienced high levels of 
uncertainty. This correlated significantly with total mood disturbance.  
All negative mood sub-scales demonstrated strong relationships with 
uncertainty. These findings are consistent with previous research among 
Chinese CHD patients and those living in North America (Christman et al 1988, 
Webster and Christman 1988, Dougherty & Shaver 1995, White and Frasure-
Smith 1995). 
Kang (2005) aimed to examine the effects of uncertainty on patients with 
atrial fibrillation. He found that individuals with greater symptom severity 
perceived more uncertainty and that this uncertainty was appraised as a danger 
rather than opportunity. He found that uncertainty had a significant impact on 
the perception of mental health, through danger appraisal, identifying a possible 
area for nursing interventions.  
McCormick et al (2006) in their study of 42 individuals waiting on CABG 
found that uncertainty was present at moderate levels and was associated with 
moderate deterioration of functional status. They found that symptom distress 
had a strong relationship to both uncertainty and anxiety. Yet they also found 
that anxiety, functional status and uncertainty did not have a statistically 
significant relationship with the level of angina.   
Uncertainty is also found as a theme within patients living with HF.  Winters 
(1999) found high levels of uncertainty in this population, which increased with 
symptoms, or when treatments changed, or information was incomplete. 
Greater uncertainty was also noted during the initial diagnostic stage. 
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Uncertainty was influenced by the availability of information, trust in health care 
providers and social support.  
Early uncertainty and adjustment levels after hospital discharge was a 
strong predictor of long term adjustment among first time ICD patients more 
than 9 years later (Mauro 2008).  Uncertainty was also found to be related to 
poor QoL in patients with an ICD at long term follow-up (Flemme et al 2005).  
The concept of uncertainty is also found in work by Hallas et al (2009). They 
looked at patients requiring support for advanced cardiac disease, who were 
concerned with being unable to plan for the future, with worry about the future 
development of the disease, and the impact on their families.  
Within the exploratory study, concerns around uncertainty were raised 
consistently within the control group, whereas the intervention group appeared 
to focus on normalisation of their life and the impact o f the intervention 
(Appendix 1). Coping was measured in the YABQv2 (Table 6:5) and has been 
discussed in chapter 6:5 and 7:4, but it is interesting to note that, within the 
intervention group, coping scores improved from T1 to T3. The control group 
had only slight improvement on their coping scores in the same period. 
Studies aimed at identifying and managing uncertainty, through nursing-
specific interventions in non-cancer populations, have been conducted in 
pregnant women with multiple sclerosis (Smeltzer 1994), women with 
rheumatoid arthritis (Bailey and Nielson 1993), and adolescents with diabetes 
(Hoff et al 2002). Hallas et al (2009) argued that supportive communication and 
information gathering, which increases decision making, helps to decrease 
uncertainty, and increases perceived control.  Yet little attention has been paid 
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to this concept within the CR literature. From the information gathered during 
the exploratory study, it would appear that this theory should be studied further 
within CR.   
The third area of discussion related to uncertainty is the implications for the 
theoretical framework (CSM) underpinning the CR intervention.  The five key 
elements of this theory are identity, timeline, cause, consequences and 
cure/control. Identity refers to the label a person uses or to the symptoms that 
they view as being part of their illness. Timeline refers to an individual's beliefs 
about how long the illness will last. Cause describes an individual’s personal 
ideas about the cause of the health problem. Consequences relate to an 
individual's beliefs about the likely impact of the illness on QoL or functional 
ability. Control/cure relates to the individuals beliefs about whether the condition 
can be cured or kept under control and the degree in which the individual plays 
a part in achieving this (Leventhal et al  2003).  An individual will include both 
abstract and concrete information in their understanding of an illness. If we 
consider the presentation of MI, there is a clear identity and understanding 
within the community of what it means. It is seen as a sudden episode of central 
chest pain often linked to sweating and nausea. This is portrayed both in the 
media and in health promotion messages.  It is seen as something that you get 
over in a specific timeframe and the causes of MI are well rehearsed in the 
media.  CR specialist staff know what to advise individuals about what to expect 
of their recovery. The consequences of MI are also well rehearsed with 
individuals being aware of many friends and family who have recovered from 
just such an event. In contrast, the diagnosis and therefore the identity of 
ACSLT was unclear. The term ACSLT was not one that was clearly understood 
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by health professionals and even less by the community at large. There was no 
clear understanding among the participants of how long the recovery should be 
and many had no clear idea of the causes of their illness. It was therefore 
difficult for them to analyse the consequences for their lifestyle and future. Since 
the CR specialist staff were also unsure of their ability to advise participants 
about a return to normal activities, due to a lack of an evidence base for this 
condition, it was difficult to control the illness.  
The impact of uncertainty in this exploratory study was seen in all five 
elements of the CSM.  Since the CSM had been selected as the theoretical 
framework for the CR intervention, the impact that uncertainty had on the 
participants was clearly of importance and needs further investigation.  
The key work within the nursing theory on uncertainty is the work of Mishel 
and Braden (1988), who defined uncertainty as the inability to determine the 
meaning of illness-related events because of a lack of sufficient cues.  
These cues allow individuals to assign value to objects or events and accurately 
predict outcomes. They have developed the Reconceptualisation of Uncertainty 
in Illness Theory (RUIT), which applies to enduring uncertainty in chronic 
illness, or illness with the possibility of recurrence, and where self-management 
is the primary focus for treatment. The desired outcome from the RUIT is that 
the person grows to accept a new value system, which incorporates the 
changes brought about by the illness. The five components of the RUIT are: 
antecedents of uncertainty, appraisal of uncertainty, coping with uncertainty, 
self-organisation, and probabilistic thinking. 
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If we consider the participants, in terms of the RUIT (Mishel and Braden 
1988), we can see that there are several areas which influence the level of 
uncertainty and its impact on this group in terms of adaptation and coping. The 
antecedents of uncertainty include symptom pattern, event familiarity and event 
congruency.  The participants were admitted to hospital for a period of days with 
a delay in reaching a diagnosis. The healthcare providers themselves showed 
professional uncertainty over the diagnosis and the recovery. This was made 
worse by the differing information provided to the participants. Not only did 
healthcare professionals have difficulties in making diagnoses, but in addition 
there were several examples where healthcare professionals contradicted each 
other. This undermined their credibility and had a large impact on the 
participants (Appendix one). 
The second major theme in the RUIT is the appraisal of uncertainty. Here 
there are two components, inference which relates to the evaluation of 
uncertainty using general knowledge experience and contextual clues and 
illusion which refers to the construction of beliefs that have a positive outlook. 
The result of appraisal is the valuing of uncertainty as a danger or opportunity.  
If we consider inference first, we can see that ACSLT is a recent term with a 
confused history.  Individuals cannot relate to it in the same way they can relate 
to the term MI.  In many cases, within the participants, it was the first time that 
individuals had had a cardiac event. They did not suffer the ‘usual’ and 
‘expected’ symptoms of a MI, thereby having no recognised clues that they 
could analyse their condition with or establish a pattern for their symptoms. 
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The construction of beliefs that have a positive outlook is important in this 
context, due to the limited impact that inference can have. The content of 
programmes such as CR could be seen as a providing support, during this 
process, that assists with the identification of uncertainty in a positive manner. 
Yet there is little research in this area.  
 This appraisal of the uncertainty leads on to the third theme within the 
model that of coping. Dependent on the individual’s assessment of the 
uncertainty, it can be seen as either positive or negative. If it is seen as a 
positive, then buffering coping strategies are used to maintain it . If it is seen as 
a negative, then uncertainty implies harm and problem focused strategies are 
used to reduce it. If the coping strategies are effective then adaptation occurs, 
and if there is difficulty in adapting, this would appear to suggest an inability to 
manipulate uncertainty in the desired direction. Coping has been examined in 
this exploratory study as it relates to ACSLT and the impact of CR on coping 
scores has been discussed in chapter 7:4. This is an area of CR practice that 
warrants further study.  
Self-organisation and probabilistic thinking are the additional elements of the 
RUIT that are central when dealing with long term illness. Self-organisation 
relates to the formulation of a new sense of order, resulting from the integration 
of uncertainty into a new order of life. This is influenced by prior life experience, 
physiological status, social resources and health care providers. The person 
evaluates uncertainty gradually from a negative experience to one of 
opportunity. Uncertainty then becomes part of the new order and a part of life. 
Probabilistic thinking is a belief in a world where uncertainty and unpredictability 
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is the norm. The RUIT therefore represents the gradual acceptance of 
uncertainty and the restructuring of reality as important elements of learning to 
live with a long term condition.  
In summary, the exploratory study has suggested that uncertainty within 
ACSLT needs further research. The participants experienced professional 
uncertainty around their diagnosis, which had an impact on their recovery.  
This professional uncertainty may be resolved by the change in diagnosis of 
ACSLT to MI. However the lack of an evidence base on the outcomes for 
individuals with ACSLT will continue to be an issue for professionals. The theme 
of uncertainty and its impact on recovery has been reported to be a common 
experience of people experiencing illness or receiving medical treatment. Yet, 
while there is some research on uncertainty in cardiology, it is largely ignored 
within the CR literature. The concept of uncertainty will however be important 
for CR professionals due to the broadening of the definition of MI.   Uncertainty 
theory does not give us a theoretical framework on which to base a multi -
disciplinary intervention, however the exploratory study suggests that the impact 
of uncertainty needs further exploration, particularly around the impact that it 
has on frameworks such as CSM and on the design of CR interventions.  
7.6 The future for Cardiac Rehabilitation research 
In chapter 1:4, the importance of an effective research base for clinicians 
working within CR was highlighted. This thesis therefore contains a feasibility 
study and an exploratory study. This thesis has added to the research by 
examining the feasibility of a RCT which would test the impact of a menu-based 
CR programme, on individuals diagnosed with ACSLT, against standard care. 
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This feasibility study included staff views. It has also added to the research by 
exploring the impact that ACSLT and CR can have on this client group.  
As stated previously in section 7.2, a main finding of this thesis is that the 
feasibility study was successful in its aim of testing the CR intervention and the 
protocols for a further RCT. However, due to changes in healthcare policy and 
provision, it would no longer be feasible to carry this research out.  
An additional finding, as stated previously in section 7.4 and 7.5, is that this 
thesis has explored the impact of menu-based CR on a unique population, that 
of ACSLT, and provided an insight into the experiences of the participants at a 
time of change within CHD clinical care. Before discussing the implications of 
this thesis for clinical practice, it is important to consider the changes that have 
taken place in both the evidence base for CR and in current healthcare 
provision, since the literature review carried out in 2004 and discussed in 
chapter 3:2-3:10.  
The literature review carried out in 2004 found that the evidence base for the 
exercise component of CR as it is delivered in the RCT’s was comprehensive 
and compelling, and although there was some evidence of benefit from 
psychological interventions, the evidence base was ambiguous and there was a 
need for further research into misconceptions, anxiety and depression, and 
HRQoL. In addition, it stated that educational interventions, as part of CR, can 
provide health gain, but that further exploration of the role that education can 
play in a modern individualised programme of CR and the different benefits that 
could bring were required. The 2004 literature review also found that the 
evidence base for under-represented groups such as the elderly, women, and 
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ethnic minorities was limited and that information on modes of delivery required 
further clarification. Despite the challenges faced by researchers within CR, in 
identifying and documenting the outcomes of this complex intervention, CR has 
become an accepted part of routine care, due to both strategic direction and 
voluntary sector campaigning and funding.   
A challenge to the provision of these services has been raised by West et al 
(2012), who conducted a multi-centred RCT of CR in England and Wales 
recruiting 1813 participants between 1997 and 2000. Recruitment was halted 
early, in a manner reminiscent of this thesis, as the hospitals providing control 
groups wished to start providing CR.  West et al (2012) found that, in their trial, 
there were no statistically significant differences between patients referred to 
CR and controls in mortality at 2 years or after 7-9 years. They also found no 
significant differences in number of cardiac events, on 7 out of 8 domains of the 
SF36v2 or on scores on the psychological general wellbeing scale. Patients in 
the intervention group also reported being less active. No differences between 
groups were reported in perceived overall quality of cardiac aftercare.  
They argue that that the value of CR as practised in the UK is open to question.  
There are some limitations in the study by West et al (2012).  Although 1813 
participants were recruited, the study does not describe in detail the CR 
programmes and their component interventions. At the time West et al (2012) 
were recruiting, many CR programmes were new and CR staff were 
inexperienced. There is no information on the length of time these programmes 
had been running to indicate the expertise of the team. The CR programmes 
utilised in the study by West et al (2012) were developed more than 10 years 
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ago and there have been huge changes in this field of clinical practice since. 
West et al (2012) provide little information on the recruitment process and the 
numbers of possible participants who refused to take part. They also do not 
provide information on how many completed a programme, or dropped out, a 
regular problem for CR programmes. The participants were mainly male (72%) 
and young (mean age 65) and had suffered an MI. This is a criticism of CR 
research that has been highlighted previously, in the literature review in chapter 
3:12-3:13. The study by West et al (2012) however highlights a debate that has 
raged within cardiology for more than 20 years, with those strongly in support of 
CR as a service, and those who have opposed it on the basis that the evidence 
base is limited. West et al (2012) also highlight the belief that a RCT is the only 
way to evaluate a complex healthcare intervention and has an underlying theme 
that mortality and morbidity are the main outcome measures to evaluate any 
healthcare interventions’ utility. This paper has also stimulated debate within the 
CR community about the appropriate way to evaluate CR.  
However, it is also important in this section to examine other changes in the 
evidence base from the literature review of 2004 for the exercise, psychological, 
and education domains and for under-represented groups, and mode of 
delivery.  
In the previous literature review, it was noted that several meta-analysis of 
CR for CHD patients reported a statistically significant reduction in total and 
cardiac mortality, ranging from 20% to 32%, in patients receiving exercise 
therapy compared with usual medical care (Oldridge 1988, O’Connor 1989, 
Jolliffe 2001, Clark 2005). The origina l Cochrane review identified 35 RCT’s with 
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8,440 patients (Jolliffe 2001). This review reported a reduction in total mortality 
with an exercise intervention compared to usual care. Improvements with 
exercise were also seen in cardiac death, non-fatal MI, lipid profi le and BP. 
However this analysis was based on mainly low risk middle aged men following 
MI and this limited the applicability of the evidence. In addition, as argued by 
West et al (2012), many of the current drug therapies and treatments were not  
available at the time of some of the earlier studies and improvements in 
treatment could impact on the level of additional benefit that could be found with 
CR.  There was also limited data on HRQoL within these studies.  
An updated meta-analysis by Heran et al (2011) was recently published. 
This meta-analysis included an additional 17 studies making a total of 47 
studies reporting data for a total of 10,794 patients. Although all exercise-based 
CR, 17 studies were judged to be exercise-only intervention trials and 29 were 
judged to be comprehensive CR (exercise plus psychosocial and/or educational 
interventions); one trial randomly assigned patients to both exercise-only CR 
and comprehensive CR. The ages of patients in the trials ranged from 46 to 84 
years. Although over half of the trials (28 studies, 60%) included women, on 
average women accounted for only 20% of the patients recruited. In accord with 
the original Cochrane review and previous meta-analyses (Oldridge 1988, 
O’Connor 1989, Jolliffe 2001, Clark 2005) a reduction in both total and cardiac 
mortality was observed in CHD patients randomised to exercise-based 
rehabilitation. There was no difference between exercise-based CR and usual 
care groups in the risk of recurrent MI or revascularisation at any duration of 
follow-up. This new meta-analysis would appear to suggest that there is little 
change in the evidence base with regards to exercise and contradicts the 
204 | P a g e  
 
findings of West el al (2012). Although the study by West el al (2012) has 
provoked a great deal of debate within the CR community, the evidence in the 
meta-analyses above provides a stronger argument, as it is a synthesis of all 
the evidence in the field. This evidence base has been consistent for more than 
20 years.    
Individuals with HF is one area  where RCT’s of CR can still be carried out, 
as it is not yet common practice to offer CR to this group of patients.  This is not 
due to a belief among CR professionals that it wouldn’t work, but due to a more 
pragmatic issue of a lack of resources. Clinical trials conducted over the last 15 
years have demonstrated that exercise-based CR improves exercise tolerance, 
disease-related symptoms, and QoL in patients with HF (Williams 2006), 
without negatively impacting on left ventricular function. No adverse exercise 
training–related effects have been reported, despite the fact that these patients 
would appear to be at higher risk for events given their left ventricular 
dysfunction and heightened state of sympathetic activity.  
A recent trial, HF-ACTION, is the largest trial to look at exercise in the HF 
population with 2331 participants (O’Connor et al 2009). They found that there 
were non-significant reductions in the exercise training group for CVD 
mortali ty, CVD hospitalisation and HF hospitalisation. However, after 
adjustment for highly prognostic predictors of the primary end point, exercise 
training was associated with modest significant reductions for both a ll-cause 
mortali ty or hospitalisation and CVD mortality or HF hospitalisation.  
A systematic review of exercise in HF by Davies et al (2010a) examined 19 
RCT’s, including HF-ACTION. The review encompassed a total of 3,647 
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participants. The authors concluded that exercise programmes did not 
significantly impact on all-cause mortality, however there was a significant 
reduction in hospitalisations due to HF and they observed significantly higher 
levels of HRQoL. However they state that the precise mechanism through which 
exercise training benefits HF patients is unclear. 
In summary, it would appear that the evidence base for exercise CR remains 
in favour of the intervention, despite the negative data gathered during the trial 
by West et al (2012). The results do not seem to have changed significantly 
over the last 20 years.  However, West et al (2012) have raised some 
interesting questions and have prompted discussion on the appropriate method 
to be used to evaluate a programme of care that might only last three months.  
At the commencement of this thesis, the 2004 literature review found that 
there was some evidence of benefit from psychological interventions, however 
the evidence base was ambiguous and there was also a need for further 
research into misconceptions, anxiety and depression, and HRQoL. A review of 
the evidence base for psychological interventions in CHD undertaken by Rees 
et al (2004a) had found a wide range of interventions being used within clinical 
trials. Meta-analysis of all studies showed no strong evidence of an effect on 
total or cardiac mortality or revascularisation, although there was a significant 
reduction in the number of non-fatal infarctions in the intervention groups. 
Additionally, in some of the trials included in the original review by Rees et al 
(2004a), the intervention group received both psychological/psychosocial 
interventions alongside other components of CR (for example exercise or 
enhanced medical care) that were not available to control group participants. 
Thus, the 2004 review could not establish the independent effect of 
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psychological techniques for this patient group. A recent update by Whalley et 
al (2011) focused only on those studies which included psychological 
interventions. He argued that psychological treatments appear to be effective in 
reducing psychological symptoms in patients with CHD, although many of the 
patients treated were not diagnosed with any specific psychological condition, 
and many may not have met conventional diagnostic criteria for depression.   
In a further review of psychological interventions, Goulding et al (2010) argued 
that interventions to change beliefs can be successful, with cognitive 
behavioural interventions being the most consistently effective. The evidence of 
impact on psychological, functional and behavioural outcomes however was 
unclear.  Goulding et al (2010) also argued that, it is negative illness 
perceptions rather than physiological factors that are the major cause of 
psychological and occupational disability in people with CHD. The evidence 
would therefore appear to suggest that there is a benefit to psychological 
interventions, but that more research is required into the link between 
psychological interventions and changes in attitudes and beliefs.  
In the 2004 literature review it was argued that educational interventions as 
part of CR can provide health gain, but that further exploration of the role that 
education can play in a modern individualised programme of CR, and the 
different benefits that could bring were required. Lau-Walker (2007) in her study 
looking at the link between i llness beliefs and self-efficiency indicated that 
different educational approaches to exercise and diet within current CR 
programmes have contrasting effects in terms of patient outcomes. The two CR 
programmes attended by patients in her study contained an individualised 
approach to exercise, allowing patients to work at their own pace, developing 
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skills and confidence to manage their exercise regime leading, it would appear, 
to increased patients’ confidence in their ability to change their exercise 
lifestyle. The approach to the dietary education was however quite different. 
Generic educational information was given to the patients using leaflets and 
discussion groups. This approach did not individualise information or build skills, 
with the potential result of failing to increase patients’ confidence to manage 
their dietary lifestyle changes. The patients’ initial belief, following diagnosis, 
that the cardiac condition was controllable was shown to be an important factor 
in predicting patients’ confidence in their ability to maintain exercise health 
behaviour in the long term. Therefore, the assessment and management of 
CHD patients’ illness beliefs in the controllability of their condition at the initial 
phase of their cardiac illness is of particular importance. 
This concept, that knowledge, attitudes and beliefs are inter-connected, and 
that for an educational programme to work, the impact has to be felt across all 
three domains, is one that has been examined by Tullman et al (2007), who 
looked at an intervention to reduce delay in seeking help for symptoms of MI. 
They found that knowledge and beliefs were improved by an intervention, but 
there was no change in attitudes.  Buckley et al (2007) studied the  effectiveness 
of an education and counseling intervention on knowledge, attitudes and beliefs 
about MI symptoms and the appropriate response to symptoms. He argued that 
the intervention resulted in improved knowledge of CHD, MI symptoms and an 
appropriate response to symptoms that was sustained to 12 months. He found 
no differences however between groups' attitudes and beliefs over time.  The 
impact of CR educational programmes and how they are delivered for the most 
impact is one that requires further study. 
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The 2004 literature review stated that the CR evidence base consisted of 
trials that included mainly white middle class males, but found that this gap was 
gradually being addressed within the literature and the focus of research had 
shifted to identifying how CR could improve impact across diverse populations, 
such as the elderly, women, and those individuals who belong to ethnic minority 
populations.   
Elderly patients are a group that remain under-represented within the trial 
data. Yet a survey by Giallauria el al (2010) found that, in Italy, 59% of patients 
admitted to CR programmes are aged >65 years and that 25% are aged >75 
years.  In the UK, this is also seen in survey data for CR programmes, with the 
mean age for men within the CR population being 65 and for women 70 (Lewin 
et al 2011). Average ages vary across the diagnostic groups, but in general 
many patients seen within CR programmes are in the age range of 45-85 
(Lewin et al 2011). Complications of MI and myocardial revascularization 
procedures are more frequent at an elderly age, with the prolonged 
hospitalization for these events predisposing to physical deconditioning (Wenger 
2008).  In a study looking at patients older than 75, Audelin et al (2008) found 
that older patients were less likely to be referred. They found that longer 
transportation times to CR facilities, denial of i llness severity and history of 
depression are also associated with poor participation rates in the elderly. 
However, if the older patients attended CR, they had higher exercise capacity, 
and higher levels of HRQoL. Tolmie et al (2009) argued that CR programmes 
were not meeting the needs of many older people , either in terms of risk factor 
education or programme uptake, and more appropriate programmes are 
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needed. Currently, there is no evidence of interventions to improve either 
uptake or adherence to CR in the older patient (NHS 2007). 
It is clear from recent audit data (Lewin et al 2011) that women still do not 
attend CR as often as they could. This is despite the evidence that both genders 
receive equal benefit from participation in CR exercise training (Cannistra et al 
1992, Williams et al 2006) and specifically, that women, whose functional 
capacity at entry into rehabilitation is often less favourable, are likely to attain 
greater benefit (Wenger 2008).  A recent meta-analysis (Budnick et al 2009) 
looked at 37 studies with a combined sample of 3,807 women. Ten studies 
included an analysis of physiological effects of exercise. Aerobic, resistance, 
and combined exercise interventions, all yielded physiological benefits for 
women. Cardiac Rehabilitation yielded favourable HRQoL outcomes and 
women benefited from psychosocial support in both formal and informal 
environments. This programme recommended that programmes need to 
address the specific educational needs of women and a stronger emphasis 
needs to be placed on social support. Despite an improvement in the evidence 
base, there are still areas of uncertainty therefore about the impact on sub-
groups of patients, such as the elderly and women.   
In the literature review of 2004, the evidence base suggested that there 
were no significant differences between home-based and centre-based CR.   
In their review of home-based CR, Dalal et al (2007) found that the Heart 
Manual (Lewin et al 1992), a self-help home programme, was as effective as 
hospital-based CR for patients after MI. Patients admitted with uncomplicated 
MI were offered hospital-based rehabilitation classes over 8–10 weeks or a self-
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help package of six weeks' duration (the Heart Manual) supported by a nurse. 
Primary outcomes at 9 months were mean depression and anxiety scores on 
the HADS, QLMI score and serum total cholesterol.  
The mode of delivery has also been examined by Taylor et al (2010), with a 
systematic review of CR comparing either home-based or centre-based CR.  
This review identified 12 RCT’s in 1,938 cardiac patients, most of them 
performed during the previous eight years. The majority of studies recruited 
lower risk patients following an MI and revascularisation. There was no 
difference in outcomes of home- versus centre-based CR in mortality risk, 
cardiac events, exercise capacity, as well as in modifiable risk factors (systolic 
BP; diastolic BP; total cholesterol; High Density Lipoprotein-cholesterol (HDL); 
LDL-cholesterol) or proportion of smokers at follow up or HRQoL. No evidence 
was found to support a difference in outcomes in cardiac patients either in the 
short-term (3-12 months) or longer-term (up to 24 months). The study 
populations, in the trials, were mainly male with a mean age of 51.6 to 69 years.  
A recent small study carried out by Piotrowicz et al (2010) compared centre-
based CR to tele-monitored home CR. They found that tele-monitored home CR 
was equally as effective as centre-based CR and provided similar 
improvements in HRQoL and that adherence was improved in the  
tele-monitored group. The current evidence base would appear therefore to 
suggest that there are no significant differences between home-based and 
centre-based CR and that this has not changed since the original literature 
review.  
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If we consider the provision of CR in the UK, we can see that there have 
been changes over the last 8 years. Many expert scientific groups around the 
world, from the WHO to the BCS, have reviewed CR; every one of these 
reviews has supported it unequivocally and called for it to become more widely 
available. The British Heart Foundation campaigns for wider access to CR 
across the UK. Despite the recommendations for exercise-based CR as an 
integral component of the comprehensive care of patients with CHD, most 
patients still do not receive it (Bethell 2008).  In a recent report from the National 
Audit for CR (2011), 42% of patients who had a MI, CABG, or a PCI took part in 
CR across England, Wales and Northern Ireland in 2009-2010. This is an 
increase of one percentage point on the previous year and four percentage 
points on 2007-2008. Some regions improved significantly more than others 
and the participation rate for Northern Ireland as a whole increased from 30% in 
2008-2009 to 40% in 2009-2010.  Recent audit work undertaken in Scotland 
suggests that the corresponding figures for Scotland in 2010-2011 vary from 58 
% of those eligible attending for assessment, to 39% of those eligible 
completing a programme of CR. The referral rate in Scotland has also been 
reviewed and it would appear that an estimated 65% of eligible patients having 
an initiating event of either MI, CABG or PCI were referred for CR in 2011. This 
includes 75% of heart attack patients, 68% of patients undergoing CABG, and 
22% of patients undergoing PCI procedures (ISD 2012). However, of more than 
21,000 individuals who could benefit from CR, only around 9,000 were referred 
and only 5,000 completed a CR programme. This reflects the current funding 
structure for most programmes, where funding was granted for MI/CABG/PCI,  
but no further funding has been made available for HF, valves and UA. Very few 
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patients with these diagnoses are able to access CR. This is likely to remain a 
problem in the future, as any available extra resource will be utilised by 
individuals with ACSLT, who will now be eligible for CR, due to the change in 
definition. The impact of this change in definition on CR teams has been large. 
In the initial data collection, this thesis identified 396 patients with ACSLT in 
NHS Ayrshire and Arran, who would be eligible for CR under the new definition.  
Current healthcare policy is that all the groups above should receive CR. 
The current evidence base tells us that, although there are areas where further 
research is necessary, there is evidence of benefit from CR for the individual.  
However, if the policymakers are to consider further funding for CR, then one 
question that needs answered is how cost effective is it ?  One of the issues in 
studying cost effectiveness of CR provision in the UK is the wide variety of 
provision across the country and the different models of care that are used. 
Costs for the provision of CR in the UK are difficult to access, but there have 
been a number of cost-effectiveness reviews, over the last decade, that have 
examined this issue. A Health Technology Assessment by Beswick et al (2004) 
based a detailed costing on the staffing mix of 30 UK CR programmes with 
estimates of the overheads, bui lding capital and equipment costs included, 
using costs for 2000–2001. This suggested an average staffing cost of £354 
and a weighted total average cost to the health service of £486 per patient 
successfully completing the CR programme. If the costs were spread however, 
over all the patients being seen by CR, the staff costs were £157 and total costs  
£220. The cost of the programmes increased as the number of different 
disciplines of staff, who were involved in providing the programme, increased. 
The costs varied hugely depending on: the intensity of the programme, level of 
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staffing, location of programme and equipment used.  In a study by Jolly et al 
(2007), the staff costs of providing either a home programme or hospital 
programme were found to be £198 versus £182. These costs are obviously 
some time behind current costs of providing a programme.  The raw costs to the 
organisation are however only one part of the equation and it is important to 
analyse the effectiveness element as well. As part of the NICE guideline for 
secondary prevention, analysis was undertaken to examine the cost 
effectiveness of CR, compared to no CR, in unselected patients after MI. 
Clinical effectiveness data from three meta-analyses (Jolliffe et al 2001, Taylor 
et al 2004, Clark et al 2005) was used and the results suggested that CR was 
cost effective when compared with no CR (NICE 2007). The estimated cost was 
£7860 and £8360 per Quality Adjusted Life Year (QALY) for men and women 
respectively. This is well below the level usually considered to be affordable in 
the NHS (NICE 2010). Recent commissioning information suggests that CR is 
extremely cost effective at £550 per episode (DOH 2010). Staff costs in 2010-
2011 within the current CR programme in NHS Ayrshire and Arran were 
approximately £400, if spread equally over every patient seen.   
In summary, if we consider the changes to the evidence base over the 
last eight years, it could be argued that CR research still faces the same 
challenges and difficulties that it did in 2004. There is a substantial body of 
evidence that suggests exercise CR is effective across populations , and sub-
groups and different modes of delivery. But, due to the complex nature of CR, 
there remain many unanswered questions. The evidence base would also 
appear to suggest that psychological and educational interventions are of some 
benefit, but that more research is required into the link between psychological 
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and educational interventions and the impact on attitudes and beliefs. 
Questions remain about translating the evidence into practice, especially with 
the under-represented groups such as the elderly, women and those from 
ethnic minorities.  
7.7 Implications for practice  
The thesis was funded by NHS Ayrshire and Arran with the express purpose 
of improving outcomes for patients. This thesis adds to our knowledge by 
highlighting some of the difficulties in designing a RCT of CR in a specific sub- 
group of CHD. In the modern NHS, medicine does not always wait for research 
to keep up and this thesis was made difficult by changes in clinical practice and 
government policy. These changes meant that care for patients with ACSLT 
had to be provided, despite the lack of an evidence base. This group of patients 
have now been classified as having had an MI and will therefore receive a 
programme of care that reflects this diagnosis. 
 It could be argued that patients with ACSLT are no longer a novel group 
and there is no need for further research, as the MI evidence base will suffice.  
However, this would minimise the experience of these individuals.  The impact 
of this change in diagnostic categories cannot be underestimated. An individual 
with this diagnosis would have noticed little change in his or her life previous to 
the definition change. They would have gone back to work within a week and 
would not carry the label of having had a heart attack. They would likely have 
described their admission as a little warning and may have made some 
changes to their health behaviours because of that. Das et al (2006) found 
however, that at six months, mortality rates for patients with ACSLT, had risen 
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to the same level as those for patients with clinical MI. They also found 
significant differences in the treatment of patients with ACSLT, with less 
prescription of recommended drugs such as beta-blockers, ace-inhibitors and 
statins, and relatively limited use of interventional strategies. Following the 
definition change, these individuals would have had a label which would impact 
on their life in areas such as driving, work, insurance and personal 
relationships, yet it is likely that they would also have seen an improvement in 
their medical management and therefore a reduction in risk. If both groups were 
treated the same, it is possible that a difference in outcome might become 
apparent between those with troponins greater than 1 and those with ACSLT. 
This is an area that will require further evaluation.  
This change in definition also had wide ranging implications for staff.  
No data existed previously on this population to give a clear estimate of the 
numbers of additional referrals that CR programmes would see. However, the 
numbers who could have been referred, if the new diagnostic criteria had been 
in place within NHS Ayrshire and Arran, was an additional 396 patients.  
This would be a 50% increase in referrals to the local CR programme and would 
inevitably lead to stress in the system. However, in addition, staff would be 
dealing with a group of patients for whom there is little accurate data on 
outcome from CR.  There is little evidence to support the theory that outcomes 
for those with ACSLT are the same as for those with the traditional diagnosis of 
MI following CR. This thesis has attempted to provide a starting point for this 
evidence base, but more will need to be done to support staff as they tackle this 
new population within CR. The challenge of providing care to this group 
remains.   
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The evaluation of a complex intervention such as CR is difficult and some of 
the difficulties have been highlighted within the two literature reviews in this 
thesis. The intervention was designed to provide an individualised package of 
care and often one of the difficulties in the CR evidence base is the fact that 
interventions within the studies are not comparable. Research studies often 
prescribed the length of intervention and exactly what it should include. This 
then influences the results, so one study might provide six weeks of exercise 
and another might provide twelve, both could have benefits, but in clinical 
practice neither study is of use, if the patient can only attend for three weeks 
before going back to work, or if he has co-morbidities that make the usual 
exercise programme not suitable. Often a CR package in clinical practice will 
have different timescales, different constituent parts or will be delivered to a 
different standard. It is even more difficult to tease out the benefits  when the 
participants themselves determine the package as is the case in menu-based 
CR. This thesis was designed using usual CR practice and a menu based 
approach and this was reflected in the individualised packages of care that the 
participants received. Even in this small group of individuals, there was a wide 
variety in the types of interventions used. Clinicians responded to the needs of 
the participants as they arose. Clinicians are dealing with a wide range of 
people with a wide range of social, physical and psychological backgrounds. 
There are many issues that can affect a CR pathway, such as changes in a 
participant’s condition, i.e. another clinical event, or deterioration in chest pain. 
The participant may exercise personal choice over the type o f package they 
wish, or be unwilling to attend exercise classes and express a preference for 
home programmes. These are common issues in clinical CR practice that 
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clinicians manage every day. The small number of participants recruited meant 
that these issues could not be explored in any great depth. This thesis does 
highlight differences between the research base and current clinical practice 
and points to a need to find different ways of evaluating menu-based CR.  
Recent literature has shown us that in clinical practice CR programmes are 
currently struggling to reach a wide range of individuals. Approximately 60% of 
the traditional groups of MI and revascularisation, who should be receiving CR, 
are not and this does not include a wide range of individuals for whom a CR 
package could be considered beneficial (Lewin et al 2011). Only 1% of 
individuals with HF currently attend a CR programme, despite the evidence 
base for benefit. The difficulties experienced in undertaking this thesis highlight 
the need to look again about how clinical practice can be supported by 
research.  
This thesis highlighted the issue of uncertainty. The lack of an ‘identity’ for 
the i llness had an impact on the ACSLT participants who did not receive a n 
intervention. This meant that they struggled to make sense of their condition. 
The theoretical framework used within this thesis was the CSM and this is in 
some ways dependent on the i llness itself having a recognisable identity. If this 
is not the case, then the individual can struggle to make sense of their condition 
and how to manage it. Yet this issue of uncertainty has not been studied within 
CR in any great depth. This thesis suggests that the assessment of levels of 
uncertainty in CR patients and the impact this has on adherence would benefit 
from further investigation.  
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The exploratory study had a limited number of participants so it is difficult to 
draw any conclusions from the outcome data that were produced. There were 
no statistically significant differences, but there was a tendency to benefit 
across the domains of misconceptions, symptoms, anxiety, depression, and 
HRQoL. The results found during the exploratory study were similar to recent 
research carried out in patients across a variety of sub-groups.  
The evidence base shows us that even studies, done in the last ten years, 
continue to find the same evidence as was previously available. The expected 
mortality and morbidity benefit has not changed from the original meta-analysis 
in O’Connor et al (1989) to the recent review by Heran et al (2011).  
If we accept the premise that CR works, then our priority becomes caring for 
the individual. The clinical community therefore needs to focus its research 
efforts on the how, rather than the what. How do we achieve the benefits rather 
than what are the benefits? How do we focus our resources on those most in 
need? How can we ensure that those who require limited input are assisted to 
achieve the same health gain? This needs a radical rethink of both the 
organisation and the delivery of CR.   
Currently CR is monitored by diagnosis and by phase, individuals do not see 
themselves as a diagnosis or at a stage. If the focus of service provision is truly 
about individualised packages of care, then the quality of the assessment 
process needs to become the priority. Currently we have a number of tools that 
can assess physical and psychological functioning, but it is not routine practice 
to explore issues such as uncertainty or illness representation as a part of the 
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assessment process. CR professionals need to understand more of how people 
make decisions about their care in order to influence those decisions.  
7.8  Recommendations for future research  
Several implications for future research were identified as part of this thesis. 
These concern, firstly, the fact that a RCT is no longer possible due to changes 
in diagnostic categories and treatments, secondly, the impact that CR can have 
on patients with ACSLT, and the impact of psychological factors, particularly 
misconceptions and HRQoL on attitudes and beliefs in individuals with ACSLT, 
thirdly, the need to examine the impact of professional uncertainty on outcomes 
for patients, particularly those with long term conditions, fourthly, the need to 
examine uncertainty theory and its relationship to theoretical frameworks such 
as the CSM, and fifthly, the need for researchers to focus on supporting CR 
programmes to develop methods for measuring effectiveness. 
Firstly, this thesis has found that a RCT of CR in ACSLT is no longer 
possible due to changes in healthcare provision. Although the exploratory study 
was small and no statistically significant changes were found in the outcome 
measures, there was a trend to benefit that mirrors research within other 
cardiac populations. This group of patients are now routinely offered CR 
following their admission. However there is still a need to examine this sub-
group to ensure that the outcomes they gain from attendance at CR are similar 
to those with the original definition of MI. This area of practice therefore sti ll 
warrants further investigation. The MRC framework suggests different ways to 
assess a complex intervention such as CR and it is possible that a comparative 
study, looking at the recovery of individuals by troponin levels using both 
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quantitative and qualitative measures, could provide useful information that 
would guide service provision.  
Secondly, this thesis has provided interesting data on a range of 
psychological factors, within a small group of participants, and has highlighted 
areas for further research.  The key elements that require further exploration are 
misconceptions and HRQoL. Misconceptions are an area that has had little 
attention within the CR literature and the impact of misconceptions within CR 
populations on attitudes and beliefs is unknown. All the participants in the 
exploratory study expressed misconceptions at T1 and T3, even if they had 
attended CR. The methods by which CR programmes identify and address the 
misconceptions held by their clients requires further exploration. In addition, this 
thesis provided data on the issues that participants thought important to their 
QoL. This thesis found that family, health, and social arrangements were 
determinants of QoL. The results from SEIQoL appeared to suggest that 
improvements in these domains took place throughout the period of recovery. 
However, CR has a limited impact on these issues, so how do CR programmes 
measure their impact in this domain. There has been limited use of SEIQoL 
within cardiac populations and further research is required to expand our 
knowledge of the determinants of QoL within these populations.  
Thirdly, this thesis has highlighted the experience of the participants with 
ACSLT and the level of uncertainty they experienced at a time of change within 
cardiac services. Professional uncertainty and the lack of a consistent message 
had an impact on the recovery of participants and it would be useful to further 
explore areas of practice, both within cardiology and other long term conditions 
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to see the impact that this type of professional uncertainty has on outcome and 
how this can be better managed within clinical teams. 
Fourthly, this thesis has explored the theory of uncertainty, which has been 
largely ignored within the CR literature. The impact that the theory of uncertainty 
has on the theoretical frameworks that underpin CR such as the CSM requires 
further exploration. Understanding the role the theory of uncertainty could play 
in CR would be a step towards developing effective interventions that address 
the psychological needs of individuals.   
Fifthly, this thesis has highlighted that there is a need to support clinicians, 
in achieving the desired benefits of a multi-disciplinary programme of care, by 
developing methods for measuring effectiveness.   
7.9 Conclusion 
This thesis contains a feasibility study and an exploratory study. The 
feasibility study aimed to examine the feasibility of a RCT which would test the 
impact of a menu-based CR programme, on individuals diagnosed with ACSLT, 
against standard care. This feasibility study included staff views. The 
exploratory study aimed to explore the impact that ACSLT and CR can have on 
this client group.  
This thesis provides useful information for practice, but its limitations must 
be acknowledged. The studies were carried out at two hospitals in the west 
coast of Scotland and the findings may not generalise to areas where clinical 
practice is different. Due to the difficulties with recruitment and retention, the 
participants may not have been representative of the population from which 
they were drawn. All the participants came from a white Scottish ethnic 
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background. This limits the applicability of the results to other populations.  
The design of the studies had limitations due to funding and staffing and the 
qualitative aspect of both studies needed to be expanded.  
 The feasibility study was successful in testing the protocols and methods 
and showed that the intervention was acceptable to participants. The strengths 
of the feasibility study included the acceptability of the CR intervention, 
commitment from the specialist CR staff to the process, the use of validated 
tools that were easy to administer and which the participants found acceptable, 
and the collection of a wide range of data on a group not previously studied.  
The areas that would require refinement were recruitment and retention. Data 
was collected on mortality and morbidity and crossover between groups, which 
could inform any further calculations of sample sizes for a RCT, and would 
allow any further trial to be adapted in line with these difficulties. However 
following a change in government policy and clinical practice, it is no longer 
possible to carry out a RCT on this population. The new MRC framework (MRC 
2008) offers opportunities for evaluating CR in ACSLT in a different way. 
The exploratory study involved the use of a large number of measures. 
Many of these are well established measures used widely in the study of CHD. 
These measures were shown to be acceptable to the participants suggesting 
that they may be useful in the further study of patients with ACSLT.  
No statistically significant differences were found between the groups, but a 
tendency to benefit in favour of the intervention was noted. Although this 
exploratory study had small numbers and the data has to be treated with a great 
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deal of caution, it does reflect the evidence found in other studies on the impact 
of CR within different cardiac populations 
The exploratory study noted the impact that uncertainty had on this group of 
participants and this has implications for health care research and for CR 
clinical practice in particular. The participants within the exploratory study 
experienced professional uncertainty around their diagnosis, which had an 
impact on their recovery. This professional uncertainty may be resolved by a 
change in the diagnosis to MI. Yet, while there is some research on uncertainty 
in cardiology, it is largely ignored within the CR literature. The concept of 
uncertainty will however be important for CR professionals due to the 
broadening of the definition of MI.    
Uncertainty theory does not give us a theoretical framework on which to 
base a multi-disciplinary intervention, however the exploratory study suggests 
that the impact of uncertainty needs further exploration, particularly around the 
impact that it has on frameworks such as CSM and on the design of CR 
interventions. 
Changes to the evidence base over the last eight years needed to be 
considered. It could be argued that CR research still faces the same challenges 
and difficulties that it did in 2004.  As has been seen from chapter 7:6, there is a 
substantial body of evidence that suggests exercise CR is effective across 
populations and sub-groups and different modes of delivery. But, due to the 
complex nature of CR, there remain many unanswered questions. Questions 
remain about translating the evidence into practice, especially with the under-
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represented groups such as the elderly, women and those from ethnic 
minorities.  
Currently CR is monitored by diagnosis and by phase, but individuals do not 
see themselves as a diagnosis or at a stage. If the focus of service provision is 
truly about individualised packages of care, then the quality of the assessment 
process needs to become the priority. Currently, we have a number of tools that 
can assess physical and psychological functioning, but it is not routine practice 
to explore issues such as uncertainty or illness representation as a part of the 
assessment process. 
The experiences of individuals experiencing an ACSLT have largely been 
unexplored and the exploratory study findings in this regard are important. They 
are an initial exploration of an important sub-group of patients with CHD and 
although it would not possible to research further using a RCT, further work is 
required to explore how CR can best meet the needs of this sub-group. 
The findings within this thesis are in line with the substantive literature that 
suggests that CR has positive benefits for a wide range of individuals from a 
wide variety of backgrounds, with a wide range of CHD pathology.  
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Appendix One: Qualitative tools and analysis 
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A1:1 Focus group protocol 
 
Phase 1: Before the focus group 
1. Focus groups.   
 Two focus groups will be arranged to compare and identify themes 
which emerge from each discussion. 
 Focus groups should run between 60 and 90 minutes. 
 
2. Participants:  
 Each focus group will have between six and ten participants.  Fewer 
than six participants may limit the conversation and yield poor data 
while more than ten can be unwieldy. 
 Staff should work either in cardiology or cardiac rehab and should 
have been involved in the care of a participant on the study. 
 Secure names and contact information and send invitations. 
 
3. Generate your questions.  
Based on the purpose and goals of the focus group, the questions to be 
addressed are: 
 Expectations of the research process 
 Barriers to participation 
 Perceived impact of CR on the participants 
 Provision of the CR programme (CR focus group only)  
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The script 
 Part one: welcome participants, explain purpose and context, explain 
what a focus group is, and make introductions.  Explain that 
information is confidential and no names will be used.  You will 
record the proceedings. 
 Part two:  ask your questions; remember to use probes and follow up 
questions to explore the key concepts more deeply. 
 Part three: close the focus group – thank participants, give them 
contact information for further follow up if requested, explain how you 
will analyze and share the data. 
 
Role of the facilitator 
 The facili tator should be knowledgeable about the topic at hand  
 The facilitator should be able to keep the discussion going, deal 
tactfully with difficult or outspoken group members, and make sure 
all participants are heard 
 The facilitator should ask the questions and probes, but not 
participate in the dialogue or correct participants. 
 
Choose the location 
 Choose a location which is comfortable, easily accessible, and where 
participants can see one another. 
 Choose a setting which does not bias the information gathered. 
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 Consider food or snacks. 
 
Phase 2: Conduct the focus group 
Bring materials: 
 recorder to record proceedings 
 Flip chart paper  
 Focus group list of participants 
 Focus group script 
 Name tags 
 Watch or clock 
 
Arrive before the participants to set up room, refreshments, etc. 
 
Introduce yourself carry on the focus group according to the script.  
 
Conduct the session: 
 Set a positive tone. 
 Make sure everyone is heard; draw out quieter group members. 
 Probe for more complete answers. 
 Monitor your questions and the time closely – it is your job to make 
sure you are on track. 
 Don’t argue a point with a participant, even if they are wrong.   
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 Thank participants and tell them what your next steps are with the 
information. 
 
Phase 3: Interpreting and reporting the results  
Summarize each meeting 
 Immediately after the meeting write up a quick summary of impressions.  
 Transcribe the recording of the focus group.  This should be done as 
soon as possible after the focus group has been conducted. 
 
Analyze the summaries 
 Read the notes and look for themes/trends.  Write down any themes 
which occur more than once. 
 Note context and tone  
 Interpret the results 
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A1:2 Interview Protocol  
The questions in this guide represent the main issues to be explored. 
Preferably, each participant will go through the same set of topics, although the 
order in which these topics are introduced may vary according to the particular 
participant.  
 
1. Introduction  
In this part of the interview I introduce the participant to the interview situation 
and explain that there is no intention to judge performance or report ‘bad’ 
practice within the healthcare system, but purely to understand the experiences 
that they have had.  
 
2. Main interview 
In the main part of the interview my aim is to get information about the 
participants’ experiences of their illness. In this main part I want to ask questions 
about how well they understand their illness, how adjusted they feel, what their 
goals are and whether they feel they are accomplishing these or not.  
Main cues  
 How have you been since your discharge from hospital (to be asked at T2)?  
 How have you been since I saw you last (to be asked at T3)? 
 What are the next steps for you? 
 Do you have an appointment at the hospital?  
 What about getting back to work? 
 Have you discussed that with the doctor? 
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3. Is there something else you would like to tell me?  
The objective here is to find out if there are some aspects if their experience that 
the participants think I have left out or they wish to add something to things they 
have said earlier.  
 
4. Concluding remarks  
Thank the participant for the interview.  
Ask how they experienced the interview.  
Ask if I may contact them again if something comes up.  
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A1.3   A 15-Point Checklist of Criteria for Good Thematic Analysis  
Process No Criteria 
Transcription 
 
1 The data have been transcribed to an appropriate level of 
detail, and the transcripts have been checked against the 
tapes for accuracy. 
 
Coding 2 Each data item has been given equal attention in the 
coding process. 
 
 3 Themes have not been generated from a few vivid 
examples (an anecdotal approach), but instead the coding 
process has been thorough, inclusive and Comprehensive. 
 
 4 All relevant extracts for all each theme have been collated. 
 
 5 Themes have been checked against each other and back 
to the original data set. 
 
 6 Themes are internally coherent, consistent, and distinctive. 
 
Analysis 7 Data have been analysed – interpreted, made sense of - 
rather than just paraphrased or described. 
 
 8 Analysis and data match each other – the extracts i llustrate 
the analytic claims. 
 
 9 Analysis tells a convincing and well-organised story about 
the data and topic 
 
 10 A good balance between analytic narrative and illustrative 
extracts is provided 
 
Overall 11 Enough time has been allocated to complete all phases of 
the analysis adequately, without rushing a phase or giving it 
a once-over-lightly. 
 
Written 
report 
12 The assumptions about, and specific approach to, thematic 
analysis are clearly explicated. 
 
 13 There is a good fit between what you claim you do, and 
what you show you have done – i.e., described method and 
reported analysis are consistent. 
 
 14 The language and concepts used in the report are 
consistent with the epistemological position of the analysis  
 
 15 The researcher is positioned as active in the research 
process; themes do not just “emerge‟. 
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A1:4 thematic maps 
 
 
Key to thematic maps 
 
                                                                          
Theme          Subtheme    Impact on theme or subtheme     Interdependent themes 
 
 
Two way impact on themes and subthemes 
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Delivery of CR 
Impact of CR 
Barriers 
Research process 
Understanding
Information
Evidence 
base 
Variation
Diagnostic 
uncertainty
Limited 
referrals Value of 
research 
Anxiety 
over care 
provision
Control 
group 
reluctance
Lack of 
National 
Guidance 
Operational 
issues
Limited 
experience 
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Diagnostic 
difficulties  
Lack of information Non compliance 
Confusion
Anxiety 
over care 
provision
Life on hold 
Fear
Acceptance
Information Management 
of complications 
Delays in 
hospital 
treatment
Pain
Feeling 
well
Feeling 
unwell 
Uncertainty
Aim for 
normal
Confidence
Benefit of CR 
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Appendix Two: Ethics/Research and Development  
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A2:1 Ethical approval
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Dr Siobhan Sharkey              14/9/2005 
Chair  
Dept Research ethics committee  
University of Stirling  
Old Perth road  
Inverness  
 
Dear Dr Sharkey, 
  Following my application to the ethics committee in April I suffered a period of 
ill health and have had to take three months off my studies.   I am only just now 
returning to my ethics application and would like to answer the queries in your letter of 
5th of April.    
a) The patient information sheet is currently being rewritten and I will forward the 
final version for comment  
b) I agree that the CLASP questionnaire is long and I would intend to leave it with 
the participant to allow them time to complete it in privacy.  However I would 
make it clear that any answers would be completely confidential and that if they 
had any problems completing or understanding the questionnaire, that I would 
be available to help.  
c) HADS misspelling is fixed 
d) See new information sheet  
e) The application has been altered prior to submitting to NHS Ayrshire and Arran 
to allow for this to happen  
f) Updated patient consent form enclosed, information sheet updated to reflect 
this  
g) Available support to patients is now explicit in the information sheet  
h) Patients notes will be accessed in the decision making process to ensure that 
the inclusion criteria is met.   This will be done by staff who currently have 
access to these notes i.e. ward staff, cardiac rehab staff.  In addition information 
about the clinical pathway of the patient over the course of the study will be 
required, i.e. blood tests, investigations etc, however permission will be sought 
from both the clinicians and the patients to access this information.  Any data 
collected will be kept confidential and stored according to guidelines. No 
information not directly related to the study will be collected.  
 
I hope this is the information that you were looking for and look forward to hearing from 
you  
Janet McKay  
Clinical doctorate student  
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A 2.2 Research and Development approval 
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A2.3 Consent form 
Centre Number: 
Study Number: 
Patient Identification Number for this trial: 
Title of Project:  
An exploratory study to examine the impact of a Cardiac Rehabilitation 
programme on patients with Acute Coronary Syndrome  
Name of Researcher: Janet McKay    Please initial box  
1. I confirm that I have read and understand the information sheet 
dated ............................version 2 for the above study and have had the 
opportunity to ask questions.            
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal rights 
being affected.               
3. I understand that sections of any of my medical notes may be looked at by 
responsible Individuals from NHS Ayrshire and Arran or from regulatory 
authorities where it is relevant to my taking part in research.  I give permission 
for these individuals to have access to my records.     
4. I agree that my General Practitioner/Cardiologist can be informed of my 
participation in this study             
5. I agree to take part in the above study.       
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________________________ ______________      ___________________ 
Name of Patient Date  Signature 
_________________________ _____________       ____________________ 
Name of Person taking consent Date  Signature 
(If different from researcher) 
________________ ________________     __________________ 
Researcher Date  Signature 
 
1 for patient; 1 for researcher;  1 to be kept with hospital notes 
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A2.4 Information sheet for patients  
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A2.5 Letter to General Practitioner 
 
Dear Dr 
Re: 
The above patient has consented to take part in a study looking at the 
impact of Cardiac Rehabilitation on patients with Acute Coronary Syndrome 
without Myocardial Infarction. I enclose a copy of the information sheet for this 
study. Patients can of course withdraw from the study at any point without 
giving a reason.   It is hoped however that this study will provide information that 
will inform future developments in care for this group of patients.   Any medical 
care provided will of course continue as usual no matter which arm of the study 
they are placed in.  If you require any further information on this study I can be 
contacted at the address below: 
Mrs Janet McKay  
Cardiac Rehabilitation, Lister Centre, Crosshouse Hospital 
Kilmarnock, KA2 0BE, Tele: 01563 577175 
Yours sincerely  
 
Janet McKay Clinical Co-ordinator  
Cardiac Managed Clinical Network  
NHS Ayrshire and Arran  
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A2.6 Information sheet for General practitioners and Cardiologists 
Study title:  An exploratory study to examine the impact of a Cardiac 
Rehabilitation programme on patients with Acute Coronary Syndrome without 
myocardial infarction 
What is the purpose of the study? For several years in Ayrshire people, 
who are admitted to hospital with a heart attack, have been able to receive 
cardiac rehabilitation.  This is a programme of education, support and exercise 
provided by specialist nurses and physiotherapists with the help of doctors and 
other member of the healthcare team. This has been found to be beneficial for 
this small group. However this is only a small number of the people admitted to 
hospital every year with a heart problem. Currently there is very little information 
about the impact of a programme such as this on other heart problems. We are 
keen to improve services for all individuals with heart problems and would like 
to know if Cardiac Rehabilitation would be beneficial to others. For this reason 
NHS Ayrshire and Arran is supporting a pilot study looking at the impact of 
Cardiac Rehabilitation on people with Acute Coronary Syndrome without heart 
attack. The study will last from April 2005 until November 2007 . 
How do we choose who takes part? They have been chosen for this study 
because they were admitted to Crosshouse and Ayr hospitals with a diagnosis 
of Acute Coronary Syndrome. All patients admitted with this diagnosis during 
the study, who are able to take part, will be approached.  We expect to interview 
100 patients over the course of the study. 
What will happen to them? They will be seen on three occasions over one 
year, in hospital and at home.  They will be asked to complete five short 
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questionnaires each time and to answer some questions from the researcher on 
their current health. They will be asked to keep a diary of any chest pain and to 
measure their activity for a week at two time points using a pedometer.  It is 
anticipated that each interview will last approximately one hour.  They will not 
need to have any blood tests or investigations other than they would normally 
be expected to receive.    They will be allocated to either the usual care group 
or the intervention arm. If they are allocated to the usual care group, but feel at 
the end of the study that they would like the opportunity to take part in Cardiac 
Rehabilitation programme, this will be offered to them provided their cardiologist 
is in agreement that they are well enough to take part. If they are allocated to 
the intervention group they will receive information from the Cardiac 
Rehabilitation team.  Cardiac Rehabilitation is a programme of care provided by 
experienced healthcare professionals, usually a specialist nurse and a 
physiotherapist.    The team will: 
 provide information on the diagnosis and its impact on lifestyle   
 talk about the risk factors for future health problems   
 Provide an individualised programme of exercise to improve activity 
levels.  
They may be asked to participate in an exercise programme twice a week 
for up to three months.  This will be designed according to their abilities and 
needs. If this is the case, they will be able to claim travel expenses to and from 
the hospital. The information gathered from this study will be important in 
helping to design services for people with similar health problems. 
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Although they have agreed to take part they are still free to withdraw at any 
time and without giving a reason.  A decision to withdraw at any time, or a 
decision not to take part, wi ll not affect the standard of care they receive. 
What are the possible disadvantages, side effects and risks? This 
project does not include drugs or additional investigations and should have no 
impact on treatments you may wish to provide.   We would expect that all 
individuals recruited to the trial would continue to receive routine medical care. 
Sometimes during the course of a study like this some health problems such as 
high blood pressure or high cholesterol levels may be detected. They may wish 
to discuss these issues with you. 
What are the possible disadvantages, side effects and risks of taking 
part in a Cardiac Rehabilitation programme? Occasionally some people may 
suffer pain either from bony injury or muscular problems.  Occasionally some 
people may suffer cardiac problems.    The risk of a patient taking a cardiac 
event is calculated at one patient every six years. A senior physiotherapist and 
an experienced cardiac nurse will assess them and they will tailor the 
programme to suit their needs and to minimise risk.  The consent of a 
Cardiologist will be needed before they can commence the exercise classes. 
Sometimes people can become anxious or depressed when they develop a 
health problem and this may be made worse by a discussion of the problem.   
The Cardiac Rehabilitation staff will get them the help they need if they develop 
any of these problems.  If the team discover while an individual is attending the 
classes that they have developed a health problem of which they were 
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unaware, the team will wish to report this change to yourself and their 
Cardiologist. Permission will be obtained from the individual for this. 
The researcher’s responsibility is to collect information on the individual’s 
experiences and recovery from this illness.  She will not provide medical advice 
or support.  The information we get from this study may help us to treat future 
patients with Acute Coronary Syndrome better. 
What if new information becomes available? Sometimes during the 
course of a research project, significant new information becomes available 
about the treatment that is being studied.  If this happens, the researcher will tell 
the individual about it and discuss with them whether they want to continue in 
the study.  If they decide to withdraw the researcher will make arrangements for 
their care to continue.  If they decide to continue in the study they will be asked 
to sign an updated consent form. Also, on receiving new information the 
researcher might consider it to be in their best interests to withdraw them from 
the study.  She will explain the reasons and arrange for their care to continue.  
What happens when the research study stops? The provision of Cardiac 
Rehabilitation to people with Acute Coronary Syndrome is not currently funded 
within NHS Ayrshire and Arran. So following the completion of the study this 
service will be withdrawn. The results of this pilot study will be used to decide if 
a study looking at large numbers of people with Acute Coronary Syndrome 
across Scotland is possible. This and any follow-up study will provide 
information on whether Cardiac Rehabilitation for Acute Coronary Syndrome is 
a useful and safe form of treatment for the NHS to provide. Any results will 
inform future service developments within the NHS.  
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What will happen to the results of the research study? The study will last 
until November 2007 and it wi ll then be submitted to NHS Ayrshire and Arran for 
comment and for publication to various journals. Meetings will be also be held 
with various local organisations to disseminate the results. Individuals will not 
be identified in any report/publication. The researcher will make a copy of the 
results available to anyone involved in the research.   Copies can be obtained 
from the Cardiac Rehabilitation office in Crosshouse hospital. 
Who is organising and funding the research? NHS Ayrshire and Arran 
CHD Managed Clinical Network supports this research and the researcher will 
be supervised by the Department of Nursing and Midwifery at the University of 
Stirling.No one will be paid for this study. 
Who has reviewed the study? This study has been reviewed by NHS 
Ayrshire and Arran Ethics Committee and Research and Development group 
and by the Ethics committee of the Department of Nursing and Midwifery at the 
University of Stirling. 
What if something goes wrong? If they are harmed by taking part in this 
research project, there are no special compensation arrangements.  If they are 
harmed due to someone’s negligence, then they may have grounds for a legal 
action but they may have to pay for it.  Regardless of this, if they wish to 
complain, or have any concerns about any aspect of the way they have been 
approached or treated during the course of this study, the normal National 
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Health Service complaints mechanisms should be available to them. 
Will information be kept confidential? All information, which is collected, 
about them during the course of the research will be kept strictly confidential.  
Any information, which leaves the hospital, will have the individuals name and  
address removed so that they cannot be recognised from it. Both General 
practitioners and Cardiologists will be informed of their participation in this study 
and consent for this will be sought from the individuals concerned.  
Further information about this study can be obtained from: 
Mrs Janet McKay, Cardiac Rehabilitation  
Lister Centre, Crosshouse Hospital, Kilmarnock  
KA2 0BE,    Tele: 01563 577175 
If you have a complaint to make about this study pleases contact:  
Professor C.A.Niven 
Department of Nursing and Midwifery,   University of Stirling  
Stirling  FK73LA          01786466341 
If you wish further independent information about being involved in a 
research study please contact: 
Research Governance office, Department of Clinical Effectiveness  
Ayr Hospital, Dalmellington road, Ayr 01292610555 
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A2.7 Referral protocol  
 All patients on admission to the cardiology should be given information on 
the study  
 Suitable patients should be notified to the researcher who will assess 
suitability for the study  
 Once the diagnosis and suitability  has been confirmed the patient can be 
approached for consent to be approached by the researcher 
 The researcher and patient will discuss the study and the procedure for 
obtaining informed consent will be completed  
 Following entry to the study the researcher will find a suitable time to 
complete the baseline assessments   
 Thereafter all patients in the treatment arm should be referred to the Cardiac 
Rehabilitation Liaison Sister (phone Crosshouse ext 2175 or Ayr ext 4177).   
 If it is necessary to contact the Cardiac Rehabilitation team for any other 
reason,  they can be contacted on: 
Sister McAskill  bleep 3510   Sister Bogle bleep 3350 
 Patients will be visited as soon as possible following referral 
 During their hospital stay the following subjects will be explained 
o Anatomy and Physiology of the heart 
o Angina and its management  
o Reducing appropriate risk factors  
o Return to normal activities 
 
 Every attempt will be made to see the carer of the client either in hospital or 
at home 
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 Referral to appropriate members of the multi-disciplinary team will be made  
i.e. dietician pharmacist physiotherapist social work  
 All patients who are able to leave their home for day time activities normally 
will be offered an appointment at the Cardiac Clinic within 6 weeks of 
discharge.  
 Any investigations will normally be carried out prior to attendance at the 
clinic 
 Patients who are assessed fit will normally be offered a place at the Cardiac 
Rehabilitation Classes commencing within 14 days of the c linic  
(see exercise class referral protocol) 
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Appendix Three: Questionnaires 
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A3.1 York Angina Beliefs Questionnaire v2 
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Here are the answers.  
To score the YABQv2: Items 2, 3, 5, 7, 8, 9, 10, 12 & 13 score normally;  
Strongly agree=4, agree=3, don’t have any idea about this=2, disagree=1, 
strongly disagree=0.    
Items 1, 4, 6, 11 & 14 are reverse scored. 
 
1. It is not always 
necessary for people 
with angina to stop 
what they are doing 
when they get angina 
pain 
Although it may be more comfortable to stop as 
soon as an attack occurs it is not always strictly 
necessary. Some people worry that not stopping will 
cause damage, and need reassuring that if the pain 
is slight and they want to carry on a reduced pace 
then that’s ok. There are people who work through 
an attack. Stopping immediately may not always be 
practical or safe, (if driving or working machinery 
etc.) 
2. Angina is a kind of 
small heart attack  
No it isn't. 
3. People develop 
angina because they 
have too much stress 
in their lives  
Probably not, the major causes of angina are risk 
factors like smoking, high blood pressure, diabetes, 
high cholesterol or a family history. Stress may 
cause people to adopt risky lifestyles (smoking, fatty 
diets, lack of exercise etc.) but it is still the risky 
lifestyle that they need to change. People who 
believe that the major cause of their developing IHD 
is stress are less likely to alter their risky lifestyles 
and have greater morbidity than people who 
310 | P a g e  
 
acknowledge that their known risk factors need 
changing. 
4. There is no need for 
people with angina to 
take life easy 
That's right. They should keep up the exercise they 
do (or increase it slowly if they do none). The main 
thing is to keep going and build up gradually. 
5. People with angina 
should always avoid 
things that bring it on  
Not necessarily, this could result in the person sitting 
in the house afraid to do anything. Try taking GTN 
before hand, or break the task down into small 
chunks, doing a little at a time and building up 
activity levels slowly. It is usually possible to give 
people combinations of drugs that limit the amount 
of angina. Recent research also suggests that 
people who suffer from angina attacks may not 
suffer as much if they subsequently have a heart 
attack, the angina may provide a sort of protection.  
6. People with angina 
should exercise 
It is very advisable for them to exercise, as people 
who increase their fitness slowly may reduce the 
amount of angina that they suffer. 
7. Any sort of 
excitement is bad for 
people with angina 
Believing this could severely limit their quality of life. 
Giving up fun but exciting things could also 
contribute to depression. 
8. Angina is caused by 
a worn out heart  
No. 
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9. If people with angina 
don't rest when they 
get angina pain it 
could be fatal  
Not so. See question 1. However people with angina 
should be taught how to spot if the pain may be a 
heart attack and what to do, a great deal of fear is 
generated because they have not been taught this. 
10. People with angina 
must stay calm 
Although this may lead to a more relaxing life it is 
not strictly necessary. It could affect quality of life 
and family life if the striving for calm causes bottling 
up of problems, by either the angina sufferer or their 
family. 
11. Rest is not the best 
treatment for angina 
Rest causes people to become less fit, and this can 
cause more angina pain, so rest is a poor treatment 
for angina. 
12. Too much worry 
causes people to 
develop angina 
No, see question 3. 
13. Angina pain causes 
permanent  damage 
to the heart  
No it doesn't. 
14. It's usually safe to 
argue with people 
who have angina. 
Believing that it is not safe can cause problems in 
relationships, and make the family overprotective. 
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A3.2 Cardiac Limitation and Symptoms Profile 
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A3.3 Hospital Anxiety and Depression Scale 
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A3.4 Short Form 36v2 
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A3:5 Feasibility Questionnaire  
 
To be asked by researcher at the end of six month interview  
1. Did the information you received before starting the study prepare you for 
what actually happened in the study? 
 
 
2. How do you feel about being involved in the study? 
 
 
3. How did you find filling in the questionnaires? 
 
4. If someone asked you to be involved in another similar study would you 
consider it? 
 
(If in intervention group) 
5. Did you have any problems take part in the Cardiac Rehabilitation 
programme? 
6. Do you have any comments about the study or the Cardiac Rehabilitation 
programme that you would like to share with us? 
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A3.6 GRACE Score 
 
 
 
332 | P a g e  
 
  
333 | P a g e  
 
A3.7 Data collection sheets 
Demographics   
Name: 
Address  
Postcode: 
NHS Number: Participant number  
Date of Birth: Date of Death:  
GP Address 
 
Consent obtained                           YES/NO 
Group                                               CONTROL/INTERVENTION 
 Date  Completed 
Baseline assessment   YES/NO 
Eight  week assessment   YES/NO 
Nine month  assessment   YES/NO 
2 year assessment   YES/NO 
Withdrawn   reason 
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Participant number                                                    
Gender: Not Known  Male  Female  Unspecified  
Marital Status:   Single  Married  Permanent partnership 
 Divorced  Widowed  Unknown  
Age on leaving full-time education: 
Current Employment status:     Employed full-time  Employed part-time
 Self-employed full-time  Retired  
Self-employed part-time   Unemployed looking for work  Gov. training 
course Looking after family/home  
Permanently sick/disabled  Temporarily sick or injured  Student  Other 
reasons        
Occupation if employed _________________________________ 
Ethnic origin:      White (British) White (Irish)  White (other)  Mixed 
white/Asian  Mixed other  Indian Pakistani    Bangladeshi  
Other Asian   Black African Black other   Chinese  Black Caribbean  
Mixed white/black Caribbean   Other Ethnic Group  Mixed white/black 
African           Not stated  
Site   Ayr Hospital                                  Crosshouse  Hospital    
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Previous Events  
Acute Coronary Syndrome  Bypass Surgery  Angioplasty 
Cardiac Arrest         Angina   Other Surgery  HF         Pacemaker
  ICD      Congenital Heart        Transplant   
LV Assist Device         Other None  
Weight:                                    kg               
Height:                                     cm                            
BMI:
Blood Pressure:                       /                      
mm Hg 
Has patient smoked in last 4 weeks:  
Yes  No    Is patient  an ex-smoker    
Smokalyser reading     ____________ 
How many cigarettes per day  __________ 
How active on a scale of 1-10 are you 
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Comorbidity   
Angina                Arthritis (osteoarthritis)        Cancer                 Diabetes              Stroke               
Osteoporosis    Chronic bronchitis         Emphysema      Asthma               HBP       Claudication  
Rheumatism    Chronic Back Problems      Other Comorbid Complaint    
Cholesterol: Total: HDL: LDL: Ratio: Triglycerides:                                                     
Troponin T  
ECG: 
Exercise test: 
Echocardiography: 
Grace score (see attached info) 
Previous interventions: 
Angiography       Angioplasty           Angioplasty with stent   Bypass Surgery       Thallium  
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Follow-up medical treatment:       
Medical follow-up                     Rehab follow-up     Both   Angiography         Angioplasty with stent    
Bypass Surgery              Thallium  
Drugs:  
Aspirin         Other antiplatelet agent  ACE inhibitor  BetaBlocker               Statin                               
Other:  
Drugs:  
Aspirin         Other antiplatelet agent  ACE inhibitor  Beta Blocker  Statin  Other: 
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Examinations & Tests  eight  weeks                                                                                                                   
Participant no  
 
Weight:         kg             Height:               cm BMI: 
Blood Pressure:                       /                      mm Hg  
How active on a scale of 1-10 are you 
 
Pedometer reading over a week: 
 
Have you had a episode of chest pain over the last week      
Yes/No                 If Yes how many times : 
 
Is it worse or better than the pain you went into hospital 
with: Yes/No 
Has patient smoked in last 4 weeks:  Yes   No     
ex-smoker   
Smokalyser reading                    ________________ 
How many cigarettes per day   ______________ 
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Further cardiac incidents : 
Routine attendance at GP            Emergency attendance at GP           emergency call out of out of hours service                       
Admission to hospital                                           
Outcomes:________________________________________  
Further treatments: Angiography      Angioplasty     Angioplasty with stent  Bypass Surgery      Thallium                      
other  
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Examinations & Tests ( nine months  ) 
Participant no  
Weight:    kg                            BMI: Blood Pressure:       /       mm Hg 
How active on a scale of 1-10 are you 
 
Pedometer reading over a week: 
Have you had a episode of chest pain over the last week      
Yes/No                 If Yes how many times : 
 
Is it worse or better than the pain you went into hospital 
with: Yes/No 
 
Has patient smoked in last 4 weeks:  Yes   No     
ex-smoker   
Smokalyser reading                    ________________ 
How many cigarettes per day   ______________ 
Cholesterol: Total: HDL: LDL: Ratio: Triglycerides: 
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Further cardiac incidents : 
Routine attendance at GP            Emergency attendance at GP           emergency call out of out of hours service                       
Admission to hospital                     Outcomes:________________________________________ 
Further investigations: Angiography    Angioplasty    Angioplasty with stent  Bypass Surgery       
Thallium                      other  
Drugs: Aspirin         Other antiplatelet agent      ACE inhibitor     Beta Blocker      Statin   
Other: 
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Appendix Four: Article 
 
A4.1 Article 
Type of article  Research  
Journal for 
submission  
Journal of Cardiac Nursing 
Title Anxiety, Depression and Quality of Life in patients with Acute 
Coronary Syndrome  
Authors Janet McKay, Consultant Nurse Cardiac Care  
NHS Ayrshire & Arran  
Dr Ashley Shepherd,   Senior Lecturer,  University of Stirling  
Professor Kate Niven, University of Stirling 
 
Correspondence Cardiac Rehabilitation, The Lister Centre, University Hospital 
Crosshouse, Kilmarnock, KA2 0BE 
t: 01563-827175 
janetmckay2@nhs.net 
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Abstract 
 
Cardiac rehabilitation (CR) has been shown to be effective in reducing 
mortality and morbidity in Coronary Heart Disease (CHD).  There is a limited amount 
of research that evaluates the impact of menu-based CR, in patients with Acute 
Coronary Syndrome with low Troponin levels (ACSLT).  
This feasibility study was a repeated measures case control study of menu-
based CR using a range of health assessments. Participants (n=33) were recruited 
from cardiology wards following an admission with ACSLT.  Both groups had an 
improvement in anxiety and their Health Related Quality of Life (HRQoL). 
Approximately 29% of the total study population were found to be depressed at 
baseline. A pattern of change across all the subscales of the SF36v2, was found that 
requires further investigation.  
This study is an initial exploration of the experiences of individuals 
experiencing ACSLT and further work is required to explore how CR can best 
improve the psychological well being of individuals with ACSLT.  
Key words: acute coronary syndrome, cardiac rehabilitation, anxiety, 
depression, quality of life  
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Introduction 
Coronary Heart Disease (CHD) is a leading cause of death across the world, with 
Scottish CHD mortality amongst the highest in the United Kingdom (BHF 2012b).  
Significant attention has been paid over recent decades to reducing mortality and 
morbidity from CHD.  
Acute Coronary Syndrome (ACS) is a term that has appeared over the last 
decade within the CHD medical terminology (Fox et al 2004). The diagnosis of ACS 
is determined by elements of the clinical presentation. These include a history of 
CHD, electro-cardiographic changes and raised biochemical markers such as 
Troponin T.  Initially in the UK, there were three categories of ACS: ACS with clinical 
MI, ACS with myocyte necrosis, and ACS with UA (Fox et al 2004). However the 
Joint European Society of Cardiology/American College of Cardiology (ESC/ACC 
2000) defined an MI as any troponin rise and did not accept the need for  the 
category of ACS with myocyte necrosis. This debate led to differences in clinical 
practice across the UK.   
Many people with CHD experience anxiety, depression, emotional and social 
disturbance, reduced Health Related Quality of Life (HRQoL) and failure to return to 
work (Petrie and Weinman 1997, Rugulies 2002, Shibeshi 2007). In a recent meta-
analysis looking at anxiety as a predictor of medical prognosis after MI, Roest et al 
(2010) found that post MI anxiety is consistently related to adverse cardiac events. 
Between 31-45% of patients with CHD including those with stable and UA or MI 
suffer from clinically significant depressive symptoms (Carney 2008, Thombs 2008).   
Persistent psychological distress and poor social support are powerful predictors of 
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outcome following MI, independent of the degree of physical impairment 
(Hemingway and Marmot 1999).   
Cardiac rehabilitation (CR) has been shown to be effective in reducing 
mortality and morbidity in CHD (Heran et al 2011). Healthcare is moving toward the 
goal of implementing evidence-based interventions that have been rigorously 
evaluated and found to be both efficacious and effective (Bowen et al 2009).  
However the design and evaluation of complex interventions, such as CR, is 
problematic. There are a large number of diverse components within a CR 
programme, including the theoretical framework, which, act and interact with one 
another to achieve a range of outcomes for the individual.  
Despite a range of research on populations such as women (Williams et al 
2006), ethnic minorities (Banerjee et al 2007), the elderly (Audelin et al 2008, 
Giallauria el al 2010) and a range of cardiac diagnosis (Davies et al 2004, Todd and 
Ballantyne 1992), the evidence base for CR remains predominantly male, middle 
aged and low risk and based on patients following a myocardial infarction (MI) or 
cardiac revascularisation procedure (Heren et al 2011).  There is also a limited 
amount of research that evaluates menu-based CR.  
This study focused on patients with ACS with myocyte  necrosis, more 
commonly described as, ACS with low troponin (ACSLT) (Troponin T<1ng/ml).  DAS 
et al (2006) found significant differences in the treatment of patients with ACSLT 
compared to MI, with less prescription of recommended drugs such as beta-
blockers, ace-Inhibitors and statins. The relatively limited use of interventional 
strategies and of short term and secondary prevention drugs further suggested that 
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patients with ACSLT would benefit from early identification and from being treated 
more aggressively.  
Prior to 2007, patients with ACSLT would not have met the referral criteria in 
place in the majority of CR programmes (Lewin et al 2004). Research has shown 
that the morbidity and mortality of patients with ACSLT is similar to those diagnosed 
with MI (SIGN 2007), yet there is limited data on other outcome measures for this 
population such as anxiety, depression, and HRQoL. There has also been limited 
research on the impact that menu-based CR might have on outcomes for these 
individuals.  
Aim: The aim of this study was to examine the feasibility of a randomized controlled 
trial (RCT) which would test the impact of a menu-based CR programme, on 
individuals diagnosed with ACSLT, against standard care. It also aimed to explore 
the impact that CR had on this client group.  
Research design: This feasibility study employed repeated measures of a range 
of health assessments in two cohorts of patients who had experienced an admission 
with ACSLT. The study was conducted in 2007, prior to the change in definition of 
ACSLT.    
Ethical approval 
Ethical approval was obtained from the Ethics Committees of the local Health board 
and the University of Stirling. Written permission to contact patients was received 
from consultant cardiologists. The study was conducted within the research 
governance framework of the NHS in Scotland. 
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Method 
Recruitment : A study information sheet was made available to all patients admitted 
to hospital with an ACSLT.  Any patient expressing an interest in the study was 
directed to speak to the investigator, at which point any queries which the patient 
had were addressed.  Those who agreed to participate were requested to provide 
informed consent prior to the completion of the five questionnaires.  
Sample size: Patients were recruited during their index admission.  A consecutive 
sample of patients (n = 33) was recruited over a 12-month period from the coronary 
care units of two District General hospitals. One cohort received standard care 
(n=19) and the remaining patients received a CR intervention (n=14). Recruitment 
was stopped in November 2007 due to the change in diagnostic criteria noted above.  
The inclusion criteria were: aged 16 or over, no previous attendance at CR, able to 
read and speak English, diagnosed as ACSLT. Additionally, anyone with a terminal 
illness was excluded from the study 
Measures: The study included three widely used screening questionnaires 
standardised for use with physically ill populations:  The Hospital Anxiety and 
Depression Scale (HADS), Schedule for the Evaluation of Quality of life- Direct 
Weighting (SEIQoL-DW) and the SF36v2, all of which have been validated in cardiac 
populations (Dempster and Donnolly 2000).  The HADS (Zigmund and Snaith 19  ) is 
a 14-item measure for symptoms of anxiety and depression, which focuses on non-
somatic indicators of anxiety and depression to allow for the identification of such 
difficulties in physically ill populations.  Index score ≥7 is thought to indicate 
caseness for both the anxiety and depression subscales (Bambauer et al 2005).   
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SEIQoL-DW is a QoL measure which is derived from the Schedule for the 
Evaluation of Individual Quality of Life (SEIQoL) (O’Boyle et al. 1993). It is a short 
form of the original SEIQoL and was validated against the original by Hickey et al 
(1996).  The practicality and brevity of this measure make it useful in clinical 
situations where QoL is important.  It has been shown to have high levels of 
consistency and validity with older medical patients, stroke, cancer and palliative 
care patients, and has been found to be acceptable and practical to use with these 
patient populations (Campbell and Whyte 1999, Waldron et al 1999; O’Boyle and 
Waldron 1997, Hickey et al. 1996). The measure allows participants to nominate the 
areas of life which are most important, rate their level of functioning or satisfaction 
with each, and indicate the relative importance of each to their overall QoL. An 
overall QoL score can then be calculated.   
The SF36v2 has been used in a wide variety of cardiac populations when 
assessing HRQoL (Lavie and Milani 1995, Mendes de leaon et al 2001). It has been 
well validated and has proven useful in monitoring general and specific populations, 
comparing the burden of different diseases, differentiating the health benefits 
produced by different treatments, and in screening individual patients. This 
comprehensive short-form with only 36 questions yields an 8-scale health profi le as 
well as measures of HRQoL. The scales of each question are coded summarised 
and transformed into a scale of 0 (the worst possible QoL) to 100 (the best possible). 
The SF36v2 also provides a summary of several of the scales to two components.  
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Demographic and clinical information 
A standard demographic form was used to collect self-report data on age, gender, 
ethnicity, marital status, education, and employment status.  Participant health status 
and diagnosis were obtained via medical notes review.  
Cardiac Rehabilitation intervention 
The intervention utilised within this study was a menu-based CR programme, as 
currently provided within NHS Ayrshire &Arran, which utilises the CSM as its 
theoretical framework (Leventhal et al 2003). Participants in the intervention group 
were referred to the specialist CR team while in hospital and were followed up for 
four months. The number and types of interventions provided can be seen in Table 1 
Insert Table one  
Procedure 
Following participant consent, patients completed a compiled booklet including all 
measures described above and a form to collect demographic information.  The 
questionnaires were completed in the ward prior to discharge (T1) and during an 
interview at home at nine months (T3).   
Insert figure one 
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Data analysis 
Statistical analysis was performed using SPSS for Windows (version 15.0).  
Descriptive and comparative analysis was carried out to provide background 
information (e.g. age, employment status, diagnosis, medical history) regarding the 
sample.  Results were then analysed according to treatment group. 
Results 
Demographic and clinical characteristics 
Eight patients were lost to follow-up at 9 months, 2 died, 3 were withdrawn due to ill 
health and 3 failed to respond to repeated contact by letter. Twenty five patients 
completed the study. During this period 11 received a package of CR and 14 did not.  
The small numbers within the study mean that the data can only be viewed as 
exploratory in nature. The demographic characteristics of the sample for the present 
study are shown in Table 2, including age, gender, marital status, and deprivation 
status. All participants in the study were on aspirin and the prescription rates of the 
three remaining secondary prevention drugs were, statins (92%), beta-blockers 
(84%) and ace-inhibitors (64%). 
[INSERT TABLE 2 HERE] 
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Anxiety and depression 
The HADS measures two key psychological factors, namely anxiety and 
depression.  This study found that means in both groups were greater than 7 (mildly 
anxious) at T1 and that in the control group they remained greater than 7 (mildly 
anxious) at T3. Anxiety levels in the intervention group had fallen to within normal 
ranges at T3. There was little change in mean anxiety levels between T1 and T3 in 
the control group. However the intervention group had higher levels of mean anxiety 
at T1 and this had reversed at T3.  The relative change between the two time points 
was -0.08 in the control group and- 2.73 in the intervention group. There was a wide 
variation in individual scores in the control group between T1 and T3 with half the 
control group showing a worsening of anxiety levels and half showing improvement, 
therefore leading to little mean change.  
[INSERT FIGURE 2 HERE] 
The control group was more depressed at baseline and at T3, but the relative 
change between T1 and T3 was 0.73 in the control group and 1.4 in the intervention 
group. It is important to note that within the control group there were four participants 
who presented with scores greater than 10.  This level of depression would be 
treated as requiring intervention in clinical practice. Of these four participants, two 
had reduced their score below 11 and the other two continued to score high levels of 
depression at T3.  Within the intervention group there were no individual scores 
above 10 at T1 and only one at T3.  Approximately 29% of the study population had 
some degree of depression throughout the period of the study 
[INSERT TABLE 3 HERE] 
352 | P a g e  
 
Quality of life 
Global QoL was measured using the SEIQoL-DW, while HRQoL was measured 
using the SF36v2. Twenty four participants completed a SEIQoL-DW at T1 and T3. 
They had to identify five variables that made a difference to their QOL. Of these, 
nineteen stated that their family was the main contributing variable to their QOL, 
rising to 21 at T3, with most suggesting that it represented approximately 50% of the 
total score.  Three participants at baseline stated that their health was the main 
contributor to their QoL, with an additional one stating faith and one work.  
The second most important contributor was often defined as health with 
eleven participants identifying this and three identifying work. The five who had not 
chosen family as variable one, did choose it as variable two. In many cases the 
second variable represented around 20-30% of the total score.  
The last three variables picked by the participants varied quite a lot but can be 
summarised as social arrangements.  These could be holidays, pets, hobbies or a 
range of other items which related to entertainment. These often had values of 
between 5-15% of the total score. Any differences between the groups at T1 and T3 
did not reach statistical significance. But both groups had an improvement in their 
QOL as measured by SEIQoL-DW across the time of the study with the mean 
change being 5.35 in the control group and 8.47 in the intervention group  
SF36v2 has several different components and can be analysed compared to 
a variety of populations. Two key scales are the physical care summary and mental 
health care summary scales. A small improvement in QoL is noted in the mental 
health scale of the SF36v2, with the control group improving slightly more than the 
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intervention group, however the control group started from a lower baseline on this 
scale.  This may also reflect the results found on the HADS scale, which showed a 
higher level of depression in the control group at T1. The results, on the physical 
summary scale show a slightly different picture; here the control group stay the same 
and the intervention group improve by 8. 
There are eight subscales of the SF36v2 and if we consider the control group 
first we can see a mixed picture of improvement and deterioration.  Physical 
functioning, role physical, and general health seem to deteriorate, and vitality, social 
functioning and role emotional improve. In the intervention group only general health 
appears to deteriorate. All other factors appear to improve.  
[INSERT FIGURE Three HERE] 
Information on norms within different groups are available for the SF3v2 and at T1 
the control group was worse than the CHD norms on all factors except role physical 
and the intervention group was worse than the norm on everything except general 
health, role emotional and physical functioning. At T3 the control group was below 
the norm on all factors except bodily pain, role emotional and the physical summary 
scale and the intervention group was consistently above the norms across all factors.  
Discussion 
Demographic and clinical characteristics: During this study, the incidence of ill health 
and death was high (15%), with 9% crossing over from control to intervention group, 
and an additional 9% lost to follow-up.  This combination of events is however 
recognised in other CR trials. In a Cochrane review of exercise rehabilitation by 
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Joliffe et al (2004), it was noted that losses to follow up within many trials were high, 
but often not adequately described. This was also noted in the review of home-based 
CR versus hospital where losses to follow up varied considerably across all studies 
(Taylor et al 2010). Within many studies groups were analysed according to initial 
random allocation. This trial however used a fi nal group design in that the data was 
analysed by the final outcome for the individual, control or treatment.   
Anxiety and Depression 
The literature tells us that anxiety and depression are common in various patient 
groups with CHD (Carney 2008, Roest et al 2010).    Whalley et al (2011) in the 
latest review of psychological interventions in CHD argue that psychological 
interventions may produce small to moderate reductions in depression and anxiety, 
and may also reduce cardiac mortality. As part of the CR programme, patients in the 
intervention group received psychological assessment and intervention where 
required (see Table 1). The incidence of anxiety and depression noted in the 
literature is reflected in the study participants, several of whom reported high levels 
of anxiety and depression. Across the timescale of this study there was a reduction 
in anxiety in both groups with the tendency to benefit favouring the intervention 
group.   
Quality of life  
Family is mentioned by all patients and ranked highly. This pattern of family, health, 
followed by social activities has also been noted in patients with cancer (Campbell 
and Whyte 99), and diabetes (Walker and Bradley 02). The results from this study 
show that both groups had an improvement in their global QoL as measured by 
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SEIQoL-DW across the time of the study with slightly larger changes in the 
intervention group.    
The use of the SF36v2 is advantageous in allowing comparisons across 
disease states and populations.  Chan et al (2005) examined HRQoL using the 
SF36v2 in a group of 182 CR participants that included some with ACSLT and found 
significant differences in SF-36 scores for all eight subscales: physical functioning, 
limitations due to physical health problems, bodily pain, general health, vitali ty, social 
functioning, limitations due to emotional health problems and mental health. The 
main differences were higher mean scores on all subscales of the SF-36 at the 6-
month period, as compared with baseline data for those who received an 
intervention. Within this study the control group had a mixed picture of improvement 
and deterioration and in the treatment group, with the exception of general health all 
factors appear to improve.  This study has highlighted a pattern of change across all 
the subscales of the SF36v2, within a defined subgroup, that requires further 
investigation.  
Cardiac Rehabilitation and ACSLT 
This study was a feasibility study of ACSLT and the changed definition of MI meant 
that patients could no longer ne recruited as they became eligible for CR. However 
the evidence base for CR is primarily based on trials conducted on MI populations 
prior to the reclassification of MI and the results of those trials cannot be applied 
without some reservations to this patient group.  This study has highlighted that there 
is a need for further research on the impact of menu-based CR in this area. 
Clinicians working within CR require more information on which to base their clinical 
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practice and the updated MRC framework for researching complex interventions may 
provide some direction for future research.(MRC 2008).   
Limitations: Although the study provides useful information for practice, its 
limitations must be acknowledged. It was carried out at two district general hospitals 
in the west coast of Scotland and the findings may not generalise to areas where 
clinical practice is different. The sample was small and no significant differences 
were found.  The control and intervention groups had substantial drop-outs 
throughout the course of the study and in addition there were three participants who 
crossed from the control to intervention group due to further cardiac events.  
The study population consisted of a high number of males versus females and 
the experiences of the women may not have been adequately reflected within the 
data that was collected, in addition all the participants came from a white Scottish 
ethnic background. This reflects the local population but limits the applicability of the 
results to other ethnic populations.  Furthermore, it was a requirement of the study 
that participants could read and understand English, which resulted in the exclusion 
of people who required interpreters.  
Conclusions: The experiences of individuals experiencing an ACSLT have largely 
been unexplored and the study’s findings in this regard are important. They are an 
initial exploration of an important subgroup of patients with CHD and, further work is 
required to explore how CR can best meet the needs of this subgroup. These 
findings are in line with the substantive literature that suggests that CR has positive 
benefits for a wide range of individuals from a wide variety of backgrounds, with a 
wide range of CHD pathology (ref). The updated MRC framework (ref) suggests 
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different ways to assess a complex intervention such as CR and it is possible that a 
comparative study looking at the recovery of individuals by troponin levels using both 
quantitative and qualitative measures could provide useful information that would 
guide service provision. 
Recommendations: Further research studies on the experiences of individuals with 
ACSLT are needed to expand the existing body of knowledge on CR and to ensure 
that CR services are responsive to the needs of their clients.  
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undertaken as part of a Doctorate in Nursing at the University of Stirling. 
Professional support was given by the Managed Clinical Network for CHD, the 
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Key Point sentences: 
 Cardiac rehabilitation is now a cornerstone in the recovery process for 
individuals following a cardiac event 
 Levels of anxiety and depression have been noted in patients with ACSLT 
similar to those found in  patients with MI 
 family, health, followed by social activities are the key domains  of QoLfound 
in this study 
 ACSLT is now classified as MI 
 the evidence base for CR based on trials conducted on MI populations prior to 
the reclassification of MI cannot be applied to ACSLT without some 
reservations 
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 Further research studies on the experiences of individuals with ACSLT are 
needed 
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Table 1  CR  interventions in the intervention group 
Participant 
code/Intervention group 
21
9 
22
0 
22
2 
22
3 
22
4 
22
5 
10
6 
10
7 
10
8 
10
9 
11
0 
Education (nurse)            
Risk factor 
management (nurse) 
           
Exercise advice 
(physio)  
           
Medication 
advice(nurse/pharmaci
st) 
           
Healthy eating 
(nurse/dietician) 
           
Specialist smoking 
cessation advice  
           
Outpatient programme 
or Home programme (i) 
   1/2    1/2    
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Table 2 Baseline demographic factors on admission 
 Study groups Overall total 
 Control group  Intervention 
group 
 tota
l 
s
ig 
 % cou
nt 
% coun
t 
% Co
unt 
 
Gender 
M 78.5 11 63.6 7 7
2 
18 n
s F 
 
21.5 3 36.4 4 2
8 
7  
Age group 
<50 7.1 1 27.2 3 1
6 
4 n
s 
50-59 42.8 6 36.4 4 4
0 
10  
60-69 28.5 4 18.2 2 2
4 
6  
70-79 7.1 1 9.1 1 8 2  
>79 14.2 2 9.1 1 1
2 
3  
Mean age   61.7  57.2  59.
7 
 
Marital status 
Living alone  21.4 3 9.1 1 1
6 
4 n
s Married/with partner  78.6 11 91 10 8
4 
21  
Employment status 
Working  28.6 4 45.4 5 3
6 
9 n
s 
On Sick  35.7 5 9.2 1 2
4 
6  
Retired 35.7 5 45.4 5 4
0 
10  
Depcat class 
1-2 
3-4 
5-6 
14.3 2 18.2 2 1
6 
4 n
s 3-4 28.6 4 27.3 3 2
8 
7  
5-6 57.1 8 54.5 6 5
6 
14  
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Figure 1  Flow chart of withdrawals 
 
Entry to Study (n=33) 
 
Allocated to 
control (n=22) 
 
Allocated to 
Intervention (n=11) 
T2 (n=21) 
Withdrawn T2 
Health problems (1c 2int)  
T2 (n=9) 
Missed (n=6) 
Completed 
assessments 
T3  (n=8)+3  
from control  
Completed 
assessments 
T3 (n=17)-3  
to intervention 
Withdrawn 
Failed to respond (3c) 
Died (1c 1int) 
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Figure 2: Change in anxiety scores 
 
  Table 3     Depression Scores by category  at T1 and T3 
 
 control intervention 
 T1  T3  T1  T3  
 
score        
% cou
nt 
% cou
nt 
% cou
nt 
% cou
nt 
0<7 57 8 57 8 82 9 91 10 
7-10 14 2 21.5 3 18 2 0 0 
>10 29 4 21.5 3 0 0 9 1 
 
 
-8 -6 -4 -2 0 2 4 6 
1 
3 
5 
7 
9 
11 
13 
15 
17 
19 
21 
23 
25 
Change in anxiety score  from T1 to T3  
Tendency to 
benefit 
Participants  
1-14=control 
15-25=intervention 
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Figure 3 
 
  
-4 
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0 
2 
4 
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10 
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Mental health 
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change in SF36v2 scores between T1 
and T3  
control 
treatment 
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A4.2 Guidelines for submission 
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Appendix  Five Protocols  
A5.1 In-Hospital Education programme 
 A full explanation of the structure of the heart and the process that causes 
Acute Coronary Syndrome  
 Risk Factors associated with CHD 
Topics such as smoking cessation, diet, lack of exercise, hypertension and 
diabetes will be discussed if appropriate.   
 Assessment of Psychological functioning should take place using the Hospital 
Anxiety and Depression scale  
 Return to Normal 
The patient and their spouse will be advised about topics such as  
Mobility 
Managing chest pain 
Return to work 
Marital relations Drugs 
Driving 
Resuming hobbies 
Sexual activity 
Discharge planning 
At this time it is important to recognise any issues that might impede the return to 
normal of the client and their family and referrals are often made to other agencies.  
This includes  
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 Fitness assessment by the physiotherapist/occupational therapist  
 Information on drugs by pharmacist  
 Home help referral to Social Work if appropriate  
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A5.2 Guidelines for psychological assessment 
 
1. All patients prior to discharge should be assessed using the Hospital Anxiety 
and Depression scale.   This will provide baseline data for future assessment.  
2. All patients should be assessed at four weeks as part of the routine review. 
3. Any patient with a score greater than 10 should be discussed with the acute 
rehabilitation  team and General Practitioner with regards to future 
management. 
4. Any patient with a score of greater than 7 should be reassessed within a 
fortnight and if the score remains higher than 7 should be discussed with the 
acute rehabilitation team and  General Practitioner with regards to future 
management. 
5. All patients should have a final assessment prior to discharge from the 
programme. 
6.    The HAD scale is only suitable for use with individuals with no prior history of 
Psychiatric illness. 
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A5.3 Staff standards for phase three Cardiac Rehabilitation  
 
1. All staff involved with cardiac patients should have Basic Life Support 
Training. 
 
2. B.L.S. training should be updated annually. 
 
3. At least one member of staff should be trained in A.L.S., able to recognise 
V.F. and defibrillate. 
 
4. Procedures for cardiac arrest should be rehearsed and recorded. 
 
5. CPR training should be offered to patient’s spouses and families. 
 
6. Staff should keep a personal development log to record relevant ongoing 
learning. 
 
 
 
 
 
 
Based on ‘Cardiac Rehabilitation – Guidelines and Standards, D.R. Thomson, G.S. 
Bowman, A. Hopkins et al © 1997 Royal College of Physicians, London.  
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A5.4 Phase three exercise class standards 
Aims 
 To increase patients knowledge about the benefits of exercise. 
 To enable patients to exercise symptom free/manage their own symptoms. 
 To enable patients to exercise within their own personal limits, safely using any 
equipment. 
Staffing 
 Two Cardiac Rehabilitation professionals present at all times during exercise. 
 Aim towards a staff: patient ratio of 1: 5 as recommended by B.A.C.R. 
 All new patients have a named member of staff to work with them on their first 
day. 
Classes 
 Are offered twice weekly at two different sites (Ayrshire Central Hospital and 
Crosshouse) for equity of local access. 
 The class should consist of a low impact aerobic warm up lasting around 15 
minutes and including major muscle group stretches. 
 This should be followed by a 20 minute conditioning phase – circuit training. 
 Patients work up to a target heart rate that is individually set and self monitor 
using the Borg Scale of Exertion. 
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 This is followed by a cool down – low intensity activities and muscle stretching of 
10 minutes duration. 
 Relaxation. 
 Individuals record their attendance and pulse response to exercise at every class. 
 Patient documents are reviewed monthly for pulse aberrations by the 
physiotherapist, those patients with problems are then reviewed individually.  
 Patients normally can attend for three months. 
 Patients are discharged with the option of attending a Phase IV maintenance 
class if this is appropriate. 
The patients G.P. is notified of attendance and any other relevant information.  
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A5.5  Phase three entry standards – exercise programme 
AIM 
Screening and risk stratification of patient’s prior to recruitment to the exercise 
component of phase III cardiac rehabilitation. 
 All patients should have a signed consent form/letter from their cardiologist, 
G.P. or surgeon. 
 All patients will be assessed by the physiotherapist prior to entry to the class. 
 Phase III exclusion criteria – see attached sheet. 
 All patients should be given at date for starting class at the six week review 
clinic. 
 All patients should receive written information preparing them for entry into 
class prior to assessment – see attached sheet. 
Monitoring – Possible through documentation audit. 
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A5.6 Phase three physiotherapy assessment standard 
 
Aim: To identify problems that may influence participation in the class. 
Assessment should be written and include  
Subjectively: 
Presenting condition and investigations 
Social history 
Drug history 
Past medical history – specifically:  Asthma/Epilepsy/ Diabetes 
            Joint Problems/Depression 
Objectively:   Heart rate/Blood pressure 
       ETT result  
       Echocardiogram result  
       Angina/Orthopnea 
       Palpitations/ Ankle Swelling        
                                     Dizziness 
                                    BMI (if appropriate) 
       HAD scale (if appropriate) 
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1. All patients should be taught how to monitor their pulse with written advice 
available. 
2. All patients should be familiarised with the Borg Scale. 
3. Patients should be given individual advice on any co-morbidity problem that 
may affect them exercising. 
4. All patients should be familiarised with fire exits, changing and toilet facilities.  
5. All patient should be familiarised with documentation, clothing. 
6. Induction also includes: 
Monitoring during exercise 
The importance of advising staff on changes in symptoms and medication 
Advice re eating prior to class if necessary 
 
Based on CSP Standards for Phase III Cardiac Rehabilitation.  June 1999.   
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A5.7 Exclusion criteria phase three 
 
1. Acute pericarditis, myocarditis. 
2. Exercise induced ventricular arrhythmia’s. 
3. Aortic Stenosis. 
4. Acute Febrile illness/viral infection. 
5. Uncontrolled resting hypertension >  200/100 mmHg. 
6. Severe Cardiomyopathy. 
7. Some psychiatric disorders. 
8. Thrombophlebitis – if requiring active treatment. 
9. Aortic aneurysm. 
10. Recent pulmonary embolus. 
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A5.8 Health & safety 
 
1. There are a minimum of two C.R. health-care professionals present at all 
times during exercise. 
2. The recommended ratio of staff : patients is 1 : 5. 
3. All patients are observed during the exercise session. 
4. No patient should leave class complaining of any cardiac symptoms. 
5. There is a clear emergency protocol. 
6. All classes are within close proximity to a telephone and to resuscitation 
equipment. 
7. All resuscitation equipment is checked weekly. 
8. All exercise equipment is checked annually. 
9. The temperature should ideally be 65 - 72°. 
10. Drinking water is always available. 
 
 
 
 
Based on CSP Guidelines for Cardiac Rehab Phase III, Published Jan 2000.  
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A5.9  Phase three emergency protocols 
 
1. Each class should be attended by a minimum of two members of staff, one 
of which should possess an A.L.S. qualifications, all others B.L.S. (annually 
updated). 
2. A defibrillator and emergency trolley and telephone should be situated in 
the immediate vicinity of the class. 
3. Emergency equipment should be checked weekly. 
4. Cardiac class staff should rehearse and record an arrest situation. 
5. Any acute coronary incident should be reported to  
i) cardiac rehab officer 
ii) clinical services manager 
iii) relevant cardiologist 
        within one working day and the local R.T.O. within five worki ng days. 
6. All staff should be debriefed within five working days. 
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Phase three roles in an arrest scenario 
 
Aim 
To act quickly and safely in treating casualty while keeping other patients calm and 
clear of causing an obstruction. 
Person 1 (C.R. Nurse) 
 Stays with patient assessing and treating as appropriate. 
 
Person 2 (C.R. Physio) 
 Bring defibrillator 
 Bring emergency trolley 
 Make crash call (3333 Crosshouse, 2222 Ayrshire Central Hospital)  
 Call ambulance ( (9)999)) 
 Return to assist with patient. 
 
Person 3 (Physio Assistant) 
 Clear room of all unaffected patients 
 Return to casualty if required 
 Keep unaffected patients calm 
 Direct crash team/paramedics to casualty. 
 
